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« […] occorre diffidare del quasi-uguale, 
[…] del praticamente identico, del pressapoco, 
dell’oppure, di tutti i surrogati e di tutti i rappezzi. 
Le differenze possono essere piccole, ma portare 
a conseguenze radicalmente diverse, 
come gli aghi degli scambi; 
il mestiere del chimico consiste in buona parte 
nel guardarsi da queste differenze, nel conoscerle 
da vicino, nel prevenirne gli effetti.  
Non solo il mestiere del chimico. » 
 
Primo Levi, in Il sistema periodico, Einaudi Editore, 1975, pag. 63 
 
« […] one must distrust the almost-the-same, 
[…] the practically identical, the approximate,  
the or-even, all surrogates, and all patchwork.  
The differences can be small, but they can lead  
to radically different consequences,  
like a railroad’s switch points;  
the chemist’s trade consists in good part 
 in being aware of these differences, knowing them  
close up, and foreseeing their effects. 
And not only the chemist’s trade. » 
 
Primo Levi, in The Periodic Table, translation from Raymond Rosenthal, Schocken Books, 1984, pag. 63 
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Résumé 
L’usage des nanoparticules (NPs) remonte à très longtemps dans l’histoire et 
les preuves de l’exploitation des propriétés optiques uniques des nanoparticules 
dans des objets antiques ont déjà été avancées dans la célèbre 
coupe de Lycurgue, conçue au 4ème siècle après J.-C.[1]. Cependant, le 
phénomène restait inexpliqué jusqu’à ce que le développement de la physique 
quantique clarifie la raison pour laquelle les propriétés des matériaux changent 
de façon aussi spectaculaire lorsque nous descendons à l’échelle nanométrique. 
Quand un objet est réduit à des dimensions nanométriques, nombreuses sont les 
propriétés qui changent par rapport à l’échelle macroscopique. Par exemple, 
dans le cas des « quantums dots » (points quantiques), apparaît le phénomène 
de fluorescence ou dans le cas des matériaux magnétiques, le phénomène de 
superparamagnétisme apparaît en dessous d’une taille critique. En 1960, 
Richard Feynman fut l’un des premiers à prédire le grand potentiel des 
nanosciences[2]. Il est inouï de constater qu’après plus de 50 ans, le 
“nanomonde” représente encore autant d’opportunités, que les nanosciences et 
la nanotechnologie représentent encore un domaine riche et encore à explorer. 
Les nanoparticules sont utilisées pour de nombreuses applications[3] allant de 
l’électronique à l’optoélectronique, et des senseurs à la médecine[4-5]. En 
particulier, la possibilité de concevoir et d’ajuster la taille, la fonctionnalisation 
et les propriétés des nanoparticules suscite de plus en plus l’intérêt dans le 
domaine de la nanomédecine[4, 6-9], à la fois pour l’imagerie in vitro et in vivo [9-
10], mais également pour l’administration de médicaments[11]. La Figure 1 
résume schématiquement les applications des nanoparticules en médecine. 
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Figure 1. Applications les plus courantes des nanoparticules en médecine  
 
En ce qui concerne l’imagerie, et en particulier pour la visualisation in vivo des 
organes et des tissus, il est important d’augmenter le plus possible la résolution, 
et récemment, l’imagerie multimodale, c’est-à-dire la combinaison de plusieurs 
techniques d’imagerie sur la même sonde[12], a démontré d’intéressantes 
potentialités. En particulier, la combinaison de la tomographie par émission de 
positrons (PET), de l’imagerie optique et/ou de l’imagerie par résonance 
magnétique (IRM), a donné des résultats prometteurs dans la direction du 
régime de résolution submicronique. Pour ce concept, de nombreuses sondes 
multimodales ont été conçues en utilisant des systèmes dendritiques[13-15] où de 
grosses molécules dotées de différentes fonctionnalités. Mais la synthèse est 
souvent complexe et la purification est extrêmement difficile. Une voie 
alternative, qui peut offrir plusieurs avantages, est de développer des plates-
formes appropriées pour l'ancrage des différentes fonctionnalités nécessaires 
pour l'imagerie multimodale et, dans le même temps, assez petites pour être 
transportées et éliminées dans les organismes vivants. Les NPs, avec leur 
rapport surface/volume élevé et plusieurs de possibilités de fonctionnalisation, 
ont attiré l’attention dans ce domaine[16-18]. Les NPs permettent de combiner les 
propriétés du cœur[19], telles que magnétisme ou photoluminescence, avec 
celles provenant de groupements fonctionnels qui peuvent être attachés à leur 
surface (par exemple des radiomarqueurs ou des agents ciblants). Bien que 
l’usage des nanoparticules soit très étendu, leur toxicité et leur accumulation 
dans les organes limite encore leurs applications in vivo[20-21]. En outre, parmi 
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les nanoparticules, beaucoup ne sont pas fonctionnalisées par liaison covalente, 
causant ainsi une éventuelle instabilité du système final in vivo[22]. Une autre 
question à considérer pour des applications in vivo est la capacité de passer à 
travers les barrières qui protègent certains organes, tels que la barrière hémato-
encéphalique, qui doit être franchie afin de cibler les tumeurs cérébrales[23-24]. 
En fait, seuls les très petits objets correctement fonctionnalisés peuvent franchir 
cette barrière naturelle, et cela est l'une des raisons pour stimuler la recherche 
vers les NPs de très petite taille (<5 nm)[19]. 
La thèse s’attaque à certaines de ces problématiques en préparant, caractérisant, 
fonctionnalisant et étudiant différents types de nanoparticules de très petite 
taille (NPs de silicium : Si NPs ; « carbon dots » : CQDs ; NPs de cobalt 
couvertes de silice : Co@SiO2 NPs) dans le but final de proposer des sondes 
innovantes qui peuvent être utilisées, par exemple, dans l’imagerie multimodale 
et qui peuvent être facilement excrétées du corps. Quelques systèmes ont 
également été testés in vitro et in vivo. 
Figure 2. Représentation schématique d’une sonde multimodale. Dans cette étude, le 
cœur peut être une nanoparticule de silicium, de cobalt ou de carbone. 
 
Comme on peut le constater sur la Figure 2, l’idée est de concevoir une sonde 
composée d’un cœur de très petite taille, dans notre cas à base de silicium, de 
cobalt ou de carbone, portant des groupes fonctionnels tels que des complexes 
radioactifs, des colorants ou/et des agents ciblants. Grâce aux différentes 
propriétés du cœur (luminescence pour les Si NPs et les CQDs, ou magnétisme 
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pour les Co@SiO2 NPs) et aux groupes fonctionnels à la surface, on peut 
obtenir une sonde d’imagerie multimodale, soit pour la tomographie par 
émission de positrons, l’imagerie optique et/ou l’imagerie par résonance 
magnétique. Un point commun entre toutes les NPs étudiées, est la possibilité 
de fonctionnalisation à travers des liaisons covalentes. Les caractéristiques 
spécifiques des NPs sélectionnées sont mentionnées ci-dessous. 
Les Si NPs offrent de nombreux avantages liés à : i) leur biocompatibilité, 
biodégradabilité et non-toxicité[25-28]; ii) leurs propriétés de photoluminescence 
qui sont fortement dépendantes à la fois des effets de fonctionnalisation de la 
surface et de confinement quantique[29]; iii) une excellente stabilité 
photophysique et chimique; iv) la possibilité de fonctionnaliser leur surface 
d'une manière covalente par des liaisons stables Si-C. 
Les CQDs sont biocompatibles[30-31], ils montrent une luminescence 
multicolore, dépendant à la fois des effets de confinement quantique et de 
fonctionnalisation de la surface. Ils possèdent également une stabilité 
photophysique et chimique élevées et sont préparés par synthèse très 
facilement. En outre, en raison des nombreuses similitudes, il est très 
intéressant de comparer le comportement in vivo des CQDs et des Si NPs. 
Enfin, l'intérêt pour les nanoparticules de cobalt est principalement dû à leurs 
propriétés magnétiques. En effet, les Co NPs possèdent des valeurs de 
saturation de magnétisation plus élevées que celles composées d'oxydes 
métalliques comme l'oxyde de fer ou les ferrites[32]. Cette propriété permettrait 
d'introduire dans le corps une plus petite quantité de NPs, tout en conservant 
une réponse magnétique similaire, et donne des attentes prometteuses pour une 
utilisation future en IRM. De plus, tel que rapporté sur les NPs magnétiques[32-
34], les Co NPs ultrapetites peuvent avoir un comportement 
superparamagnétique[33, 35-36]. Cependant, la toxicité rapportée[37] de Co NPs 
doit être surmontée, au moyen d'une enveloppe protectrice[38-41], avant de les 
utiliser in vivo. Pour cette raison, nous nous sommes concentrés sur la 
préparation d'une coquille mince de silice autour du cœur de cobalt, également 
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utile pour l'exploitation de la chimie de surface de la silice pour plus de 
fonctionnalisations de surface. 
Après une introduction sur l'état de l'art sur les NPs de l'intérêt pour ce travail, 
la première partie de la thèse est consacrée aux Si NPs de très petite taille. 
La préparation de Si NPs ultra-petites avec dispersion de taille étroite est 
toujours une tâche difficile, et en particulier la purification est difficile, avec un 
manque de méthodologies bien établies et claires. Les Si NPs peuvent être 
obtenues par des procédés chimiques ou physiques, impliquant soit des 
approches dites « bottom-up » ou « top-down ». Ici, nous nous sommes 
intéressés à des techniques « bottom-up » car le contrôle de la taille et de la 
terminaison à la surface des particules est beaucoup plus élevé avec ces 
méthodes. 
Pour étudier les propriétés des nanoparticules de silicium, nous avons décidé de 
ne sélectionner qu’un type de fonctionnalisation (amine-terminaison) mais pour 
la synthèse des particules nous avons utilisé plusieurs approches afin de 
comprendre l’influence de la méthode de synthèse sur la taille, la luminescence, 
la structure, la composition et les effets biologiques. La terminaison amine a été 
choisie car notre but est d’obtenir des particules solubles dans l’eau et qui 
peuvent être facilement liés à d’autres molécules. Comme nous allons le 
constater, les groupements amines sont particulièrement indiqués dans ce but. 
Les méthodes « bottom-up » discutées dans la thèse sont les méthodes de 
microémulsion et hydrothermale, toutes deux basées sur la réduction d’une 
source de silicium. Les techniques ont été optimisées pour obtenir de très 
petites NPs (de taille inférieure à 5 nm) avec une fonctionnalisation amine à la 
surface (amine-terminées Si NPs). Elles ont été caractérisées par plusieurs 
techniques, telles que la spectroscopie infrarouge (ATR/FTIR), la microscopie 
électronique en transmission à haute résolution (HR-TEM), la spectroscopie à 
rayons X à dispersion d'énergie (EDX), la spectroscopie photoélectronique aux 
rayons-X (XPS), l’analyse thermogravimétrique (TGA) et des mesures 
photophysiques. Une comparaison entre les propriétés des NPs obtenues par les 
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deux techniques a ensuite été effectuée afin d'étudier d'éventuelles différences, 
surtout de comportement dans l’imagerie in vivo. 
Dans la méthode de microémulsion, les nanoparticules de silicium ont été 
préparées en utilisant une modification d’une méthode reportée[42-44] basée sur 
la réduction de tetramethoxysilane ou de tetrachlorosilane avec de l’hydrure de 
lithium et d’aluminium (LiAlH4) et sur la réaction ultérieure (hydrosilylation) 
des nanoparticules obtenues (portantes la terminaison Si-H), avec de 
l’allylamine en présence du catalyseur H2PtCl6. La méthode de microémulsion 
est également appelée méthode de réduction en micelles inverses parce que la 
réaction a lieu dans des micelles de surfactant (tetraoctylammonium bromide, 
TOAB) qui nous permettent de contrôler la taille des NPs. Avec cette méthode, 
nous avons obtenu des nanoparticules très petites (environ 2 nm) avec la 
terminaison amine. Le schéma général de la méthode de microémulsion est 
présenté dans la Figure 3. 
 
 
 
Figure 3. Méthode de synthèse, par réduction en micelles inverses, des Si NPs avec 
terminaison amine. 
 
La purification a été une étape cruciale du travail. Enlever l’excès des réactifs 
et de surfactant après la synthèse, est très difficile parce que les NPs peuvent 
être facilement perdues au cours des étapes de purification conduisant à une 
diminution drastique du rendement global. Nous avons essayé plusieurs 
méthodes parmi lesquelles la dialyse et l’ultracentrifugation en gradient de 
densité, mais la chromatographie d’exclusion stérique fut la meilleure 
technique pour obtenir des Si NPs pures. 
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La Figure 4 présente des images HR-TEM montrant que les amine-terminées Si 
NPs obtenues avec la méthode de microémulsion sont très petites, avec une 
distribution de taille étroite (taille moyenne : 2,5 ± 0,6 nm). De plus, dans le 
micrographe TEM reporté en Figure 4a, il est possible de voir le réseau 
cristallin du silicium. La distance entre deux franges est 0,2 nm ce qui coïncide 
avec la distance interplanaire des plans (220) du silicium cristallin. 
 
 
 
    
 
 
 
 
 
 
 
 
Figure 4. Images HR-TEM de Si NPs fonctionnalisées par un groupement amine, 
obtenues par la méthode de microémulsion ; a) nanoparticule isolée montrant les 
franges du réseau, caractéristiques des nanocristaux de silicium. 
 
Le spectre d’absorption et d’émission dans l’eau (Figure 5a) montrent une 
émission dans la région du bleu du spectre électromagnétique. Selon le débat 
dans la littérature, cela est dû à un effet de taille ou de fonctionnalisation de la 
surface[29, 45-46]. Les photographies dans la Figure 5a montrent que la solution 
est transparente et jaune pâle sous la lumière ambiante et bleue sous irradiation 
UV. Si les spectres d'émission sont mesurés à différentes longueurs d'onde 
d'excitation, il est évident (Figure 5b) que le maximum d'émission est décalé 
vers le rouge lorsque l'on augmente la longueur d'onde d'excitation. Ce 
phénomène peut être lié à un « direct bandgap-like » comportement qui est 
induit par la présence des liaisons Si-C sur la surface des NPs[47]. Le rendement 
a 
b 
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quantique de photoluminescence (PLQY) est d'environ 2% à toutes les 
longueurs d'ondes d'excitation et, généralement, les durées de vie de 
luminescence peuvent être ajustées avec une décroissance tri-exponentielle en 
accord avec les résultats rapportés pour systèmes similaires[44, 48]. 
 
Figure 5. a) Spectres d’absorption (bleu) et d'émission (rouge), dans l'eau, des 
nanoparticules de silicium (méthode de microémulsion) avec une terminaison amine 
(λexc = 300 nm; filtre 350 nm); encadré: photos de la solution dans des conditions 
ambiantes (à gauche) et sous irradiation UV (à droite); b) spectres d'émission à 
différentes longueurs d'ondes d'excitation de les mêmes Si NPs (les longueurs d'ondes 
d'excitation sont rapportées, en nm, en haut à droite) 
 
Concernant la synthèse hydrothermale, les nanoparticules de silicium avec une 
terminaison amine ont été préparées selon la modification d’une méthode[49] 
basée sur le chauffage dans l’eau de (3-Aminopropyl)trimethoxysilane en 
présence de citrate de trisodium. Le procédé décrit dans la littérature est basé 
sur le chauffage par irradiation aux micro-ondes (15 min.), mais ici nous 
démontrons que, avec une durée de réaction plus longue (5 heures), les 
particules peuvent également être préparées dans un four conventionnel. 
L’avantage du chauffage conventionnel est la possibilité d’un écaillage facile à 
l’échelle industrielle. À l'échelle du laboratoire, chaque réaction peut produire 
jusqu'à 400 mg de Si NPs. Un schéma synthétique général pour cette méthode 
est reporté en figure 6. 
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Figure 6. Approche synthétique pour la synthèse hydrothermale des nanoparticules de 
silicium terminées par un groupement amine; [APTMS = (3-
aminopropyl)trimethoxysilane; citrate = Trisodium 2-hydroxypropane-1,2,3-
tricarboxylate] 
 
Les particules obtenues ont une taille légèrement plus grande (environ 4 nm) 
que celles obtenues par méthode de microémulsion. La synthèse donne moins 
d’impuretés car il y a seulement deux réactifs de départ, la purification est donc 
plus facile et la dialyse peut être utilisée. Cependant, les Si NPs faits par cette 
méthode contiennent une plus grande quantité de silicium oxydé par rapport à 
la méthode de microémulsion. Dans la Figure 7, les images typiques HR-TEM 
des Si NPs à terminaison amine, obtenus par la méthode hydrothermale, sont 
représentés (taille moyenne de 4,3 ± 1,3 nm). En outre, sur la Figure 7b, on 
peut voir le réseau cristallin de silicium. La distance entre les franges est de 0,2 
nm, comme pour la technique de microémulsion, ce qui est une valeur 
caractéristique de la distance entre les plans (220) de silicium cristallin. 
Figure 7. a) Images HR-TEM des Si NPs avec une terminaison amine obtenues par 
synthèse hydrothermale ; b) une nanoparticule montrant les franges cristallines du 
silicium. 
a b 
xiv 
 
Des spectres caractéristiques UV-vis et d’émission dans l’eau (Figure 8a) 
montrent que les particules émettent aussi dans la région du bleu lorsqu’elles 
sont préparées par la méthode hydrothermale. Dans ce cas également, si les 
spectres d'émission sont mesurés à différentes longueurs d'onde d'excitation, le 
maximum d'émission est décalé vers le rouge lorsque l'on augmente la longueur 
d'onde d'excitation (Figure 8b). Ce phénomène est moins prononcé qu’avec la 
méthode de microémulsion, ce qui peut être expliqué par des différences de 
composition superficielle entre les deux types des NPs, selon le débat dans la 
littérature[29, 47]. Le rendement quantique de photoluminescence des Si NPs 
préparés par méthode hydrothermale dépend de la longueur d'onde d'excitation 
et il peut être plus élevé (avec une valeur maximale de 13%) que celui des NPs 
préparé par le procédé de microémulsion. Les durées de vie de luminescence 
peuvent être ajustées avec une décroissance tri-exponentielle, comme rapporté 
dans la littérature[44].  
 
 
Figure 8. a) Spectres d’absorption (bleu) et d'émission (rouge) des Si NPs avec une 
terminaison amine (méthode hydrothermale) dans l'eau (λexc = 355 nm) ; b) spectres 
d'émission à différentes longueurs d'ondes d'excitation de les mêmes Si NPs (les 
longueurs d'ondes d'excitation sont rapportées, en nm, en haut à droite) 
 
Les particules préparées par ces deux méthodes ont été comparées également 
en termes de composition, de degré de fonctionnalisation et de stabilité de 
luminescence dans le temps. A partir des données XPS et IR, il en résulte que 
les NPs obtenues par procédé hydrothermale contient une teneur légèrement 
plus élevée de liaisons Si-O. A partir des données XPS et TGA, il était 
a b 
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également possible d'estimer pour les deux types de particules que la quantité 
de groupes amine par particule est de l’ordre de quelques centaines. 
Afin de tester la stabilité à long terme de la photoluminescence des particules 
préparées par les deux méthodes, des mesures d'émissions ont été répétées 
après 18 semaines de stockage à l’abri de la lumière. Les deux types des NPs 
montrent une diminution de l'intensité d'émission. Cependant, alors que pour 
les NPs préparées par microémulsion, l'intensité d'émission devient environ 
60% de la valeur initiale, dans le cas de la synthèse hydrothermale, il descend à 
environ 10% de la valeur initiale.  
Une fois les propriétés comparées, les deux types des Si NPs avec terminaison 
amine ont été testés in vitro en utilisant des lignées de cellules A549 (cellules 
cancéreuses du poumon). Les NPs montrent une faible toxicité dans la gamme 
de concentrations généralement utilisés pour des tests in vivo (1-10 µg/mL), 
mais celles faites par synthèse hydrothermale montrent une viabilité cellulaire 
très élevée même lorsque des concentrations allant jusqu'à 1 mg/mL sont 
utilisées. 
En conclusion, les deux méthodes conduisent avec succès à la formation des Si 
NPs de très petite taille à terminaison amine. Avec la méthode de 
microémulsion, des particules moins oxydées, plus petites (taille moyenne : 2,5 
nm) et avec une stabilité d'émission plus élevée dans le temps peuvent être 
obtenues. D'autre part, la méthode hydrothermale permet d'obtenir des 
nanoparticules légèrement plus grosses (taille moyenne de 4,3 nm) dans de plus 
grandes quantités avec une biocompatibilité supérieure. 
Le deuxième type de NPs étudiées, afin de comparer leur comportement in vivo 
avec les Si NPs, sont les CQDs. Ils ont été préparés par traitement par micro-
ondes d'une solution aqueuse de chlorhydrate de L-arginine (2M) et 
d'éthylènediamine (2M)[51]. Dans la littérature, les CQDs sont décrits sous 
forme de particules quasi-sphériques ou des structures nanométriques plates de 
graphène avec plusieurs multifunctionalités sur la surface[30, 52-53]. La méthode 
synthétique utilisée dans ce travail est connue pour entraîner une surface riche 
en groupements amines, carboxyliques et hydroxyles, qui contribuent de 
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différentes manières, selon les discussions dans la littérature, à la luminescence 
des CQDs. La Figure 9a rapporte une image typique HR-TEM, montrant la 
présence de nanoparticules avec une taille moyenne d’environ 3 nm. 
Comme représenté sur la microphotographie à grossissement élevé d'une seule 
particule, rapportée dans l’encadré, ces CQDs sont cristallins avec une distance 
interplanaire de 2,1 Å, conformément à l'espacement indiqué dans le 
graphène[50] et le plan basal (0001) de la graphite[51].  
 
Figure 9. a) Images HR-TEM de CQDs; l'encadré montre une image à grossissement 
élevé d'une seule particule ; b) spectres d'émission de CQDs dans l'éthanol à 
différentes longueurs d'onde d'excitation (les longueurs d'ondes d'excitation sont 
rapportées en haut à droite). 
 
Sur la Figure 9b, les spectres d'émission obtenus dans l'éthanol à différentes 
longueurs d'onde d'excitation sont rapportés, montrant que les propriétés de 
photoluminescence dépendent de la longueur d’onde d’excitation comme cela 
est indiqué généralement dans les données de la littérature[30, 51, 54-56]. Le PLQY 
pour les CQDs dans l’éthanol est de 7-8% à toutes les longueurs d'onde 
d'excitation utilisées et la durée de vie est ajustée avec une décroissance bi-
exponentielle, ce qui est également rapporté pour des nanoparticules 
similaires[57]. 
Les Si NPs et CQDs ont été, ensuite, étudiés in vivo et leur comportement a été 
comparé. Avant les expériences de bio-imagerie, les Si NPs et les CQDs ont été 
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fonctionnalisés avec un seul type de marqueur (soit un colorant ou un 
radiotraceur), mais il sera montré que les résultats obtenus sont prometteurs 
pour une future sonde avec des multifunctionalités sur la même particule. Les 
Si NPs avec terminaison amine et les CQDs ont été fonctionnalisés avec le 
colorant cyanine 5 ou avec des complexes de 64Cu. La raison pour 
fonctionnaliser les NPs avec le colorant cyanine est d’obtenir d'émission dans 
la région spectrale du rouge lointain, utile pour effectuer imagerie optique in 
vivo. En effet la radiation rouge est plus pénétrante dans les tissus et, par 
conséquent, elle peut être détectée même lorsque les particules atteignent les 
organes internes tels que le foie, les poumons et les reins. Le complexe de 64Cu 
permet de réaliser la tomographie par émission de positrons en raison des 
propriétés de désintégration radioactive de l'isotope de cuivre. 64Cu a une 
demi-vie d'environ 12 heures et, en certain pourcentage, il se désintègre en 64Ni 
par émission des positrons. Cette émission est utilisée comme un marqueur en 
médecine nucléaire. Les [Cy5 couplées-] et [64Cu complexe couplées-] NPs ont 
été caractérisées montrant que leur taille est encore très petite et la cytotoxicité 
a été évaluée in vitro, confirmant leur biocompatibilité. Par conséquent, des 
expériences d'imagerie optique et de PET in vivo ont été effectuées. Dans les 
expériences d'imagerie optique, les Si NPs couplées avec la sulfo-cyanine 5 (s-
Cy5-Si NPs) ont été injectés, à travers la veine de la queue, dans NMRI nu/nu 
souris femelles. A partir des images en Figure 10, il est clair que, 50 minutes 
après l’injection, la plupart des particules est dans la vessie. 
 
Figure 10. Images optiques de NMRI nu/nu souris à 0, 5, 20, 50 minutes après 
l'injection de s-Cy5-Si NPs ; le point lumineux sur la partie supérieure de chaque 
image est une solution de s-Cy5-Si NPs avec la même concentration que la solution 
injectée. 
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Des expériences de biodistribution ont montré que, bien que certaines des 
nanoparticules s’accumulent dans l'intestin, elles sont très prometteuses pour 
une future sonde multimodale, puisque la majorité des NPs est déjà excrétée à 
50 minutes après l'injection. Dans des expériences d'imagerie PET in vivo, les 
deux types de Si NPs ont été comparés entre eux et par rapport aux CQDs. 
Comme on peut le voir sur la Figure 11, les Si NPs préparées par la méthode 
hydrothermale et marquées avec le complexe de 64Cu [64Cu-NOTA-Si NPs 
(hydro)] sont toutes dans la vessie 50 minutes après l'injection. Les Si NPs 
préparées par microémulsion et aussi marquées avec l’isotope radioactif de 
cuivre [64Cu-NOTA-Si NPs (micro)] vont également à la vessie, mais, à un 
certain pourcentage, restent dans l'intestin. Enfin, l'activité des CQDs marqués 
avec le complexe du 64Cu (64Cu-NOTA-CQDs) est principalement dans la 
vessie 50 minutes après l'injection, mais une petite quantité reste dans la 
vésicule biliaire et dans l'intestin. 
Des expériences de biodistribution ont montré que, 60 minutes post-injection, 
les CQDs sont principalement excrétés dans l'urine, mais une quantité 
appréciable est toujours présente dans le foie et dans l'intestin. Les mêmes 
études de biodistribution pour les deux types de Si NPs montrent qu'ils sont 
principalement excrétés dans l'urine, mais les [64Cu-NOTA Si NPs (micro)] 
s’accumulent également, dans un certain pourcentage, dans l'intestin comme 
déjà vu dans les images PET. Le comportement observé pour les CQDs est 
similaire à celui observé pour les 64Cu-NOTA-Si NPs préparées par 
microémulsion, mais la quantité de matière qui reste dans le corps et qui 
s’accumule dans les organes est plus élevée pour les CQDs que dans le cas des 
Si NPs. En fait, les courbes en bas de la Figure 11 montrent que tous les types 
de nanoparticules s’accumulent principalement dans la vessie pour être, par la 
suite, excrétés mais, 50 minutes après l'injection, le pourcentage de la dose 
injectée (% ID) présent dans la vessie pour les CQDs est inférieur (environ 40 
%) à celui pour les Si NPs (environ 60 %). 
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Figure 11. Images de tomographie par émission de positrons, à différents moments 
après l’injection, de NMRI nu/nu souris injectés avec 64Cu-NOTA-CQDs (en haut à 
gauche) et [64Cu-NOTA-Si NPs] faite par microémulsion (haut milieu) ou méthode 
hydrothermale (en haut à droite) ; pourcentage de la dose injectée en fonction du 
temps post-injection dans la vessie des souris injectés avec 64Cu-NOTA-CQDs, en bas 
à gauche, [64Cu-NOTA-Si NPs (micro)], au milieu, ou avec [64Cu-NOTA-Si NPs 
(hydro )], en bas à droite. 
 
Il est très intéressant de comparer les mécanismes d'excrétion, rénale et 
hépatobiliaire, pour les trois types de particules. En fait, le mécanisme 
d’excrétion rénal, c’est-à-dire par les reins et la vessie, est le plus préférable 
comme rapporté dans la littérature[20-21].  
En Figure 12, il est évident que [64Cu-NOTA Si NPs (hydro)] sont les 
matériaux les plus prometteurs entre les trois types de particules parce que ces 
NPs sont éliminées, presque entièrement, par l'excrétion rénale. [64Cu-NOTA-
Si NPs (micro)] et CQDs suivent, au contraire, tous les deux mécanismes 
d'excrétion, rénale et hépatobiliaire (c'est à dire à travers le foie et l'intestin). En 
conclusion, les trois types de NPs présentent quelques différences dans le 
64Cu-NOTA-CQDs 
 
64Cu-NOTA-Si NPs (micro) 
 
64Cu-NOTA-Si NPs (hydro) 
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comportement in vivo, mais tous sont principalement excrétés très rapidement 
de l'organisme grâce à leur très petite taille.  
 
 
Figure 12. Histogramme montrant le rapport entre le mécanisme rénal et 
hépatobiliaire d'excrétion du [64Cu-NOTA-Si NPs (hydro)] (bleu), [64Cu-NOTA-Si 
NPs (micro)] (vert) et [64Cu-NOTA-CQDs] (orange) 
 
Étant donné que le seul papier disponible[16] sur la biodistribution par PET de 
Si NPs de très petite taille (préparés par une méthode différente) rapporte 
qu'elles s'accumulent dans le foie, les résultats obtenus dans cette thèse sont 
très encourageants. En fait les deux types de Si NPs étudiées, ne montrent pas 
d'accumulation dans le foie donnant ainsi des attentes prometteuses pour une 
future application dans l'imagerie multimodale. 
Le dernier exemple de nanoparticules de très petite taille étudié dans cette 
thèse, concerne les nanoparticules de cobalt avec une coquille de silice 
(Co@SiO2 NPs). Les nanoparticules de cobalt (Co NPs) sont préparées selon 
une méthode basée sur la décomposition thermique de Co2(CO)8, en présence 
de composés alkyliques d'aluminium[58-60]. Cette technique permet de produire 
des nanoparticules de cobalt stables à l'air grâce à une étape d'oxydation douce 
ce qui crée une coquille mince d'oxyde de cobalt autour des particules, 
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empêchant une oxydation supplémentaire. Les Co NPs utilisées pour le 
revêtement de silice ont une taille moyenne de 7,3 ± 1,5 nm. Beaucoup de 
publications rapportent sur la création d'une coquille de silice autour des 
particules magnétiques[61-66], y compris sur le cobalt[38-41] ; mais seulement 
quelques-uns[67-68] rapportent sur des petites Co NPs avec une coquille très 
mince de silice. Nous avons optimisé une stratégie de synthèse à température 
ambiante pour préparer des NPs cœur/coquille de très petite taille (taille totale 
d’environ 10 nm) avec une très mince coquille de silice (environ 2 nm). 
Obtenir une coquille très mince de silice est très difficile et, parfois, nous avons 
obtenu des nanoparticules d’oxyde de silicium isolées ou des Co NPs 
encapsulés dans une matrice de silice plutôt que des particules cœur/coquille 
isolées. Après plusieurs essais, nous avons optimisé la synthèse et contrôlé la 
croissance de silice en utilisant la stratégie présentée dans la Figure 13. 
 
Figure 13. Schème de synthèse de nanoparticules de cobalt avec une coquille de 
silice. 
 
Les Co@SiO2 NPs ont été caractérisées par HR-TEM, EDX, XPS et par 
microscopie électronique en transmission filtrée en énergie (EFTEM). 
La taille moyenne des NPs est de 8,5 nm ± 1,5 nm, donc en dessous de 10 nm, 
même après revêtement avec silice. Les images HR-TEM à grossissement élevé 
et les spectres EDX confirment la présence d'une très mince coquille de silice. 
Une autre preuve de la formation de la coquille de silice autour des Co NPs 
sont les images EFTEM. En particulier, la Figure 14 rapporte une image TEM 
conventionnelle de les Co@SiO2 NPs (a) et les distributions EFTEM de cobalt 
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(b) et de l'oxygène (c). Toutes les images se rapportent à la même zone 
d'intérêt. Les distributions élémentaires sont obtenues à partir des spectres de 
perte d'énergie du faisceau d'électrons de la TEM. L’image en d) est la 
superposition des deux distributions élémentaires (cobalt en vert et oxygène en 
rouge). La superposition confirme que le cœur de cobalt est entouré par une 
peau d'oxyde de cobalt couverte par une autre coquille où l'oxygène est seul, 
c’est-à-dire la coquille de silice obtenue. Ceci est plus évident dans la Figure 
14e, où un zoom sur une particule individuelle est rapporté.  
Les Co@SiO2 NPs ont été fonctionnalisées avec des groupements amines et 
caractérisées par XPS. Quelques premières tentatives pour fonctionnaliser ces 
amine-terminées Co@SiO2 NPs avec des colorants, comme ATTO 655 et la 
rhodamine B, ont été réalisées avec succès, même si les intensités d'émission 
du système final étaient trop faibles pour réaliser des expériences in vitro. 
Néanmoins, ces résultats préliminaires montrent qu'il est possible de modifier 
la surface des Co@SiO2 NPs avec des molécules souhaitées. La 
fonctionnalisation des NPs avec des groupements amines laisse ouverte la 
possibilité de coupler les NPs avec d'autres molécules, comme par exemple des 
ligands pour des radio-isotopes, afin d’effectuer d’imagerie PET, ou des agents 
pour cibler les cellules cancéreuses. 
 
En conclusion, cette thèse montre que des NPs très petites, telles que Si NPs, 
CQDs et Co@SiO2 NPs peuvent être préparées, caractérisées et 
fonctionnalisées, par des liaisons covalentes stables, avec des colorants ou des 
radiotraceurs pour étudier leurs comportement in vitro et in vivo. 
Les NPs exhibent les propriétés attendues et, lorsqu'elles sont testées in vitro, 
elles ont montré une très faible cytotoxicité. Des résultats prometteurs ont été 
obtenus dans les expériences in vivo depuis les Si NPS et les CQDs ont été 
excrétés par le corps en temps très courts (50 minutes). 
En outre, les Si NPs, obtenues par la méthode hydrothermale, ont donné le 
meilleur résultat dans l'imagerie PET in vivo, étant excrétées 
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Co oxyde 
Co cœur 
SiO2 coquille 
Figure 14. a) Image HR-TEM de Co@SiO2 NPs ; distribution EFTEM de cobalt (b) 
et d’oxygène (c) ; superposition (d) des images (b) et (c) ; e) zoom de l’image (d) sur 
une seule particule 
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d c
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seulement 50 minutes après l'injection dans le corps et montrant aucune 
accumulation  dans les organes. 
Enfin, Co@SiO2 NPs ont été préparés avec succès et leur surface a été 
fonctionnalisée avec des groupements amine appropriés pour des subséquentes 
conjugaisons. Les couplages avec des colorants indiquent la disponibilité des 
restants groupements amine pour d’éventuels autres couplages pour une future 
application dans des sondes magnétiques multimodales.  
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Chapter 1 
Introduction 
 
Abstract 
This Chapter, after a brief introduction on nanoparticles and their applications in 
medicine, introduces the advantages and opportunities offered by ultrasmall 
(< 5 nm) nanoparticles in bioimaging with particular attention to multimodal 
imaging. The second part of the chapter gives an overview on the state-of-art on 
properties, methods of preparation, functionalization, in vitro and in vivo 
applications of ultrasmall silicon nanoparticles, carbon dots and cobalt based 
nanoparticles that will be the object of this thesis. 
 
1.1 Ultrasmall nanoparticles and their 
bioapplications 
The use of nanoparticles (NPs) has a long history and their unique optical 
properties were already exploited in ancient objects and paintings such as the 
famous Lycurgus cup, manufactured in the fourth century AD[1]. This cup 
displays different colors depending if it is irradiated from the exterior or the 
interior, being red or green depending on the direction of the incident light. This 
is due to the presence of NPs in the material composing the cup. However, the 
phenomenon remained unexplained until the development of quantum physics, 
which clarified why properties of materials change dramatically when the size 
goes down to the nanoscale. In 1960 Richard Feynman was one of the first to 
predict the great potentialities of nanoscience[2]. It is amazing to see that, after 
more than 50 years, the « nanoworld » is still full of opportunities and 
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nanoscience and nanotechnology represent a wide and rich field to explore. 
Nanoparticles are used in many applications[3] ranging from electronics, 
photonics, photovoltaics to sensing and medicine[4-5]. In particular, the possibility 
to design and tune size, functionalization and properties of NPs is attracting 
increasing interest in the field of nanomedicine[4, 6-9], both for in vitro and in vivo 
imaging[9-10] as well as  for drug delivery[11]. Figure 1.1 tries to summarize, 
schematically, the applications of nanoparticles in medicine. 
 
 
Figure 1.1. Some of the most common applications of nanoparticles in medicine 
 
For these applications several kinds of NPs can be used[12]. Actually the field is 
very broad and a comprehensive overview is difficult and beyond the scope of 
this thesis. Limiting the attention to inorganic NPs, noble metal[13] and oxide-
based ones[14] are very popular, but many other systems can be employed, 
depending on the specific application.  
Concerning imaging applications and, in particular, in vivo visualization of 
organs and tissues, an increasing resolution is desired. In this respect, the new 
frontier of diagnostics is multimodal imaging that combines several imaging 
techniques on the same probe[15]. More precisely, the combination of positron 
emission tomography (PET), optical imaging and/or magnetic resonance 
imaging (MRI) has given promising results in the direction of the submicron 
resolution regime. For this concept, many multimodal probes have been designed 
using dendritic systems[16-18] or large molecules with different functionalities. 
However, the synthesis is often complex and purification is extremely difficult. 
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An alternative route, that can offer several advantages, is that of developing small 
"platforms" suitable for the anchoring of the different functionalities needed for 
multimodal imaging and, at the same time, small enough to be transported and 
eliminated by living organisms. Nanoparticles, with their high surface area and 
easy functionalization, have indeed attracted large attention in this field[19-21]. 
NPs allow combining the properties of their core[22] (e.g., magnetism or 
photoluminescence) with those deriving from the functional groups present on 
their surface (e. g., radioactivity).  
Although the use of NPs is wide, toxicity and accumulation in organs still limit 
their in vivo applications. Also, in many cases, the functionalization does not 
occur through covalent bonds, and this can lead to a decomposition of the system 
in vivo[23]. Another issue to be considered for in vivo applications is the ability to 
pass through the barriers that protect certain organs, such as the blood-brain 
barrier (BBB) that must be crossed in order to target brain tumors[24-25]. Actually, 
only extremely small objects, properly functionalized, can cross this natural 
barrier, and this is one of the reasons for boosting research towards ultrasmall 
sized (< 5 nm) NPs[22]. For these reasons, the type of the materials and the size 
of nanoparticles are a crucial issue. Ultrasmall NPs tackle some of the issues 
discussed above since, due to their size, they have intermediate properties 
between molecules and larger particles and they possess a very large surface 
area. The great advantage offered by ultrasmall NPs is that they can be excreted 
easily from the body reducing accumulation in organs and, as mentioned before, 
they could be exploited to cross barriers in the body, e.g. the BBB. In addition, 
when shrinking the size to small and, in particular, to ultrasmall dimensions, 
many are the properties that change compared to the corresponding bulk 
materials. For example, in the case of magnetic materials, superparamagnetism 
starts to occur below a certain size and, in the case of quantum dots, fluorescence 
properties arise. Such kind of size-depending properties are very useful in order 
to achieve bioimaging of cells, tissues and organs and this is another reason why 
ultrasmall nanoparticles are very promising in the field of nanomedicine.  
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For the reasons illustrated above, i.e. the properties deriving from ultrasmall 
dimensions, the possibility to functionalize the surface via stable covalent bonds 
and also for the specific features that will be outlined in the following paragraphs, 
the aim of this thesis is the synthesis, characterization, functionalization and in 
vitro and in vivo applications of three kinds of ultrasmall nanoparticles: silicon 
NPs (Si NPs), carbon dots (CQDs) and silica coated cobalt NPs (Co@SiO2 NPs). 
They show the properties of ultrasmall NPs, but they are also characterized by a 
very stable surface functionalization since the desired groups are anchored on 
their surface by covalent Si-C or C-C bonds.  
The idea is to design innovative probes for multimodal imaging, which are non-
toxic and can be easily excreted from the body. The probe is composed of an 
ultrasmall core, in our case a silicon, carbon or silica coated cobalt based one, 
properly functionalized, e.g. with radiolabels, dyes and/or targeting agents as 
sketched in Figure 1.2. Due to the different properties of the core (luminescence 
for Si NPs and CQDs or magnetism for Co@SiO2 NPs) and the functional groups 
on the surface (for instance radioactivity), a multimodal probe, either for positron 
emission tomography, optical imaging and/or magnetic resonance imaging, can 
be obtained. If the particles are functionalized also with targeting agents, they 
could selectively reach e.g. tumour tissues in the body.  
Figure 1.2. Schematic representation of a multimodal probe. In this study, the core can 
be silicon, cobalt or carbon nanoparticles. 
The choice of the core material is dictated by different advantages we can gain 
from its specific properties, but an important feature common to all the NPs 
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investigated is that their surface can be functionalized through stable covalent 
bonds.  
The specific characteristics of the selected NPs can be outlined as follows.  
Silicon nanoparticles offer many advantages connected with: their 
biocompatibility, biodegradability and non-toxicity[26-29]; photoluminescence 
properties that are strongly dependent both from quantum confinement and 
surface functionalization effects[30]; an excellent photophysical and chemical 
stability; the possibility to functionalize their surface in a covalent way through 
stable Si-C bonds. 
Carbon dots are biocompatible[31-32], show a bright multi-coloured luminescence, 
dependent on both quantum confinement and surface functionalization effects, 
possess a high photophysical and chemical stability and are prepared through 
very facile one-step synthesis. However, it is more difficult to control their size, 
their shape and their surface chemistry. In view of the several similar properties, 
it is very interesting to compare the behavior in vivo of CQDs and Si NPs. 
Finally, the interest for cobalt nanoparticles is mainly in their magnetic 
properties. Indeed, Co NPs possess higher values of saturation magnetization 
than the ones composed of metal oxides such as ferrite or iron oxides[33]. This 
property would allow to introduce in the body a smaller quantity of NPs while 
retaining a similar magnetic response, and gives promising expectations for a 
future use in MRI. In addition, as reported for other magnetic NPs[33-35], 
ultrasmall Co NPs can display superparamagnetic behaviour[34, 36-37]. However, 
the reported toxicity[38] of Co NPs must be overcome, by means of a protecting 
shell[39-42] before using them in vivo. Also, the synthetic methods to obtain Co 
NPs have been well established and it is possible to obtain very stable and quite 
monodisperse particles. 
Since these NPs are good candidates as cores for multimodal probes, this chapter 
continues with a brief introduction on multimodal imaging, followed by an 
overview on the preparation, functionalization and bioapplications of these three 
kinds of ultrasmall NPs.  
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1.2 Multimodal imaging 
Bioimaging is an important tool for non-invasive detection of tumour or disease 
in the body. Nowadays, MRI, PET and optical imaging techniques are widely 
used in the hospitals for bioimaging. The new frontier of diagnostics is 
multimodal imaging that combines several techniques using an unique probe. 
The combination of these multiple informations can be reached either acquiring 
the images at the same time (synchronous) and merging them automatically, or 
at different times (asynchronous) and fusing them, afterwards, by digital 
manipulation techniques.[15] In order to make multimodal imaging working in an 
appropriate way, it is necessary to use probes that can give detectable signals and 
that are highly specific for the desired target. NPs are very useful in this respect 
both for their special properties deriving from their “nano-size” and for their 
large surface area that can be functionalized with different biomolecules and/or 
specific targeting agents.  
In 1966 Kuhl et al.[43] were the first to use a prototype of SPECT-CT (Single 
photon emission computed tomography-computed tomography), a multimodal 
technique, to obtain thoracic images of a patient. In diagnostics, nowadays, the 
most used multimodal techniques are SPECT-CT and positron emission 
tomography-computed tomography (PET-CT). More recently, positron emission 
tomography combined with magnetic resonance (PET-MR) started to have an 
increased use. Indeed MR imaging has several advantages vs the most common 
X-ray detection, like high soft-tissue contrast, and allows to obtain 
multidimensional, morphological, structural, and functional informations.  
Regarding the probes, a great research effort is directed towards the design and 
preparation of nanoparticles possessing more than one detectable property to 
exploit multimodal imaging[9, 12], which is still a rather new and exciting field of 
research. For example, Fan et al.[44] reported on magnetite nanorings decorated 
with semiconductor quantum dots, namely CdSe/ZnS nanoparticles. The 
particles were functionalized with polyethylenimine (PEI) and then grafted on 
the surface of magnetite nanorings that were modified with citric acid. The final 
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system, as can be seen in Figure 1.3, is a dual-modality magnetic-fluorescent 
nanoprobe, with a size of 100-200 nm, which is uptaken by MGH bladder cancer 
cells. 
 
Figure 1.3. A) Model of a fluorescent magnetic nanoring; B) pictures of the magnetic-
fluorescent nanorings in water in: I) ambient conditions; II) under UV-irradiation; III) 
under UV irradiation and applied magnetic field; C) Transmission electron micrographs 
of the fluorescent-magnetic nanorings; D-E) model of fluorescent-magnetic nanorings 
in solution (D) and under applied magnetic field. Reprinted from ref[12], adapted from 
ref[44]  
 
In another example, Sun et al.[45] report on NaYF:Yb, Tm@NaGdF upconversion 
nanoparticles (UCNPs), that were coated with mesoporous silica (mSiO2). 
Afterwards, the silica surface was functionalized with lanthanide (Eu, Sm, Er, 
Nd, Yb) β-diketonate derivatives through the use of alkoxysilane-modified 
dibenzoylmethane (dbm-Si). The final system UCNPs@mSiO2-Ln(dbm)4, with 
a size of 95-110 nm, show low toxicity and high biocompatibility and can give 
both down-conversion and up-conversion luminescence showing a multi-
coloured emission (from 450 to 1700 nm). Up-conversion is suitable for 
performing in vivo studies, while down-conversion is appropriate for in vitro 
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tests. Furthermore, the presence of Gd (III) in the particles, allows their use also 
as contrast agents in magnetic resonance imaging. Therefore these particles are 
another promising example of bimodal imaging. In Figure 1.4, a schematic 
model of the above mentioned particles and of their applications in imaging are 
shown.  
 
Figure 1.4. Scheme of the preparation of UCNPs@mSiO2Ln(dbm)4 and their 
applications in imaging (in vitro and in vivo); Ln = Eu, Sm, Er, Nd, Yb). Reprinted from 
ref[45] 
 
A more relevant example is the work of Kauzlarich group[19] (Figure 1.5). They 
were the first to perform in vivo biodistribution experiments with ultrasmall 
silicon nanoparticles (Si NPs) radiolabelled with a 64Cu complex. The 64Cu 
complex allows to perform positron emission tomography due to the presence of 
the copper isotope that has interesting radioactive decay properties.  64Cu has a 
half-life of about 12 hours and a certain percentage of it decays, by positron 
emission, to 64Ni. The positron emission is then used in nuclear medicine as a 
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label. Kauzlarich, therefore, reports on PET of mice using dextran-coated 
manganese doped silicon nanoparticles that are functionalized with a 64Cu 
complex (final average hydrodynamic radius 15.1 nm). The manganese doping 
is, probably, done in the perspective of a future use of these NPs in multimodal 
imaging since the same authors reported in another contribution about the 
appearance of magnetic properties in Mn doped Si NPs[46-48]. The particles are 
rapidly excreted by renal filtration, but they also accumulate in the liver. This 
could be due to the distribution of sizes, with smaller particles being rapidly 
excreted and bigger ones accumulating in the liver. Nevertheless, this is an 
important example of biocompatible NPs that possess multiple properties (in this 
case, the photoluminescence of the ultrasmall silicon core, the radioactivity of 
the surface functional groups and the magnetic properties deriving from the 
manganese doping) and, therefore, an interesting strategy of possible multimodal 
probe with ultrasmall Si NPs. 
 
 
Figure 1.5.  A schematic representation of dextran coated manganese doped silicon 
nanoparticles that are functionalized with a 64Cu complex and PET image at 5 minutes 
post-injection in mice, showing that particles are already in the bladder, but start to 
accumulate also in the liver. Reprinted from[19] 
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1.3 Ultrasmall silicon nanoparticles 
 
1.3.1 Why silicon nanoparticles? 
 
Silicon is one of the most abundant materials on Earth. It has been widely used  
in several applications thanks to its semiconductor properties and low toxicity. 
In the last 50 years, the technological applications and, parallel, the research on 
silicon increased enormously, mostly in connection with microelectronics 
applications[49-50]. In the field of nanoscience and nanotechnology, silicon-based 
materials are of large interest, also in view of the new properties that appear when 
size shrinks to the nanoscale. Silicon nanoparticles (Si NPs) are applied in 
several fields ranging from light emitting devices (LEDs) [51-54] to solar cells [55-
61] to biological fluorescence imaging[19, 62-80]. Silicon NPs are particularly 
interesting for different reasons and, among these, the possibility to tune and 
control particle size down to ultrasmall dimensions (< 5 nm), as well as their 
luminescent properties that are dependent both on size (due to quantum 
confinement effects) and on surface functionalization. Silicon nanoparticles are 
characterized also by an excellent photophysical and chemical stability, once 
their surface is properly capped. Also, they are very versatile since they can be 
easily functionalized with various groups thanks to the well-known chemistry of 
silicon surfaces and the formation of stable Si-C bonds. To be used in 
bioimaging, it is essential that nanoparticles are non-toxic and extremely 
biocompatible. It has been already reported[26-27, 81] that porous silicon 
nanoparticles (mean size: 126 nm) are biodegradable and the degradation 
products are easily cleared through the kidneys in mice. Actually silicon already 
exists in mammalians [humans] as a trace element and the biodegradation 
product of silicon nanomaterials is the highly biocompatible orthosilicic acid.  
For their properties, silicon nanoparticles can be included in the bigger family of 
semiconductor quantum dots. For long time, classical semiconductor quantum 
dots, such as CdSe, CdS or ZnS, have been proposed as an alternative to organic 
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dyes for the labelling in bioimaging due to their higher resistance against photo-
bleaching and the intense and narrow emission spectra. But it is well known[82] 
that these nanoparticles show a quite high cytotoxicity, and therefore their use in 
vivo has been limited to fluorescence driven surgery[83]. Si NPs are therefore a 
good alternative since they retain the properties of semiconductors, bright 
tunable luminescence and high resistance against photobleaching. In addition, 
contrary to classical quantum dots, they are highly biocompatible and non-toxic. 
Finally, for the possibility to obtain different functionalizations on their surface, 
Si NPs can be used as a modifiable platform on which to perform specific 
bioconjugations.  
 
 
1.3.2 Synthetic methods to produce silicon nanoparticles 
 
The preparation of ultrasmall silicon nanoparticles with narrow size dispersion 
is still a challenging task, and, in particular, the purification is tedious and 
difficult, with a lack of well-established and clear methodologies. In this section 
we focus on the different synthetic methods[84-85] to produce non porous silicon 
nanoparticles, with special attention to the preparation of ultrasmall NPs.  
Si NPs can be obtained by chemical or physical methods, involving either 
bottom-up or top-down approaches. A non-exhaustive sketch, trying to 
summarize the most common methods, is reported in Figure 1.6.  
Usually top-down techniques can produce very clean particles, but, with 
chemical bottom-up methods the control of the size and the surface termination 
of the particles is much higher. Typical physical or physico-chemical techniques 
to produce silicon nanoparticles include top-down techniques such as ball 
milling[86-87], electrochemical etching, laser ablation as well as gas phase 
reactions (including chemical vapour deposition and plasma methods) and 
pyrolysis methods[85, 88-89]. 
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Figure 1.6. Scheme of the main synthetic routes for the preparation of silicon 
nanoparticles 
 
In the last years, several bottom-up chemical techniques have been developed 
allowing a quite precise control of the size and the surface termination of silicon 
nanoparticles. 
These techniques can be roughly divided in a few main categories: i) reduction 
or ii) oxidation of a silicon precursor, iii) microwave-assisted reductions or 
oxidations and iv) high temperature thermal reduction of silsesquioxanes. In the 
following paragraphs we will describe in details these bottom-up chemical 
approaches. 
 
1.3.2.1 Reduction of a silicon precursor  
In Figure 1.7, a general scheme for the production of silicon nanoparticles 
through the reduction of a silicon precursor is reported. One of the first reactions 
in this direction was reported by Heath[90], but the harsh reaction conditions 
limited the use of this method. Indeed Heath method is based on the simultaneous 
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reduction of SiCl4 and RSiCl3 (R = H, octyl) by means of sodium in a non-polar 
solvent (pentane or hexane) under inert atmosphere at high temperature (385 °C) 
and pressure (> 100 atm) for 3-7 days. The use of different organic chains (R) in 
RSiCl3 allows a control on the size of the final particles and, indeed, when R = H, 
there is no control on the size of particles, but when R = octyl, the mean particle 
size is 5.5 nm ± 2.5 nm. Later on, several syntheses, carried out under much 
milder conditions, have been established as can be seen in Figure 1.7. All these 
syntheses are performed under strict inert atmosphere and are based on the 
reduction of a silicon precursor. They can be divided in three typologies: 
microemulsion method, simple reduction without surfactants and metathesis 
reactions with Zintl salts. In the case of the microemulsion method, the reduction 
of the silicon precursor happens inside reverse micelles of a surfactant to produce 
H-terminated Si NPs that are further functionalized through a hydrosilylation 
step catalyzed either by a Pt catalyst or by UV irradiation. Both the surfactant 
and/or the reducing agent used influence dramatically the final size obtained, but 
the use of micelles as “nano-reactors” allows a quite precise control of the size 
with a low degree of polydispersion. The scheme in Figure1.7, takes into account 
the variations on this method reported from different authors. Wilcoxon et al.[91] 
were the first to report this kind of reaction, but they stopped at the production 
of H-terminated NPs without further functionalization. The particles produced 
by Wilcoxon have a size between 1.8 and 10 nm and they were separated in two 
smaller distributions of sizes using high-pressure liquid chromatography 
(HPLC). These H-terminated Si NPs show luminescence in all the range 
350 - 700 nm with the most intense emission situated in the blue region of the 
spectrum (365 nm). Tilley et al.[63, 92] used both SiCl4 and SiBr4 as precursors and 
tetraoctyl ammonium bromide (TOAB) or pentaethylene glycol monododecyl 
ether (C12E5) as surfactants. They studied the influence, on the size and properties 
of the particles, of  different  reducing agents and methods of capping  (Pt catalyst 
or UV irradiation). By changing reducing agent, they 
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Figure 1.7. General scheme of the methods based on the reduction of a silicon source 
(R = alkyl-, alkenyl-, amine-, epoxy-, alkoxy-, azide-groups, etc.) 
 
could tune the size from 1.6 nm ± 0.4 nm in the case of the strongest reducing 
agent (LiAlH4) to 2.5 nm ± 1.0 nm in the case of the weakest reducing agent 
(NaBH4). All the particles prepared by this method emit in the blue region of the 
spectrum, and a slight red shift was observed for the biggest particles. Rosso-
Vasic et al.[64, 93] used always Si(OMe)4 as a silicon precursor and TOAB as a 
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surfactant, but several different kinds of capping agents (mean size of the 
particles: 1.6 nm) and, also in this case, the particles emit in the blue region of 
the electromagnetic spectrum. Doyle et al.[94] changed various surfactants such 
as TOAB, tetrabutyl ammonium bromide (TBAB), cetyltrimethyl ammonium 
bromide (CTAB), didodecyldimethyl ammonium bromide (DDAB), 
dodecyltrimethyl ammonium bromide (DTAB), tetradodecyl ammonium 
bromide (TDAB) to show how size of the final particles is affected by the 
different micelles that act as “nano-reactors”. The smallest size is obtained with 
TOAB (≈ 2.0 nm) and they can tune the size up to 6.0 nm with the other 
surfactants.  
The second possible kind of reaction (simple reduction) was reported by 
Kauzlarich et al.[95]. They reduced SiCl4 using sodium naphthalide in 1,2-
dimethoxyethane (glyme) to obtain Cl-terminated particles that were then capped 
with n-octanol. They did not use any surfactant to control the growth of the NPs 
and the mean particle size, in this case, was 5.2 nm ± 1.9 nm with a high 
polydispersion due to the absence of the template. The photoluminescence of the 
particles is still in the blue region of the electromagnetic spectrum. 
Kauzlarich et al. also reported[96-98] the reduction of SiCl4 by means of Zintl salts. 
The reaction produces Cl-terminated Si NPs that can be functionalized in 
different ways using methanol for example to obtain methoxy-terminated 
particles or organolithium or Grignard reagents to get different alkyl chains on 
the surface. Depending on the functionalization, the size of the particles can 
change, but all Si NPs produced are in the range 2.0 - 5.0 nm and they emit in 
the range 315 – 520 nm depending on the excitation wavelengths. 
 
1.3.2.2 Oxidation of a silicon precursor 
 
In Figure 1.8, a general scheme for the production of Si NPs through the 
oxidation of a silicon precursor is reported. This method is based on the use of 
Zintl salts that can be oxidized either by bromine or by ammonium halide. Also 
in this case, all the reactions are performed in strict inert atmosphere to avoid 
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oxidation of Si NPs. The first report in this direction is from the group of 
Kauzlarich et al.[99] in which they prepare H-terminated Si NPs through oxidation 
of Mg2Si by means of bromine and subsequent treatment of the obtained Br-
terminated particles, with LiAlH4. NPs were characterized only by FT-IR 
spectroscopy and photophysical measurements that show photoluminescence in 
the blue region of the electromagnetic 
 
Figure 1.8. Oxidation of a silicon source (R = alkyl-, alkenyl-, amine-, epoxy-, alkoxy-, 
azide-groups, etc.) 
 
spectrum. In 2003[100] the same author reported an optimized method to obtain 
alkyl/alkoxy-capped Si NPs through the oxidation of Mg2Si with bromine and 
subsequent treatment with alkyllithium reagents. The oxidation of Zintl salts by 
means of ammonium halides have been reported both by the group of 
Kauzlarich[101-102] and Cho et al.[103]. In the first reports, the particles obtained 
were H-terminated and they were not further functionalized. The size of Si NPs 
 
17 
 
was ≈ 4.0 nm and the photoluminescence, also in this case, is in the blue region 
of the electromagnetic spectrum. In the most recent report by Kauzlarich[102], 
different Zintl salts have been explored and the size and emission of particles can 
be slightly tuned from 3.1 nm to 4.5 nm, depending on the alkali metal cation of 
the Zintl salt used (increasing size of the cation usually leads to bigger particles).  
 
1.3.2.3 Microwave-assisted synthesis 
 
 
In Figure 1.9, is summarized a general scheme for the production of Si NPs via 
the microwave-assisted oxidation or reduction of a silicon precursor. 
Kauzlarich et al.[104-105] reported a method in which the oxidation of a Zintl salt, 
by means of ammonium bromide, is assisted by microwave heating under inert 
Figure 1.9. Microwave-assisted synthesis of silicon nanoparticles 
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atmosphere. In the first report, the reaction goes through the formation of 
H-terminated Si NPs that are further functionalized with terminal amine-groups 
through a second step of heating in the microwave. Otherwise, H-terminated Si 
NPs were embedded in silica formed by a base-catalyzed Stoeber method. 
Amine-terminated Si NPs prepared in this way, possess a size of 3.4 nm ± 0.7 nm 
and both amine-terminated and silica-encapsulated Si NPs show a blue 
photoluminescence. In the second report, Kauzlarich et al.[104-105] obtain 
amine-terminated Si NPs through a single step reaction in the microwave oven 
in the presence of a surfactant. They compared the two-steps and one-step 
syntheses finding out that the one-pot, two-steps method is the best for the 
production of Si NPs.  
He et al.[70] reported the reduction, in aqueous solution, of 
(3-aminopropyl)trimethoxysilane by means of trisodium citrate under 
microwave heating. The synthesis is only one-step and it produces amine-
terminated Si NPs with a size of ≈ 2.2 nm and showing blue photoluminescence 
as well. 
 
1.3.2.4 Thermal decomposition of hydrogen silsesquioxane 
 
In Figure 1.10, a general scheme for the production of silicon nanoparticles 
through the high temperature reduction of hydrogen silsesquioxane is reported. 
Veinot et al.[106-107] report the synthesis, by means of hydrogen silsesquioxane or 
other silsesquioxanes, of Si NPs embedded in silica and the subsequent 
production of H-terminated particles by etching with hydrofluoric acid. The 
particles obtained have a diameter of ≈ 3.4 nm and, after etching, they emit in 
the visible and near-infrared region of the electromagnetic spectrum. Later on, 
Veinot et al.[108] reported also the functionalization of the obtained H-terminated 
Si NPs through a thermally or photochemically activated hydrosilylation step 
and they showed that nanoparticles with different sizes react differently in the 
hydrosilylation step. Ozin et al.[109-111] and Kauzarich and Tilley et al.[30] reported 
about the synthesis of capped Si NPs through thermal reduction of 
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silsesquioxanes and subsequent functionalization through thermal activated 
hydrosilylation. Indeed, H-terminated nanoparticles obtained during the 
reduction of silsesquioxanes, are etched from the silica and functionalized with 
organic moieties thanks to a thermally activated hydrosilylation step. Even in 
this case, particle size is quite small (around 2.0 nm), but Si NPs emit in the red 
region of the electromagnetic spectrum in contrast with the blue emission 
predicted by the quantum confinement model. Indeed, this is another piece of the 
puzzle in the wide debate in literature regarding the photoluminescence of silicon 
nanoparticles and which are the factors that influence it.  
 
 
Figure 1.10. Thermal reduction of silsesquioxanes for the production of silicon 
nanoparticles (R = alkyl-, alkenyl-, amine-, epoxy-, alkoxy-, azide-groups, etc.) 
 
In conclusion, bottom-up techniques give the opportunity to functionalize the 
surface of the particles with several different groups going, e.g., from alkyl or 
alkenyl chains to amine-, epoxy-, alkoxy-, azide-groups. Usually the size of the 
particles obtained is very small and the emission properties can change from blue 
to red according to the synthetic method used. 
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1.3.3 On the origin of photoluminescence in silicon 
nanoparticles 
 
It is worth to have a deeper look at the photoluminescence properties of silicon 
nanoparticles and discuss about their origin. Silicon nanoparticles belong to the 
bigger family of semiconductor quantum dots, called in this way to underline the 
appearance of quantum effects as consequence of their “nano-size”. As all 
semiconductors, silicon possesses a characteristic energy gap (Eg) between the 
conduction and the valence band. For bulk silicon, Eg corresponds to 1.12 eV. 
The particularity of silicon is that this energy band gap is indirect, that means the 
top energy level in the valence band and the bottom one in the conduction band 
do not correspond to the same value of momentum k. The structure of the energy 
gap in bulk silicon is shown in Figure 1.11. 
 
Figure 1.11. Energy band structure of bulk silicon. Reproduced with permission 
from[112]  
 
Due to the indirect energy gap, bulk silicon does not show any emission because 
the transition from the conduction to the valence band is electronically forbidden. 
When the size is reduced to the nanoscale, many events that are negligible in the 
“macro-world” start to occur influencing dramatically the properties of 
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materials. Photoluminescence properties in silicon nanomaterials and, in 
particular, red emission in silicon nanowires have been observed for the first time 
in 1990[113]. It was the first proof that silicon could emit if its size shrinks to the 
nanoscale. Since that moment, many efforts have been done to understand deeply 
the nature of this luminescence and it seems that several are the factors that 
contribute to the expression and the modulation of emission properties in silicon 
nanoparticles. Indeed the most accepted theory of the emission of Si NPs is 
related to the quantum confinement effect. In this paragraph, it will be explained 
how luminescence of the particles can be also influenced by defects in the 
structure of the particles, by surface functionalization effects and by the method 
of preparation. 
From the point of view of the electronic structure, nanoparticles behaviour can 
be described with the quantum-mechanic model of “particle in a box”. In 
particular, in semiconductor quantum dots, the energy levels of the valence and 
conductance band become discrete and the energy gap between the two bands is 
inversely proportional to the size of the particles. This means that smaller 
particles will show a higher energy gap and therefore their emission will be more 
blue-shifted. A schematic view of this size-dependent effect on 
photoluminescence is shown in Figure 1.12[114].  
 
Figure 1.12. Quantum confinement effects on the photoluminescence of semiconductor 
quantum dots. Reproduced with permission from[114]. 
 
22 
 
In the case of silicon nanoparticles, it seems that the indirect band gap undergoes 
to changes and transformations that bring to a transition from indirect to direct 
energy gap[115-116]. Nevertheless, photoluminescence in Si NPs is not easily 
explained and many factors are influencing it. Recently, it has been also shown 
how the emission properties of silicon nanoparticles can be tuned by introducing 
defects in the structure, for example by doping with boron and phosphorus 
atoms[117-118]. The particles obtained by this method are very small (≈ 3 nm), but 
they emit in the near-infrared region in contrast with the model of “particle in a 
box”. It seems that the co-doping with boron and phosphorus brings to the 
formation of donor and acceptor states in the band gap of silicon, similarly to 
what happens in doped bulk silicon, and this allows to tune the 
photoluminescence properties.  
Also the synthetic route strongly influences the photoluminescence of silicon 
nanoparticles. Indeed the groups of Kauzlarich and Tilley reported how the 
luminescence of Si NPs shifts to the blue in the presence of nitrogen and oxygen-
containing chemicals used during the synthetic procedure[30]. They compared 
dodecyl-terminated Si NPs made by three different methods: thermal reduction 
of hydrogen silsesquioxane (HSQ) followed by hydrosilylation; oxidation of 
Zintl salt by means of ammonium bromide; reduction of SiCl4 with hydrides in 
the presence of the surfactant tetraoctylammonium bromide (TOAB). All the 
obtained particles emit in the blue region of the electromagnetic spectrum except 
the ones made by reduction of HSQ that emit in the red. Even the excited state 
lifetimes are quite different, being longer in the case of the synthesis starting 
from HSQ. To prove that nitrogen- and oxygen-rich environments can shift the 
photoluminescence in the blue, red-emitting H-terminated Si NPs made by HSQ 
reduction were reacted with TOAB and ammonium bromide. At increasing 
concentrations of nitrogen-containing reagents, the emission of the particles 
shifts to the blue, but if the reaction is made in inert atmosphere, the shift in the 
emission does not occur showing that it is fundamental the contemporary 
presence of nitrogen and oxygen to have blue emission. All these findings 
support the idea that emission in silicon nanoparticles is not only due to quantum 
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confinement effects, but is highly influenced also by surface properties, defects 
in the structure and synthetic route. 
Also Zuilhof et al.[119-120] studied the photophysics of Si NPs and they reported 
that, when the surface of silicon nanoparticles is capped with carbon-containing 
groups, changes and transformations in the band gap occur bringing to a more 
direct-like energy gap transition. However if oxygen is present on the surface of 
the particles, the emission is shifted more to the red.  
Gonzalez et al. [121-122] demonstrated that is indeed the functionalization on the 
Si surface responsible for the different emission of the particles since when a 
small layer of Si-O-Si bonds is present on the Si surface the emission properties 
are not influenced by the synthetic route or by the functionalization.  
In literature, the debate on the emission properties of Si NPs is still open and 
many are the factors that influence the photophysics of such material making 
more complicated a deeper understanding. 
 
1.3.4 Bioapplications of silicon nanoparticles 
 
The first authors to test ultrasmall Si NPs in vitro are Ruckenstein et al.[62] and 
Tilley et al.[63] who reported, respectively, that polyacrylic acid coated red-
emitting Si NPs are uptaken on the surface of Chinese hamster ovary (CHO) cells 
and that blue-emitting amine-terminated Si NPs are uptaken by HeLa cells and 
distributed uniformly inside the cytosol. Rosso-Vasic et al.[64] incubated blue-
emitting amine-terminated Si NPs with different amine-length chains in murine 
cell line BV2 and particles accumulate in the cell cytosol showing very low 
cytotoxicity. Si NPs were, later on, tested through MTT (3-(4,5-dimethylthiazol-
2-yl)2,5-diphenyl tetrazolium bromide) assay[65-67] to show how different surface 
functionalizations can influence the cytotoxicity of these nanoparticles. In these 
studies, it has been found that amine-terminated Si NPs, that are usually 
positively charged, are quite toxic, if compared, e.g., with their neutral and 
carboxylic-terminated analogues. Swihart et al.[68] and Ozin et al.[69] reported 
about small (4 nm) and bigger (100 nm) Si NPs encapsulated either in 
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phospholipid or solid lipid micelles. The particles are highly uptaken by 
pancreatic cancer cells or human breast cancer cells and show very low 
cytotoxicity.  He et al.[70-71] reported that amine-terminated Si NPs, made by two 
different methods, conjugated with the goat anti-mouse IgG antibody are a very 
suitable probe for long-term imaging of cells. Indeed, the antibody-conjugated 
NPs have been incubated with HeLa cells and they stain either the nuclei or the 
microtubules, showing stable photoluminescence up to 2 hours of continuous 
observation. Yamaguchi et al.[72] reported that aggregates of Si NPs with a size 
of 20 - 40 nm, coated with a block polymer (Pluronic F127), selectively label the 
endoplasmatic reticulum of human umbilical vein endothelial cells (HUVECs). 
In a later work, Yamaguchi et al.[73] show how internalization in cells is 
influenced by surface functionalization and size of Si NPs. Two kinds of 
functionalization (allylamine and block copolymer Pluronic F127) and two 
different sizes (few tens of nanometers and > 100 nm) of Si NPs were incubated 
in live and fixed HUVECs cells. In Figure 1.13, an experiment of co-localization 
with Lyso-tracker that labels selectively lysosomes is shown. From the figure, it 
is clear that amine-terminated NPs are always aggregating selectively in 
 
Figure 1.13. Confocal microscopic images of live HUVECs incubated with small and 
large amine-terminated (Si-Amsmall and Si-Amlarge respectively) and F127-
functionalized Si NPs (Si-F127 small and Si-F127 large respectively). HUVECs were also 
labeled with Lyso-Tracker/ER tracker to do the co-localization experiment. Left and 
central columns are the fluorescent images of Si NPs and Lyso-Tracker/ER-tracker 
respectively. The right columns are the superimposed images. Scale bar is 10 µm. 
Reproduced with permission from[73] 
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lysosomes independently from their size. Instead, F127-functionalized Si NPs 
label selectively the endoplasmatic reticulum (ER) when they are small and the 
lysosomes when they are bigger.  
Klein et al.[74] reported on the possible use of silicon nanoparticles for 
radiosensitization of cancer and tissue cells. They incubated uncapped and 
amino-silanized oxidized silicon nanoparticles with human breast cancer cells 
(MCF-7) and mouse fibroblast healthy cells (3T3). The cells were, then, exposed 
to X-rays and only amine-terminated Si NPs increase the production of reactive 
oxygen species (ROS) resulting in higher cytotoxicity for the cancer cells in 
respect to the healthy ones. Zuilhof et al.[123], Intartaglia et al.[124] and Wang et 
al.[125] reported on the coupling of Si NPs with single-strand DNA for further 
possible bioapplications. Erogbogbo et al.[75] showed that folic acid-
functionalized Si NPs are uptaken by human pancreatic cancer cells (Panc-1), 
while the same particles without folic acid on the surface are not internalized. 
Ahire et al.[76] coupled amine-terminated ultrasmall porous Si NPs with different 
kinds of sugars. Sugar-terminated Si NPs exhibit very low cytotoxicity in 
comparison with amine-terminated Si NPs and are more readily uptaken by 
cancer cells than by healthy cells. Kauzlarich et al.[19, 77-78] doped Si NPs with 
iron or manganese to obtain a multimodal agent both for magnetic and optical 
imaging. The iron doped NPs show very low toxicity when incubated in HepG2 
liver cells and the manganese doped ones functionalized with dextran can be 
used as contrast agents for MRI and near-infrared excited two-photons imaging. 
Manganese doped Si NPs functionalized with dextran are non-toxic for 
mammalian cells and accumulate, in specific way, in the macrophages. This is 
an important result since atherosclerotic plaques that are vulnerable to rupture 
are usually associated with a high density of macrophages and these particles 
represent a good alternative for the multimodal imaging. In addition the group 
of Kauzlarich[19] was the first to perform in vivo biodistribution experiments on 
ultrasmall Si NPs. Indeed, they reported PET imaging of mice using dextran 
coated manganese doped Si NPs that are functionalized with a 64Cu complex 
(final average hydrodynamic radius 15.1 nm). Most of the particles are rapidly 
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excreted by renal filtration, but some also accumulate in the liver. This is maybe 
due to the distribution of sizes, smaller particles are rapidly excreted and bigger 
ones accumulate in the liver. 
Erogbogbo et al.[79] describe a system in which Si NPs (4 nm) and iron oxide 
nanoparticles (7 nm) are co-encapsulated in phospholipid-polyethyleneglycol 
(DSPE-PEG) micelles to obtain a multimodal imaging probe, both fluorescent 
and magnetic with an average size of 50 nm. These systems were incubated with 
macrophage RAW cells both in the absence and in the presence of a magnetic 
field. When the magnetic field is applied, the uptake of the particles is increased 
and can be detected through fluorescence. Then, particles were tested in vivo 
being injected directly in tumour xenograft of a tumour-bearing mouse and at 24 
hours post-injection, they still show bright luminescence proving that, if particles 
are targeted to the tumour, their stability can be enhanced (usually reported 
luminescence stability of quantum dots in tumour site is around 6-8 hours). In 
another report, Erogbogbo et al.[80] prepared Si NPs by laser pyrolysis of silanes 
and subsequent etching and functionalization obtaining particles with different 
sizes (from 2 to 8 nm) and a range of photoluminescence wavelengths from 450 
to 900 nm. 
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Figure 1.14. In vivo luminescence imaging, at different times post-injection, of Panc-1 
tumor bearing mice (the tumor is on the left shoulder and it is indicated with white arrows) 
injected with 5 mg of micelle-encapsulated RGD-Si NPs (A-E) and of micelle-
encapsulated Si NPs (K-O). The autofluorescence and the Si NPs signals are in green and 
red respectively. Images F-J and images P-T correspond to the luminescence images A-E 
and K-O, respectively. In U,W ex vivo images and in V,X luminescence images of 
tumours at 40 hours post-injection in mice treated with micelle-encapsulated RGD-Si NPs 
(U,V) or with micelle-encapsulated Si NPs (W,X). Reproduced with permission[80] 
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Si NPs were, then, encapsulated in phospholipidic micelles and conjugated with 
RGD peptides which are highly specific for integrins overexpressed in the 
tumour vasculature. Micelle-encapsulated RGD-Si NPs and micelle-
encapsulated Si NPs were injected, through the tail vein, in tumour bearing mice 
and the in vivo fluorescence imaging, at different post-injection times, is shown 
in Figure1.14. The luminescence intensity in the tumour site increases with time 
when RGD-particles are used, but in the case of particles without RGD 
functionalization, no uptake was observed. With the same kind of particles, the 
authors were able also to perform mapping of sentinel lymph nodes and 
multicolor near-infrared imaging in live mice. In conclusion, ultrasmall Si NPs 
have been already widely explored in vitro and in vivo, but more knowledge must 
be acquired on the behaviour in vivo. 
 
 
1.4 Carbon dots 
 
1.4.1 Properties of carbon dots 
 
Since the discovery of the Buckminsterfullerene in 1985[126], carbon based 
nanomaterials have attracted increasing interest in many fields of science. 
Amongst them, carbon quantum dots are very interesting for their relatively easy 
synthesis and for their luminescence properties that are dependent on their size 
and on their surface functionalization as in the case of silicon nanoparticles. In 
Figure 1.15, the different structures of some of the most used carbon based 
nanomaterials are shown[31]. 
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Figure 1.15. Most common carbon based nanomaterials: fullerene, carbon nanotubes, 
graphene, carbon dots and nanodiamonds. Reproduced with permission from[31] 
 
Fluorescent carbon quantum dots were discovered quite recently in 2004 almost 
accidentally during the electrophoretic purification of single-walled carbon 
nanotubes (SWNTs) obtained by arc-discharge[127]. On the structural 
organization and shape of carbon dots there is still an open discussion, but they 
are mostly described as nanosized graphene (< 10 nm)[31]. In reality, some 
authors divide carbon quantum dots in two kinds of materials: carbon dots 
(CQDs or C-dots) and graphene quantum dots (GQDs). They describe CQDs as 
quasi-spherical nanoparticles with a diameter smaller than 10 nm and GQDs as 
a single or a-few layered nanosized graphene (size can reach up to 60 nm)[128-
129]. One of the most interesting features of carbon dots is their 
photoluminescence that can cover all the visible electromagnetic spectrum from 
400 until 750 nm. The emission peaks usually shift according to the excitation 
wavelength used and this is due to the heterogeneity of sizes and composition in 
carbon dots samples. The photoluminescence properties are still under 
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investigation but it seems that, in addition to the size confinement effect, they 
are due to a variety of composition (surface and inner structure) effects. Indeed 
carbon dots have usually a multifunctional surface with different groups that are 
excited with different excitation wavelengths. The strong, stable and 
multi-coloured emission of carbon dots together with their biocompatibility 
make this kind of material an appealing alternative for bioapplications.  
 
1.4.2 Synthetic methods of preparation of carbon dots 
 
Many are the methods to produce carbon dots and both top-down and bottom-up 
techniques are used[31, 128, 130]. Top-down techniques includes arc-discharge, laser 
ablation or electrochemical oxidation of graphitic bulk materials. Bottom-up 
techniques include several methods such as thermal decomposition of organic 
compounds, template-assisted synthesis, hydrothermal, solvothermal or 
microwave-assisted treatment of amino-acids, organosilanes, polymers and 
many natural compounds[131]. The most widely used methods are the 
hydrothermal and microwave-assisted syntheses[132]. In Figure 1.16, one 
example of hydrothermal[133] and microwave-assisted synthesis[134-135] are 
shown. In the hydrothermal synthesis reported by Zhu et al.[133], citric acid is 
heated up at high temperatures for several hours in water in the presence of 1,2-
ethylendiamine. The obtained particles have a size of 2 - 6 nm and contain mostly 
sp2 - hybridized carbon atoms, some sp3 - hybridized carbon atoms and also 
amide and carboxylic groups. Jiang et al.[134] and Mazzier et al.[135] report, instead 
the preparation of CQDs by microwave-assisted synthesis in which an 
amino-acid is heated for few minutes in a domestic microwave oven in the 
presence of 1,2-ethylendiamine in water. With this method, particle size is in the 
range 1 - 4 nm and particles contain both carboxylic, amide and amine groups on 
their surface.  
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Figure 1.16. Two examples of hydrothermal and microwave assisted synthesis for the 
preparation of carbon dots  
 
1.4.3 Bioapplications of carbon dots 
 
Due to their biocompatibility, their bright multi-colored emission and their 
stability against photobleaching, carbon dots are promising materials for 
bioimaging. Indeed, they have already been tested both in vitro and in vivo. Yang 
et al.[32], in 2009, reported the first example of in vivo experiments using carbon 
dots. They showed that CQDs remain strongly emissive also in vivo, opening 
many applications for imaging with these nanoparticles. Ruan et al.[136], e. g., 
report of the use of carbon dots to detect glioma, a malignant tumour present in 
80% of brain tumours. CQDs were incubated in vitro with C6 glioma cells 
showing that they are uptaken by cells with a mechanism mediated by 
endosomes. Then CQDs were tested in vivo in glioma bearing mice and it was 
found that they accumulate more where the glioma is located than in normal 
brain tissue. In Figure 1.17, in vivo images of glioma bearing mice at different 
times after injection of carbon dots are shown. CQDs were injected through the 
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tail vein and, as it can be seen, the intensity of emission, at 5 minutes post-
injection, is higher in the brain where the glioma is located. In addition the 
emission intensity decreases in time showing that particles are excreted quite 
quickly. The 3-D reconstruction of the distribution of CQDs into the brain after 
2 hours from CQDs injection together with the ex vivo images show that CQDs 
are localized in the glioma. 
 
 
Figure 1.17. A) In vivo images, at different times post-injection of CQDs, of glioma 
bearing mice; B) 3-D reconstruction of the distribution of CQDs inside the brain at 2 
hours post-injection; C) ex vivo images of tissues at 2 hours post-injection of CQDs. 
Reprinted with permission from[136] 
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1.5 Ultrasmall cobalt nanoparticles 
 
1.5.1 Properties of cobalt nanoparticles 
 
Magnetic nanoparticles have attracted increasing interest due to the wide range 
of applications they might be used for. Indeed they are used for magnetic 
inks[137-138], recording media[139], sensors[140] and, more recently, also for 
bioapplications[141-145] in magnetic resonance imaging[146-147] , drug delivery[148] 
or hyperthermia therapy[149-151]. For biomedical applications, magnetic metallic 
nanoparticles, such as cobalt, nickel, iron and their alloys, are very interesting 
because they usually possess higher saturation magnetization than metal oxides 
such as ferrite or iron oxides[33]. This property would allow to introduce in the 
body a smaller quantity of NPs while retaining a similar magnetic response, and 
gives promising expectations for a future use in MRI. When the particle size 
shrinks to the nanoscale and reach a critical value, which may change for each 
material, magnetic particles can show a superparamagnetic behaviour[33-35]. This 
means that the magnetic moments will be randomized and can be easily 
manipulated with an external magnetic field. This property becomes very 
interesting for bioapplications such as magnetic resonance imaging and 
hyperthermia therapy. Cobalt has a ferromagnetic behaviour, but it is reported 
that ultrasmall cobalt nanoparticles can have superparamagnetic 
properties[34, 36-37]. Cobalt has a very important role in biological systems. Indeed, 
it is a constituent of cobalamin, the vitamin B, which is involved in the formation 
of blood and in the normal operation of brain and nervous system. In addition, 
cobalt is present in several other vitamins[152]. However, toxicity and instability 
have limited the use of cobalt nanoparticles in the past. It has been shown[38] that 
cobalt nanoparticles have a quite high toxicological effect in many cell lines in 
vitro. In particular, cell sensitivity to Co NPs increases in the following way for 
some cell lines:  A549 = MDCK = NCIH441 = Caco-2 > DCs > HepG2. Al 
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Samri et al.[153] showed that C/Co/SiO2 and C/Co3O4/SiO2 NPs increase caspase 
activity and alter the structure of lungs, but the presence of a silica shell could 
improve the biocompatibility of Co NPs. For this reason, recent research focused 
on the surface modification of cobalt nanoparticles with a silica shell[39-40] to 
render them less toxic and to facilitate surface functionalization.  
 
1.5.2 Synthetic routes to prepare cobalt nanoparticles and 
their bioapplications 
 
Ultrasmall cobalt nanoparticles can be prepared by several bottom-up methods 
and, playing with parameters of the reaction, it is possible to tune particles size, 
shape and composition. Usually high temperatures and inert atmosphere are 
necessary conditions. In Figure 1.18, four examples of bottom-up synthesis are 
reported. Cobalt nanoparticles can be obtained by three main different typologies 
of reaction[33, 154]: high temperature liquid phase synthesis; reduction, at room 
temperature, of cobalt salts in reverse micelles[34, 155]; reduction or thermal 
decomposition of cobalt salts using templates[156-157]. The high temperature liquid 
phase synthesis includes either the thermal decomposition of Co2(CO)8 in 
organic solvents in the presence of a polymer, a peptide or an aluminium alkyl 
compound[158-159], or the reduction of cobalt salts by means of superhydrides or 
polyalcohols in the presence of a trialkylphosphine[160-161]. One of the challenges 
of the preparation of Co NPs is to avoid the formation of cobalt oxide, to tune 
particle size and to stabilize the final particles. In this direction, the group of 
Boennemann et al.[162-164] reported on the synthesis of Co NPs (size 5 to 10 nm) 
by thermal decomposition of Co2(CO)8 in the presence of aluminium alkyl 
compounds (AlR3). This technique produces long-time air-stable cobalt 
nanoparticles due to the step of smooth oxidation, which creates a thin cobalt 
oxide layer around particles preventing further oxidation. Particles size can be 
tuned changing the length of the alkyl chain in the AlR3 compound or the molar 
ratio between Co2(CO)8 and AlR3. As an example of reduction of cobalt salts by 
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poyalcohols, Murray et al.[165] use long chain 1,2-diols as reducing agents instead 
of the common used ethylene glycol or glycerol and this procedure helps to 
disperse well the precursors during particles growth. Also in this kind of 
synthesis, the use of different lengths for the alkyl chain of the trialkylphosphine, 
helps to tune particle size (usually a longer chain brings to the formation of 
smaller particles). Sorensen et al.[34] reported, instead, on the synthesis of Co NPs 
reducing CoCl2 with NaBH4, under inert atmosphere, in toluene inside reverse 
micelles of the surfactant didodecyldimethyl ammonium bromide (DDAB) 
obtaining particles with a size of 1.8 - 4.4 nm. As an example of synthesis of Co 
NPs inside templates, Escalera et al.[156] described the synthesis of Co NPs 
(2 - 4 nm) made by the reduction of a cobalt salt with NaBH4 inside the pores of 
mesoporous silica nanoparticles, that act as a template. Once Co NPs are formed, 
silica NPs are removed by dissolution with NaOH. 
 
Figure 1.18. Four examples of bottom-up synthesis of ultrasmall cobalt nanoparticles 
(R = CH3, C2H5, C8H17; trialkylphosphine = tributyl- or trioctylphosphine; DDAB = 
didodecyldimethyl ammonium bromide) 
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As it is described in literature[166-168], cobalt ferrites, cobalt complexes, cobalt 
doped iron oxide and mixed cobalt/metal nanoparticles find several applications 
in magnetic resonance imaging, but for pure cobalt nanoparticles, coated with 
carbon or silica, few applications are shown till now. Hwang et al.[169] reported 
on the toxicity of cobalt ferrite and silica coated cobalt ferrite NPs showing that 
the coated ones show an increased biocompatibility. Indeed, due to the toxicity 
of cobalt and on the few reports, at date, on the preparation of silica or carbon 
coated metallic cobalt nanoparticles, there are still only  a couple of tests in vitro 
and in vivo, except the ones assessing their cytotoxicity in various cell lines or 
the penetration in human skin[153, 170-172]. For example Balla et al.[173] report of 
carbon coated Co NPs (≈ 30 nm) conjugated with the β-cell-specific single-chain 
antibody fragment, SCA B1, as a new contrast agent for magnetic resonance 
imaging (MRI). In particular, they successfully performed in vivo visualization 
of single native pancreatic islets, the sites of insulin production, in the pancreas 
of mice using MRI, but excretion is still an issue because the particles used, 
accumulate in the liver and in the spleen due to their rather large (30 - 40 nm) 
size. 
 
1.6 Aim of the thesis 
The aim of this thesis is the synthesis, characterization, functionalization and in 
vitro and in vivo investigation of different kinds of ultrasmall nanoparticles, 
which are good candidates for the design of innovative multimodal imaging 
probes. We focused on silicon NPs, carbon dots and silica-coated cobalt NPs. 
This choice was dictated by the unique properties deriving from both the 
ultrasmall size and the nature of the material, as outlined previously in this 
chapter. The goal is to combine the properties of the core with the ones of the 
molecules (e.g. radiotracers or dyes) that can be covalently anchored to the 
surface in order to perform in vivo imaging and to compare the behaviour of 
different ultrasmall NPs.  
The thesis is divided in 6 chapters.  
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Chapter 1, after a brief introduction to multimodal imaging, gives an overview 
of the state of art on properties, methods of preparation, functionalization, 
characterization and bioapplications of ultrasmall silicon, carbon and cobalt NPs. 
Chapters 2 focuses on the preparation, via two different approaches, of ultrasmall 
amine-terminated Si NPs and on their characterization and comparison. 
Chapter 3 discusses the further surface modification of these NPs with functional 
molecules suitable for bioimaging and reports on the results of in vitro and in 
vivo experiments.  
Chapter 4 deals with the preparation, characterization, surface functionalization 
and in vivo experiments of carbon dots with the aim to compare the behaviour of 
such material to silicon NPs. 
In Chapter 5, the preparation, characterization and surface modification of silica-
coated cobalt NPs will be discussed, in the perspective of a future in vivo use of 
this material.  
Finally, Chapter 6 gives a short overview of the main instrumental techniques 
used during the thesis work. 
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Chapter 2  
 
Synthesis and characterization of 
ultrasmall silicon nanoparticles 
 
Abstract 
 
This Chapter focuses on the preparation, via two different bottom-up approaches, 
of ultrasmall water-soluble amine-terminated silicon nanoparticles and on their 
characterization from the morphological, compositional and photophysical point 
of view. Differences and similarities in size, polydispersity, core and surface 
composition and photoluminescence properties of the NPs are discussed in the 
perspective of their use as platforms for further functionalizations. 
 
 
2.1 Introduction  
The development of multimodal probes that are non-toxic and can be applied for 
in vivo imaging, is the main challenge of this thesis. Amongst the possibilities, 
we have chosen ultrasmall silicon nanoparticles (Si NPs) because of the many 
advantages, connected with their biocompatibility and non-toxicity[1-2], the 
tunable luminescence properties and, not least, the possibility to functionalize 
their surface in a covalent way. We decided to investigate the properties of 
silicon nanoparticles, by focusing our attention on a single kind of initial surface 
functionalization, namely the amine termination, and to explore different routes 
of preparation in order to understand how the synthetic route can influence size, 
emission, structure, composition and biological effects. The amine-termination 
has been chosen because the aim is to obtain water-soluble particles that can 
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easily undergo further functionalization (e.g. with labels or targeting agents), and 
amine groups are particularly well suited to this goal.  
In this Chapter, we report on the wet-chemistry methods we used for preparing 
the amine-terminated Si NPs. These bottom-up techniques, namely 
microemulsion and hydrothermal syntheses - both based on the reduction of a 
silicon source - were optimized for obtaining ultrasmall (< 5 nm) amine-
terminated Si NPs. The NPs were then characterized by means of several 
techniques, including attenuated total reflectance infrared spectroscopy (ATR-
FTIR), high-resolution transmission electron microscopy (HR-TEM), energy 
dispersive X-ray emission analysis (EDX), X-ray photoelectron spectroscopy 
(XPS) and photophysical measurements.   
 
 
2.2 Amine-terminated silicon nanoparticles from 
microemulsion synthesis 
 
2.2.1 Synthetic route  
 
In the microemulsion synthesis, silicon nanoparticles were prepared using a 
modification of a reported method[3-5] based on the reduction of either Si (OCH3)4 
or SiCl4 with LiAlH4, followed by a hydrosilylation reaction of the obtained Si-H 
terminated NPs with allylamine in the presence of the catalyst H2PtCl6. This 
method is also known as “reduction in reverse micelles,” since the reaction takes 
place inside micelles of the surfactant tetraoctylammonium bromide (TOAB) 
that allow to control the growth of the particles. With this synthesis we obtain 
ultrasmall amine-terminated silicon NPs (size: 1.5 - 3 nm). All reactions were 
performed under strictly controlled oxygen and water free atmosphere (glove 
box, pO2 < 0.1 ppm, pH2O < 0.1 ppm) in order to prevent oxidation of the NPs. 
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The general scheme of the microemulsion synthesis of amine-terminated Si NPs 
is shown in Figure 2.1. 
 
 
 
Figure 2.1 General reaction scheme for the preparation of amine-terminated Si NPs via 
microemulsion synthesis  
 
Table 1 reports a summary scheme of the different reaction conditions used in 
this thesis. Several parameters, such as the silicon source, reaction time and 
temperature of the hydrosilylation step were changed, with the aim to establish 
a reproducible and scalable procedure for obtaining amine-terminated Si NPs.  
 
Table 1. Summary of the different reaction schemes performed by changing 
different parameters (capping agent is allylamine for all reactions) 
Silicon precursor  Time of hydrosilylation Temperature during 
hydrosilylation 
Si (OCH3)4 1 hour room temp. 
Si (OCH3)4 Overnight 70 °C 
SiCl4 Overnight room temp. 
Si (OCH3)4 Overnight room temp. 
 
The best results, in terms of photophysical and morphological properties of 
Si NPs, were obtained at room temperature with a prolonged (overnight) 
hydrosilylation step, which yielded properties comparable with the highest 
standards reported in the literature. 
Purification has been an important and crucial part of the work. The removal of 
the excess of capping agent and surfactant from the particles is a non-trivial task 
since the nanoparticles can be easily lost during the purification steps due to their 
ultrasmall size. This can lead to a drastic decrease of the overall yield. We 
explored several methods including dialysis and density gradient 
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ultracentrifugation (DGU), but size exclusion chromatography turned out to be 
the best technique to obtain clean ultrasmall Si NPs. Dialysis purification 
methods led to the loss of large fractions of particles through the membrane pores 
(even when using the smallest available molecular weight cut-off, such as 1KDa) 
and, in addition, they leave some surfactant impurities in the sample. 
Centrifugation methods are often used for NPs purification, but Si NPs have low 
density (e.g., compared to other NPs) and very small size. Therefore, satisfactory 
separation cannot be obtained by conventional centrifugation methods.  
Inspired by a recent paper[6] in which different sizes of Si NPs were separated by 
DGU, we attempted to use this method for separating Si NPs from unreacted 
reagents, surfactant and reaction by-products.  
As can be seen in Figure 2.2, we succeeded in separating different fractions. The 
ones containing our particles are easily distinguished due to their blue 
luminescence under UV light. Although effective in separation, the DGU 
method is not suitable for the purification because it introduces the density 
 
Figure 2.2. Different fractions of Si NPs separated by DGU under UV irradiation (the 
blue emission comes from the fractions containing the nanoparticles) 
 
gradient medium itself (Iodixanol solution) as an impurity. A high content of 
iodine was found in the samples when they were analyzed by XPS (Figure 2.3). 
This impurity is not easily removed and it is non-compatible with further 
bioapplications of the particles. 
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Figure 2.3. Survey XPS spectrum of a DGU fraction containing the blue emitting 
Si NPs. Note the massive presence of iodine coming from the density gradient medium.   
 
To our knowledge the best purification technique is size exclusion 
chromatography (Sephadex LH-20; eluent: methanol) as it has been shown also 
in literature[7]. In particular, the best results are obtained if the column is repeated 
several times, being the first fraction that comes out the cleanest, as verified by 
the absence of impurities in thin-layer chromatography.  
 
2.2.2 Characterization  
 
After purification, an extensive characterization of amine-terminated Si NPs has 
been carried out to determine size, crystallinity, photoluminescence (PL) 
properties and degree of functionalization.  
Typical HR-TEM images of amine-terminated Si NPs obtained by 
microemulsion method (Figures 2.4a and 2.4b), show that the particles are 
ultrasmall. In Figure 2.4c, a typical size distribution histogram shows that the 
particles have an average size of 2.5 ± 0.6 nm. In addition, in the TEM 
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micrograph reported in Figure 2.4a it is possible to see the crystal lattice of 
silicon. The distance between fringes is 0.2 nm, characteristic value for the lattice 
spacing of the (220) planes of crystalline silicon. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. a), b) HR-TEM images of amine-terminated silicon nanoparticles obtained 
by microemulsion synthesis; in a): the crystal fringes of silicon are clearly visible; c) 
size distribution graph (average size 2.5 ± 0.6 nm)  
 
In the same HR-TEM microscope, it is also possible to perform energy dispersive 
X-ray (EDX) analysis. In Figure 2.5, a typical EDX spectrum for amine-
terminated Si NPs is reported. As can be seen, the characteristic peak (1.75 keV) 
of the silicon Kα radiation confirms the NPs composition and does not reveal the 
presence of major impurities. The signals of copper, carbon and oxygen are due 
to the copper-coated carbon grids used to support the sample. 
a 
b 1 2 3 40
5
10
15
20
25
30
35
F
re
q
u
e
n
c
y
 %
Diameter (nm)
 
 
c 
 
53 
 
 
Figure 2.5. EDX spectrum of amine-terminated silicon nanoparticles prepared by 
microemulsion method  
Figure 2.6. a) Absorption (blue) and emission (red) spectra of amine-terminated Si NPs 
(microemulsion method) in water (λexc = 300 nm; filter 350 nm); inset: pictures of the 
solution under ambient illumination (left) and under UV irradiation (right); b) 
excitation spectrum in water (λem = 449 nm). 
 
The typical absorption and emission spectra of amine-terminated Si NPs in water 
(Figure 2.6a) show that the particles emit in the blue region of the 
electromagnetic spectrum. According to the debate present in the literature, such 
emission is due to either a size effect or to surface functionalization effects[8-10].  
The inset in Figure 2.6a shows that the solution is transparent and pale yellow 
under ambient illumination and bright blue under UV irradiation. The emission 
a) b) 
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maximum when exciting at λexc = 300 nm is centered at 449 nm.  In Figure 2.6b 
it is shown a typical excitation spectrum (λem = 449 nm) in water of amine-
terminated Si NPs prepared by microemulsion method. The spectrum shows two 
features: a first peak close to the peak in absorption (290 nm) and a second more 
intense peak at 360 nm, which is not visible in the absorption spectrum. In 
literature, the excitation spectra of Si NPs are often missing but, when shown, 
they do not correspond to the absorption spectra[9, 11].  
Figure 2.7 reports the effect of the excitation wavelength on the emission spectra. 
The position of the emission maximum is not constant, and in particular, it 
red-shifts at increasing excitation wavelengths. This effect is attributed to a direct 
bandgap-like behaviour induced by the presence of Si-C bonds at the NPs 
surface[12].  
On a different perspective, the intensity of emission is higher when we are 
exciting at 375 nm, confirming that the species that mostly contributes to the 
emission, features larger absorption in this spectral region. 
The photoluminescence quantum yield (PLQY) was measured by integrating 
sphere (for details see page 148) and it is around 2% at all excitation wavelengths 
and the PL lifetime was measured at λem = 450 nm, exciting at 290 nm (maximum 
value in absorption) and at 375 nm (in the region of the  maximum intensity in 
Figure 2.7. Emission spectra at various excitation wavelengths of amine-terminated 
Si NPs (microemulsion method) in ethanol (the excitation wavelengths, in nm, are 
reported on the top right) 
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emission). Both lifetimes can be fitted with a three-exponential decay (Table 2) 
in agreement with the findings for similar systems[5, 13]. 
  
 
The full excitation versus emission wavelength map is shown in Figure 2.8. The 
intensity, given in color scale, shows that the most intense emission takes place 
at excitation wavelength values of 350 - 390 nm. The black dots in the figure 
represent the measured position of photoluminescence maxima at each excitation 
wavelength. In order to estimate NPs size from the emission spectra, we 
determined the photoluminescence peak maximum under UV excitation 
(290 nm) and at the excitation maximum. According to a theoretical model[12], 
we can estimate the average NPs size and we found that the amine-terminated 
Si NPs have an average diameter of <1.9 nm. This value is in good agreement 
with the HR-TEM data, showing sizes in the range of 1.5 - 3.0 nm. 
 
 
Table 2. Photoluminescence lifetimes (and relative contributions) of amine-
terminated silicon nanoparticles in ethanol 
 Lifetime 
(λexc = 290 nm; λem = 450 nm) 
Lifetime 
(λexc = 375 nm; λem = 450 nm) 
NH2-Si NPs 
τ1 : 4.8 ns (35 %) 
τ2 : 11.8 ns (13 %) 
τ3 : 1.1 ns (52 %) 
τ1 : 4.4 ns (46 %) 
τ2 : 10.5 ns (14 %) 
τ3 : 1.1 ns (40 %) 
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Figure 2.8. Emission versus excitation wavelengths map: intensity is given by color 
scale. Black dots indicate position of PL maximum at different excitation 
wavelengths. 
 
The long-term stability of PL was checked by measuring the emission of NPs 
after 18 weeks of storage in the dark. The NPs display good stability, since their 
emission is still more than 60% of the initial value. 
 
Figure 2.9. ATR-FTIR spectrum of amine-terminated Si NPs (microemulsion method); 
top right: model of a single nanoparticle. Peaks are assigned according to literature and 
IR tables[4, 14-16] 
 
The attenuated total reflectance FTIR (ATR-FTIR) spectrum of amine-
terminated Si NPs (Figure 2.9) confirms the surface composition of the particles. 
The region of the spectrum from 3367 to 2931 cm-1 contains both, the C-H 
stretching (3084 and 2931 cm-1) and the N-H asymmetric (3367 cm-1) and 
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symmetric (3255 cm-1) stretching of the -NH2 group of the protecting 
propylaminic chain. The peak at 1631 cm-1 is associated to the bending of the 
NH2 bond. The peak at 1545 cm-1 is probably associated to a deformation mode 
of H-bonded amine groups (as reported[17] in similar systems) due to interactions 
of the shells of adjacent NPs or between the shell and some residual free 
allylamine hydrogen-bonded to the shell. The peaks at 1404 and 1270 cm-1 are 
related to the vibrational modes of the Si-CH2 bond, confirming the successful 
attachment of the propylaminic chain to the silicon surface. The absence of peaks 
in the region 1100 - 1000 cm-1 confirms that the particles do not contain 
appreciable amounts of silicon oxide.  
Further information on the prepared NPs was obtained from XPS measurements. 
Figure 2.10 reports the Si2p, C1s and N1s regions of the XPS spectrum of Si 
NPs.  
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Figure 2.10. From left to right: Si2p, C1s and N1s high resolution regions of XPS 
spectrum of amine-terminated Si NPs made by the microemulsion technique. 
Experimental data are in green. The results of curve resolution are reported in red 
(resulting curve) and black (individual components).   
 
The silicon peak can be resolved in three bands at ~100.5 eV, ~102.0 eV, 
~103.0 eV, assigned respectively to Si-C bonds, to silicon bound to only one 
oxygen (most probably O-Si-Si) and to more oxidized silicon species[18]. The 
elemental silicon component does not display appreciable intensity. To the best 
of our knowledge, elemental silicon signals, are only reported for particles with  
bigger size[8], where the ratio between surface and bulk silicon atoms is lower 
than in the case of ultrasmall nanoparticles. The low-oxidation fraction of silicon 
atoms (with B.E.s up to 102.0 eV) represents about 70% of the total. The 
presence of higher BE component can be explained either by the presence of 
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unreacted tetramethyl orthosilicate or by some oxidation occurred during the 
storage of the sample before XPS analysis. The presence of Si-C bond is 
confirmed by a small, but significant, low binding energy component of C1s at 
about 283.5 eV.  Finally, N1s peak features two components, the one at lower 
binding energy being assigned to free amine moieties, while the higher binding 
energy one is compatible with protonated amino groups. From the atomic ratios 
obtained from the XPS peak areas by standard procedures, we estimated the 
average number of amine functionalities per Si NP, as detailed in the 
experimental part. The calculation yields an average value of about 200 amines 
per Si NP. From geometrical considerations, we can estimate that a 2.5 nm-sized 
NP contains about 400 silicon atoms, ≈ 65% of them being surface atoms. We 
can estimate that a large fraction of the surface silicon atoms are bound to amine 
molecules.  
The above evaluation was compared with independent thermogravimetric 
analysis (TGA) measurements, performed under nitrogen atmosphere. The 
estimation was made by entirely attributing the weight loss above 200°C to the 
loss of the organic molecules covalently bound to silicon, according to literature 
data on similar systems[19-21]. This gives a value of ≈ 100 amine molecules per 
NP, again indicating that a large fraction of the surface silicon atoms are bound 
to the amine. 
 
2.3 Amine-terminated silicon nanoparticles prepared 
by hydrothermal synthesis 
 
2.3.1 Synthetic route 
 
In the hydrothermal synthesis, amine-terminated Si NPs were prepared 
according to a modification of a reported method[22] based on microwave heating 
of an aqueous solution of (3-Aminopropyl)trimethoxysilane in the presence of 
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trisodium citrate. Here we demonstrate that with a longer reaction time (5 hours), 
the particles can be prepared also in a conventional oven inside Teflon pressure-
resistant vessels. The advantage of using a conventional heating is that the 
synthesis can be easily scaled up at an industrial level. At laboratory scale, each 
run can yield up to 400 mg of Si NPs.  
A general synthetic scheme for the hydrothermal method is depicted in 
Figure 2.11. 
 
 
 
Figure 2.11. Schematic hydrothermal synthesis route for the preparation of amine 
terminated silicon nanoparticles. [APTMS = (3-aminopropyl) trimethoxysilane; 
citrate = Trisodium 2-hydroxypropane-1,2,3-tricarboxylate] 
 
As shown in the following, the particles obtained by this method are typically 
slightly bigger than the ones obtained by microemulsion method. The synthesis 
is much cleaner since there are only two starting reagents, making the 
purification easier and the use of dialysis affordable. However, we will show that 
Si NPs made by this method contain a higher amount of oxidized silicon 
compared to the microemulsion method. 
 
2.3.2 Characterization  
 
In Figure 2.12 and 2.13 the typical HR-TEM images of amine-terminated Si NPs, 
obtained by the hydrothermal method, and a typical size distribution graph are 
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shown. Figure 2.13 shows that average size of the particles is 4.3 ± 1.3 nm. In 
addition, in Figure 2.12b it is possible to observe the crystal lattice of silicon. 
The distance between fringes is of 0.2 nm, which is a characteristic value for the 
lattice spacing of the (220) planes of crystalline silicon.  
 
Figure 2.12. HR-TEM images of amine-terminated silicon nanoparticles obtained by 
hydrothermal synthesis; 15b: an isolated NP presenting the crystal fringes of silicon. 
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Figure 2.13. Size distribution histogram of amine-terminated Si NPs obtained by 
hydrothermal method (average size 4.3 ± 1.3 nm)  
 
In Figure 2.14, the EDX spectrum for amine-terminated Si NPs obtained by 
hydrothermal technique is reported. As can be seen, the characteristic silicon Kα 
a b 
20 nm 
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peak (1.75 keV) confirms the composition of the particles. Copper, carbon and 
oxygen peaks are due to the copper-coated carbon grid supporting the sample. 
 
 
Figure 2.14. EDX spectrum of amine-terminated silicon nanoparticles prepared by 
hydrothermal method.  
 
The typical UV-vis and emission spectra in water of these amine-terminated 
Si NPs (Figure 2.15a) show that they emit in the blue region of the 
electromagnetic spectrum also in this case.  
 
 
Figure 2.15. a) Absorption (blue) and emission (red) spectra of amine-terminated 
Si NPs (hydrothermal method) in water (λexc = 355 nm); b) excitation spectrum in water 
(λem = 446 nm). 
 
The emission maximum when exciting at λexc = 355 nm is centered at 446 nm. 
In Figure 2.15b a typical excitation spectrum (λem = 446 nm) in water is reported. 
a b
a 
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The excitation spectrum shows a peak at 365 nm. This value does not correspond 
to the maximum in the absorption spectrum (353 nm).   
When the emission spectra are measured at different excitation wavelengths 
(Figure 2.16), the maximum is red-shifted when increasing the excitation 
wavelength, but in less extent than in the microemulsion prepared NPs. This 
could be ascribed to some differences in surface composition of the two kinds of 
NPs, according to the literature debate[8, 12]. Also in this case, the highest intensity 
in the emission is located at excitation wavelengths close to the value of the 
maximum in the excitation spectrum. 
 
 
Figure 2.16. Emission spectra at various excitation wavelengths of amine-terminated 
Si NPs (hydrothermal method) in water (the excitation wavelengths, in nm, are reported 
on the top right) 
 
The PLQY, measured also in this case by integrating sphere, ranges from 2 % to 
13 % when exciting from 290 nm to 390 nm, and decreases again at higher 
excitation wavelengths. The maximum value of PLQY of Si NPs prepared by 
hydrothermal method is higher than the one of the NPs prepared by the 
microemulsion method. Lifetimes can be fitted also in this case with a three-
exponential decay (with corresponding contributions) being τ1: 7.5 ns (54 %), 
τ2: 2.5 ns (22 %) and τ3: 15.9 ns (24 %).  
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On the other hand, after 18 weeks of storage in the dark, the emission of the NPs 
decreased to less than 10% of its initial value.  
The attenuated total reflectance FTIR (ATR-FTIR) spectrum of amine-
terminated Si NPs is reported in Figure 2.17. In general, it is similar to the 
spectrum obtained for Si NPs made by the microemulsion technique, but 
indicates also the presence of Si-O bonds. 
 
 
 
Figure 2.17. ATR-FTIR spectrum of amine-terminated Si NPs (hydrothermal method)  
 
In detail, peaks are assigned according to reported values for amine-terminated 
silicon nanoparticles and IR tables[4, 14-16]. The region of the spectrum from 3360 
to 2930 cm-1 contains both, the C-H stretching and the N-H asymmetric and 
symmetric stretching of the -NH2 group of the propylaminic chain attached on 
the surface of the silicon NPs. The peaks in the range of 1600-1550 cm-1 are 
associated to the bending of the amine group and to the H-bonded amine as 
explained for the microemulsion method. The peaks in the region 
1400-1270 cm-1 are related to the vibrational modes of the Si-CH2 bond. The two 
peaks at 1105 and 1003 cm-1 (marked in Figure 2.17) are characteristic of the 
silicon oxide vibration modes. 
The relevant spectral regions of the XPS spectra for amine-terminated Si NPs 
prepared via hydrothermal method, are shown in Figure 2.18. 
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Figure 2.18. From left to right: Si2p, C1s and N1s high resolution regions of XPS 
spectrum of amine-terminated Si NPs made by hydrothermal synthesis. Experimental 
data in green, fitted spectrum in red, fit components in black.  
 
The overall appearance of the spectra is similar to those obtained for particles 
prepared by the microemulsion method. There are again three components in 
Si2p, four components in C1s and two components in N1s peak. In particular, 
the presence of Si-C moieties was again observed, but they are less abundant (by 
a factor 0.5-0.6) of those present on the samples prepared by microemulsion. 
This is consistent with a slightly different surface composition of NPs obtained 
via the two synthetic routes and in particular, with a higher quantity of oxygen 
at the surface of NPs from the hydrothermal method.  
The number of amine groups per Si NP was estimated from XPS intensities and 
from TGA measurements, following the same procedure reported in section 
2.2.2. From both the measurements, a value of 500 ÷ 600 amine molecules per 
particle was obtained, indicating that a large fraction of surfaces silicon atoms 
are bound to the amine-terminated chain.  
 
 
2.4 Conclusions 
 
In this Chapter, two different methods (microemulsion and hydrothermal) have 
been explored to prepare ultrasmall amine-terminated Si NPs. The obtained NPs 
were characterized from the morphological, compositional and photophysical 
point of view by several techniques and the two types of particles compared to 
each other. From the data illustrated and discussed in the Chapter, it is possible 
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to draw some conclusions on the differences, advantages and disadvantages of 
the two preparation methods. 
The great advantage of the microemulsion reaction procedure is that it can lead 
to ultrasmall silicon nanoparticles with stable photoluminescence properties on 
a time scale of several months. Also, the NPs produced with this method contain 
a lower amount of oxidized species than the ones prepared by the hydrothermal 
method. The average size of NPs is smaller (2.5 nm) than the hydrothermal one 
(4.3 nm) and the emission maximum can be tuned by changing the excitation 
wavelength. A disadvantage of the method is the need of complex purification 
procedures. On the other hand, the synthesis by hydrothermal method is cleaner, 
requires less purification efforts and can be easily scaled-up. From the point of 
view of the PL properties, hydrothermally prepared Si NPs are less stable and 
the emission wavelength is less tunable, but their initial PLQY can reach values 
much higher than those measured for the NPs generated via microemulsion 
synthesis (up to 13 % vs 2%). 
In conclusion, both methods lead successfully to the formation of ultrasmall 
water-soluble amine-terminated NPs suitable for further functionalization, e.g. 
for bioapplications. Therefore, depending on the desired properties and 
application, it results more convenient to use one or the other kind of NPs 
prepared. The comparison of the behaviour in in vitro and in vivo experiments of 
these two typologies of NPs will be the object of Chapter 3. 
 
 
2.5 Experimental section: 
2.5.1 Microemulsion method 
Materials 
All chemicals were purchased from Sigma-Aldrich and used without further 
purification, unless specified differently. Tetraoctylammonium bromide was 
purchased from Merck. Toluene (extra dry over molecular sieve 99.85%, 
AcroSeal®) was purchased from Acros and was deaerated by constant bubbling 
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of argon inside the bottle for 20-30 minutes. Methanol was deaereted before use. 
Allylamine was dried over CaCl2 overnight, distilled and deaerated before use. 
 
Synthetic procedure 
Silicon nanoparticles (Si NPs) were prepared using a modification of a reported 
method.[3-5] The reaction is performed in a nitrogen glove box (H2O and O2 
levels < 0.1 ppm). 7.5 g of tetraoctylammonium bromide was mixed with 100 ml 
of dry toluene and the mixture was stirred for 30 min. 0.5 ml of Si(OCH3)4 or 
SiCl4 was added and stirring was continued for 30 min allowing the silicon 
precursor to enter the micelles. Subsequently, 7 ml of LiAlH4 (1 M in THF) was 
added in order to reduce the silicon precursor and form hydrogen-terminated 
Si NPs. After 30 min of stirring, dry and deaerated methanol (3.2 ml) was added 
to quench the excess of LiAlH4. The quantity of MeOH was reduced in respect 
to reported methods to avoid the formation of methoxy-terminated nanoparticles. 
The final amine-terminated NPs were obtained adding distilled and degassed 
allylamine (13 ml) to the flask containing hydrogen-terminated Si NPs in the 
glove box, in the presence of 0.2 ml of H2PtCl6 catalyst (0.05 M in MeOH). After 
overnight stirring, 3-aminopropyl Si NPs were extracted with water, washed with 
ethyl acetate and filtered twice through syringe membrane filters (Millex, 
Millipore, PVDF, 0.45 µm). The resulting Si NPs were further purified by size 
exclusion chromatography (Sephadex LH-20) against MeOH. 
 
2.5.2 Hydrothermal method 
Materials 
All chemicals were purchased from Sigma-Aldrich and were used without 
further purification. Milli-Q water (Millipore) has been used as the solvent. High 
pressure resistant Teflon vessels were used for the reaction. 
Synthetic procedure 
Amine-terminated nanoparticles were prepared modifying a reported method[22]. 
0.8211 g of C6H5Na3O7 (trisodium citrate) were added to 20 ml of Ar-saturated 
Milli-Q water. After stirring and bubbling with Ar for 15 minutes, 5.0 ml of 
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NH2(CH2)3Si(OMe)3 (APTMS) were added to the solution of citrate and stirred 
under Ar for other 15 minutes. This starting mixture was transferred into a Teflon 
vessel while constantly bubbling Ar. The precursor solution was heated at 160 °C 
for 5 hours in a conventional oven. After cooling down to room temperature, the 
sample was purified by dialysis against water (MWCO: 1 KDa; Spectra/Por® 7 
dialysis tubing).  
 
2.5.3 Characterization 
XPS  
XPS analysis has performed by using a K-Alpha™ X-ray Photoelectron 
Spectrometer system from Thermo Scientific. Al K X-radiation was used 
(15kV, 72 W, 200 µm spot diameter). The transmission function of the analyzer 
had been calibrated using a standard argon ion etched copper sample. Spectra 
were measured using a pass energy of 200 eV for survey spectra and 50 eV for 
core level spectra. For XPS measurements, a dispersion of Si NPs in ethanol or 
water is deposited on a gold or aluminium support and allowed to dry overnight 
in a low-vacuum chamber before the introduction in the ultra-high vacuum 
chamber of the XPS system. Binding energies were calibrated using as reference 
the hydrocarbon C1s peak at 284.8 eV. Curve resolution was performed either 
with the proprietary Thermo Avantage data evaluation software or by means of 
the public domain software XPS peak developed by Prof. R. W.M. Kwok, The 
Chinese University of Hong Kong. Quantitative information about the surface 
composition is calculated from peak intensities using standard sensitivity factors.  
The number of amine groups per Si atom in the sample has been estimated from 
the N/Si ratio and from the C/Si ratio (considering only the C component bound 
to silicon). The calculation neglects any possible effect of photoelectron 
attenuation, and this tends to overestimate the contribution of atoms that are 
closer to the outer surface with respect to those located in inner layers. The 
obtained estimation of the amine molecules per silicon atom was then converted 
into amines/NP by using the average size of the particles obtained from TEM 
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size distribution histograms and assuming that the NPs have a spherical shape 
and the same atomic density of bulk silicon.   
 
HR-TEM 
Samples for HR-TEM and EDX were prepared drop-casting an ethanolic 
solution of the sample on carbon coated copper grids (Quantifoil, GmbH). The 
analysis were performed using a FEI Titan 80-300 transmission electron 
microscope operated at 300 KV. Size distribution histograms were built counting 
200 nanoparticles. 
 
Photophysical measurements 
Absorption spectra were acquired using a double-beam Shimadzu 
UV-3600 UV-Vis-NIR spectrophotometer. 
Steady-state emission spectra were recorded on a HORIBA Jobin-Yvon IBH 
FL-322 Fluorolog 3 spectrometer equipped with a 450 W xenon arc lamp, as the 
excitation source, and a TBX-4-X single-photon-counting device as the detector. 
Emission and excitation spectra were corrected for source intensity (lamp and 
grating) and emission spectral response (detector and grating) by standard 
correction curves.  
Time-resolved measurements were performed on FluoTime 300 “Easy Tau” 
spectrometer (PicoQuant) equipped with subnanoseconds LDH sources powered 
by a PicoQuant PDL 820 variable (0.2-80 MHz) pulsed power supply. 
Measurements were performed using a PicoHarp TCSPC (Time-Correlated 
Single Photon Countings) module. The decays were fitted by means of 
PicoQuant FluoFit Global Fluorescence Analysis Software (PicoQuant GmbH, 
Germany). 
PLQY were measured on a Hamamatsu Quantaurus-QY integrating sphere 
equipped with a 150 W CW Xenon source.  
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ATR-FTIR 
FT-IR spectra were acquired on a Shimadzu IRAffinity-1 spectrometer used in 
attenuated total reflectance (ATR) mode. 
 
TGA 
Measurements were performed, under nitrogen atmosphere, on a STA 449 F1 
(Netzsch) instrument. At least 3 mg of the waxy sample were put in an 
aluminium oxide crucible. Samples were heated to 120 °C (with a speed of 
20 K/min) and an isothermal step was performed for 20 minutes in order to 
remove any traces of solvent remained in the sample. Then samples were heated 
up to 600 °C (with a speed of 5 K/min).  
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Chapter 3 
 
Functionalization of ultrasmall Si NPs 
for bioimaging 
 
Abstract 
This Chapter deals with the surface modification of amine-terminated silicon 
nanoparticles with molecules, such as dyes or radiotracers, suitable for optical or 
positron emission tomography imaging. NPs are studied in vitro to assess their 
cytotoxicity and their in vivo behavior is investigated in order to compare NPs 
made by the two different syntheses reported in Chapter 2. Experiments of in 
vivo PET imaging and biodistribution will show that NPs are excreted very 
quickly from the body and some of them show no accumulation in organs giving 
promising expectation for future multimodal imaging. 
 
 
3.1 Introduction  
As mentioned in Chapter 1, ultrasmall Si NPs showed promising results in in 
vitro[1-18] and in vivo[17, 19-20] experiments. Some authors reported already about 
the possibility to use Si NPs in multimodal imaging.[17, 21] Nevertheless, to date, 
there is only one report on in vivo positron emission tomography (PET) with 
ultrasmall Si NPs and, in that case, NPs accumulate in the liver[17].  
In this thesis, we propose to use Si NPs as a platform for multimodal imaging. 
For this purpose, it is important to engineer the surface of the particles with 
desired imaging labels. This Chapter deals with the functionalization of 
ultrasmall Si NPs, prepared by the methods already described in Chapter 2, with 
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different molecules, such as dyes or radiolabels. After proper surface 
modification, in vitro and in vivo experiments were performed. In particular, we 
will report on in vitro cytotoxicity tests and in vivo PET imaging experiments 
performed with Si NPs prepared both by microemulsion and by hydrothermal 
methods. Experiments of optical imaging on properly functionalized Si NPs will 
be also described. The results achieved demonstrate the feasibility of the use of 
ultrasmall Si NPs as core components of a multimodal probe. 
 
 
3.2 Cytotoxicity of amine-terminated silicon 
nanoparticles 
 
In order to use Si NPs, or any type of nanoparticle, in bioimaging, it is essential 
to test the cytotoxicity in vitro before moving to in vivo experiments. Therefore, 
the in vitro experiments for amine-terminated Si NPs will be shown in this 
Chapter. 
In literature, the toxicity of ultrasmall amine-terminated Si NPs has previously 
been tested in vitro through MTT (3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl 
tetrazolium bromide) cell viability assays[4-6]. In the studies reported, 
amine-terminated Si NPs, that are usually positively charged, resulted to be quite 
toxic if compared to their neutral and carboxylic-terminated analogues. In 
addition, it was shown that the toxicity of ultrasmall amine-terminated Si NPs 
increases in the presence of serum[4] and this has been ascribed to the fact that 
the proteins contained in the serum may interact with NPs allowing an easier 
cellular uptake causing higher toxicity effects.  
In this thesis, amine-terminated Si NPs prepared by both, microemulsion method 
and by hydrothermal synthesis were tested in vitro in A549 cell lines 
(adenocarcinomic human alveolar basal epithelial cells) to assess their 
cytotoxicity. Cellular viability is determined using MTS 
(3-(4,5dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
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2H-tetrazolium) assay (similar to MTT assays previously reported), which is 
based on the measurement of the absorbance of the formazan molecule produced 
after the reduction of MTS operated by mitochondria in viable cells.  
Therefore, lower absorbance in the MTS assay indicates a reduction in the 
metabolic activity of the cells, which in turn can be interpreted as a reduction in 
cell viability. Figure 3.1 shows the results of the MTS assays performed after 
incubation of silicon nanoparticles for 24 hours in A549 cell lines in cell culture 
medium supplemented with increasing concentrations of fetal bovine serum 
(FBS). The study has been performed varying serum concentration because it 
has been shown that serum drastically influences the cellular uptake of larger 
NPs and, in particular, it is reported that increasing serum concentration 
interferes with the overall uptake of larger NPs decreasing the toxicity[22]. 
Amine-terminated Si NPs prepared by microemulsion method and by 
hydrothermal synthesis were compared to each other and to a positive control 
(amine-modified polystyrene nanoparticles with a size of 50 nm). It is well 
known[23-27] that amine-modified polystyrene NPs in this size range are quite 
toxic, inducing cell death by apoptosis. However, it has been reported[22] that the 
toxicity of  these nanoparticles can be reduced by increasing the amount of 
serum.  These reported results are in stark contrast to those reported for smaller 
nanoparticles. Indeed in the case of larger particles, the presence of high 
concentrations of proteins (serum) reduces the overall uptake of the NPs 
reducing the toxicity as explained above[22]. As can be seen in Figure 3.1a, the 
positive control (50 nm amine-modified polystyrene nanoparticles) shows the 
expected behaviour with a strong decrease of toxicity in the presence of high 
levels of serum. In the same figure, it is shown that the toxicity of amine-
terminated Si NPs prepared by both methods (microemulsion and hydrothermal 
synthesis) seems not to be dramatically influenced by the quantity of FBS present 
in the system. Actually, a careful examination of the plots reveals a slight 
increase, although not very pronounced, of toxicity at higher amounts of FBS in 
contrast to what happens in the case of the positive control.  
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This could be interpreted in terms of a different uptake mechanism for ultrasmall 
NPs compared to the bigger ones. In addition, interesting differences are found 
between amine-terminated particles obtained by the two different synthetic 
routes. Amine-terminated Si NPs made by the hydrothermal method (Figure 
3.1c) exhibit very low levels of toxicity even at concentrations as high as 
1 mg/mL. Instead, amine-terminated Si NPs made by microemulsion method, 
show higher toxicity when using high NPs concentration. Nevertheless, the 
particles exhibit low levels of cytotoxicity in the range of concentrations 
typically used for in vivo tests (1-10 µg/mL). A possible explanation for the 
different in vitro behaviour (at higher NPs concentration) could be related to a 
 
Figure 3.1. MTS cytotoxicity assay after incubation of three different kinds of particles 
in A549 cell lines for 24 hours in cell culture medium containing increasing amounts 
of fetal bovine serum (FBS): a) positive control, amine modified polystyrene (PS-NH2) 
nanoparticles with a size of 50 nm; b) amine-terminated silicon nanoparticles prepared 
by microemulsion technique (average size: 2.5 nm); c) amine-terminated Si NPs 
prepared by hydrothermal synthesis (average size: 4.3 nm)  
 
b) 
c) 
a) 
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higher content of amino-groups in the microemulsion prepared particles (as 
indicated by XPS data discussed in the previous Chapter) and/or to the possible 
presence of surfactant traces that remained adsorbed on the microemulsion 
prepared NPs even after several purification cycles.  
 
3.3 Surface functionalization of amine-terminated 
silicon nanoparticles 
 
In this section, the coupling of different molecules with Si NPs will be described. 
Prior to bioimaging experiments, Si NPs have been functionalized with a single 
kind of label, either a dye or a radiolabel, but it will be shown that the results 
achieved are promising to obtain a future multifunctional NP probe.  
More precisely, amine-terminated Si NPs have been functionalized with dyes, 
such as cyanine 5 and with radiotracers, such as 64Cu complexes. In the case of 
the cyanine 5-modified particles, the size of Si NPs remains in the ultrasmall 
range even after coupling (< 10 nm). The reason for functionalizing the NPs with 
a cyanine dye is to obtain emission in the far-red region of the electromagnetic 
spectrum, which is useful to perform in vivo experiments and optical detection. 
The red emission has deeper penetration length into tissues allowing detection 
when the particles reach internal organs such as liver, lungs and kidneys. 
The 64Cu complex instead, allows us to perform in vivo PET imaging in virtue of 
the decay properties of the 64Cu isotope.  This radioisotope has a half-life of 
about 12 hours and in a certain percentage decays to 64Ni by positron emission. 
This emission is used in nuclear medicine as a label.  
In the perspective of a future multimodal probe, NPs could also be functionalized 
with targeting agents, e.g. with specific peptides that selectively recognize cancer 
cells. A general scheme of multi-functionalized Si NPs is shown in Figure 3.2. 
As said before, we will limit mostly to the conjugation to a single kind of label 
each time (e.g., 64Cu complex or dye), but the scheme gives an idea of the future 
probe in which multi-functionalization will be carried on.  
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Figure 3.2. Schematic representation of some possible multi-functionalizations that can 
be carried on amine-terminated Si NPs 
 
3.3.1 Coupling of amine-terminated Si NPs with the cyanine 
5 dye 
Amine-terminated Si NPs were coupled to the commercial N-
hydroxysuccinimide ester of the dye cyanine 5 and to its water-soluble analogue 
(sulfo-cyanine 5). A simple scheme for the reaction is reported in Figure 3.3. 
 
 
Figure 3.3. Synthetic route for the coupling of amine-terminated Si NPs with the dye 
cyanine 5 (X, Y= H) or its water-soluble analogue sulfo-cyanine 5 (X, Y = SO3
-) 
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The coupling is based on the formation of an amide bond between the amine 
groups on the particles and the succinimidic ester on the cyanine 5. After the 
reaction is completed, cyanine 5- or sulfo-cyanine 5-modified Si NPs 
(respectively Cy5-Si NPs or s-Cy5-Si NPs) were purified from unreacted dye by 
dialysis against water until UV-Vis spectra did not show any presence of the dye 
in the external water. This step is necessary, but causes a large loss of NPs. After 
purification, Cy5-Si NPs and s-Cy5-Si NPs were investigated by HR-TEM, 
complete photophysical characterization and XPS. In Figure 3.4, a typical 
HR-TEM image shows that particles do not change morphology after coupling 
with the dye and that there are no significant changes in the particles core 
dimension, being the mean size 2.5 or 4.3 nm depending on the NPs synthetic 
method, microemulsion or hydrothermal. 
 
Figure 3.4. HR-TEM image of cyanine 5-modified Si NPs 
 
In Figure 3.5a, typical UV-vis spectra in ethanol of Cy5-Si NPs, amine-
terminated Si NPs and free cyanine 5 are compared. Sample Cy5-Si NPs features 
contributions from both Si NPs and Cy5, as clearly visible from the absorbance 
in the region 200 - 350 nm and from the peak at 650 nm, respectively.  The 
contribution from Si NPs is rather low and the peak at 300 nm is not clearly 
visible. This might be due to the dialysis step used for purification, which leads 
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to some loss of NPs. In Figure 3.5b, the emission spectra in ethanol of 
Cy5-Si NPs, amine-terminated Si NPs and free cyanine 5 are also compared. In 
the spectrum of Cy5-Si NPs both, the peak of the NPs and the one of the dye are 
present, indicating that the coupling has occurred since all the free dye has been 
removed by dialysis. In addition, another indication that the coupling has 
occurred is suggested by a slight red-shift of the emission maximum of the NPs 
in sample Cy5-Si NPs. When exciting both samples at 375 nm, Cy5-Si NPs have 
an emission maximum centered at 460 nm, while the free amine-terminated Si 
NPs show the emission maximum at 450 nm. The part of the spectrum due to the 
emission of cyanine 5 does not show appreciable differences between sample 
Cy5-Si NPs and the free dye. 
 
Figure 3.5. a) UV-vis and b) emission spectra (λexc = 375 nm; filter 400 nm) in ethanol 
of a typical sample of amine-terminated Si NPs (black), Cy5-Si NPs (red) and of the 
free dye Cy5 (green)  
 
As can be seen in Table 1, lifetimes are not particularly influenced by the 
coupling and they can be fitted with a mono-exponential decay when looking at 
the emission wavelength of the dye and with the typical three-exponential decay 
when looking at the emission wavelength of the particles. 
 
 
  
a) b) 
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Table 1. Photoluminescence lifetimes (and relative contributions) of amine-
terminated Si NPs, Cy5-Si NPs and free dye Cy5 in ethanol. 
 
 Lifetime  
(λexc = 375 nm; λem = 668 nm) 
Lifetime  
(λexc = 375 nm; λem = 450 nm) 
Cy5 τ1 = 0.9 ns (100%)  
Amine-terminated Si NPs  τ1 : 4.4 ns (46 %) 
τ2 : 10.5 ns (14 %) 
τ3 : 1.1 ns (40 %) 
Cy5-Si NPs τ1 = 1.1 ns (100%) τ1 = 3.5 ns (41.7 %) 
 τ2 = 9.9 ns (4.7 %) 
τ3 = 1.1 ns (53.6 %) 
 
In sample Cy5-Si NPs, the photoluminescence quantum yield (PLQY) increases 
in both the emission window of the dye and in the one of the particles, if 
compared to the free dye and free particles respectively. When exciting at 630 
nm, the PLQY of sample Cy5-Si NPs is 24 % instead of 17% as in the free dye 
solution, and when exciting at 375 nm, PLQY is 3% instead of 1% as in the free 
amine-terminated Si NPs dispersion. A crucial information for the in vivo 
experiments is to know how many cyanine-5 molecules per particle are present 
in sample Cy5-Si NPs. It is still challenging to get this information and also in 
literature, no reports describe the quantification of the number of groups on 
silicon nanoparticles. The concentration of dye in Cy5-Si NPs samples was 
estimated from a calibration curve built measuring absorbance of the free dye at 
different concentrations. This estimation is based on the assumptions that, after 
purification, all the remaining dye is bound to the NPs and that the absorption 
coefficient of the dye is not changed after coupling. Knowing from independent 
estimation, the concentration (w/V) of NPs in the sample after coupling, and 
knowing the average size of the NPs, it is possible to estimate the average 
number of dye molecules bound to one NP. In the case of the samples used for 
in vitro and in vivo studies, the above estimation gives an average of ~ 0.5 dye 
molecules per nanoparticle. This estimated value is in the same order of 
magnitude of the ideal 1:1 ratio that one would like to obtain in order to have all 
the particles labelled with the dye and still susceptible to be further 
80 
 
functionalized with additional label molecules. In any case, even if not all the 
particles are functionalized with the dye, the functionalized fraction obtained is 
sufficient to perform optical imaging in vivo, and leaves open the opportunity to 
add other molecules, e.g. targeting agents or/and radiotracers, on the NPs surface.  
Figure 3.6 reports the survey XPS spectrum of the sulfo-Cy5-Si NPs deposited 
on an aluminium substrate. The presence of sulfur, (originating from the sulfonic 
functional groups present in the dye), suggests that cyanine is present at the 
sample surface.  
The nitrogen to sulfur atomic ratio, calculated from the intensities of N1s and 
S2p, gives a value of ≈ 2.5, which is higher than that expected from the 1:1 
obtained from the stoichiometry of the dye. The excess of nitrogen is interpreted 
in terms of free amines still present at the surface of the NPs, giving a qualitative 
confirmation that many amine groups remain free after the coupling with the 
cyanine dye. 
Figure 3.6. Survey XPS spectrum of s-Cy5-Si NPs.  
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81 
 
3.3.2 In vitro and in vivo experiments with Cy5-Si NPs 
 
Prior to in vivo experiments, Cy5-Si NPs were tested in vitro to assess any change 
in cytotoxicity after functionalization of the particles with the dye. The cellular 
uptake mechanism of such particles was also investigated. In this paragraph, the 
results obtained with sulfo-cyanine 5 modified Si NPs (s-Cy5-Si NPs) will be 
shown. Figure 3.7 shows the result of MTS assays performed after incubation of 
s-Cy5-Si NPs for 24 hours in A549 cell lines in cell culture medium containing 
increasing amounts of fetal bovine serum (FBS), i.e. in the same experimental 
conditions used for the amine-terminated NPs not coupled with the dye. The 
behaviour of the s-Cy5-Si NPs is compared to a positive control (50 nm amine 
modified polystyrene nanoparticles) in the same cell line.   
 
 
Figure 3.7. MTS assay after 24 hours incubation in A549 cell lines of sulfo-cyanine 5-
modified silicon nanoparticles (s-Cy5-Si NPs) in cell culture medium containing 
increasing amounts of fetal bovine serum (FBS); Pos (Qnano) are the positive control 
NPs [amine modified polystyrene (PS-NH2) nanoparticles with a size of 50 nm] 
incubated in the same cells; SF = serum free 
 
As can be seen in Figure 3.7, s-Cy5-Si NPs show still a very low cytotoxicity as 
in the case of amine-terminated Si NPs checked previously. Also in this case, 
there appears to be a slight decrease in cell viability when the amount of serum 
is higher. This could be explained as in the previous Chapter by the NPs size, 
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which remains in the ultrasmall range after functionalization. However, it is 
worth noting that the A549 cell line was optimised to be cultured in 10% FBS.  
Cell metabolism (especially over 24 hours as is the exposure in this experiment) 
can greatly change with higher serum concentrations.  Therefore the lower MTS 
readouts observed from cells culture in 100% FBS compared to 10% FBS, could 
be due to the cells having lower metabolism. 
To understand the mechanism of cell uptake for s-Cy5-Si NPs, some experiments 
of flow cytometry have been carried out. Indeed, while most nanoparticles are 
believed to enter cells by energy-mediated processes such as endocytosis, it is 
possible that ultrasmall particles may passively diffuse through the cell 
membrane (similarly to the behaviour of small molecules). To investigate which 
of these two mechanisms s-Cy5-Si NPs are uptaken by cells, we incubated the 
particles in A549 cell line for 7 hours at 37 °C, and in systems where we 
purposely reduce energy mediated processes (i.e. using 4 °C or adding NaN3). 
The same experiment was also repeated in cell culture medium containing 
different concentrations of fetal bovine serum (FBS). The fluorescence 
histograms obtained are shown in Figure 3.8. 
The histograms represent the frequency distribution of the fluorescence signal 
recorded for >15,000 single cell events when analysed using 633 nm excitation 
and an emission window of 675 ± 12.5 nm. The curve in all cases appears to be 
mostly symmetrical indicating that the data is normally distributed. When the 
particles are incubated with the cells at 37 oC, there is an overall increase in the 
population of cells to higher fluorescent intensities. As Cy5 is active under these 
optical settings, we can assume that the increase in fluorescence of the cells is 
due to internalisation of the particles. (NB all efforts are made to minimise the 
number of particles stuck to the cell surfaces so that measurements reflect 
internalised particles only – the efficiency of this will be monitored by confocal 
microscopy). No difference is observed between the populations incubated in 
cell culture medium containing different concentrations of serum proteins – 
suggesting that the proteins do not have an effect on uptake. When energy is 
removed from the incubation scenario (i.e. reducing the temperature to 4 oC or 
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using NaN3 (which affects mitochondrial oxidative phosphorylation, to achieve  
ATP depletion) there is a smaller shift in the population from the fluorescent 
distribution of the cells in absence of particles (black trace) when compared to 
the cells incubated at 37 °C.  This suggests that the uptake of s-Cy5-Si NPs is 
reduced when the energy of the cells is reduced, implying that the particles 
mostly enter via energy dependent mechanisms, such as endocytosis (as opposed 
to diffusion which is a passive process). Again, even in reduced energy exposure 
conditions, the concentration of serum proteins in the exposure medium has no 
significant effect on uptake. This could be due to a different uptake mechanism 
for ultrasmall NPs in comparison with bigger particles (as increasing 
concentrations of serum usually decrease the number of particles taken up by 
cells)[22]. 
To complete the in vitro study, confocal microscopy imaging was performed on 
fixed samples of A549 cells incubated for 7 hours at 37 °C with s-Cy5-Si NPs 
(Figure 3.9). The particles (red spots in the image) are taken up by cells and co-
localized with lysosomes (green colour in the image). This confirms that the 
37 °C NaN3 4 °C 
Figure 3.8. Fluorescence histograms acquired by flow cytometry of s-Cy5-Si NPs 
incubated for 7 hours with A549 cells in cell culture medium containing different 
serum concetrations at 37 °C and in reduced energy systems (4 °C and in the 
presence of NaN3) (SF = serum free; FBS = fetal bovine serum); black traces 
represent untreated cells;  red traces represent cells incubated with s-Cy5-Si NPs in 
SF conditions; orange traces represent cells incubated with s-Cy5-Si NPs in 10% 
FBS v/v; yellow traces represent cells incubated with s-Cy5-Si NPs in 50% FBS 
v/v; green traces represent cells incubated with s-Cy5-Si NPs in 100 % FBS v/v; 
λexc = 633 nm and emission window = 662.5 - 687.5 nm 
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particles enter the cell through an energy dependent process such as endocytosis 
with final destination in lysosomes (particles that enter through passive diffusion, 
such as small molecules are found throughout the whole cytosol and not localised 
in acidified compartments like lysosomes). 
 
 
Figure 3.9. Confocal microscopy of s-Cy5-Si NPs incubated in A549 cell line for 7 
hours (nucleus is stained with DAPI, blue colour; lysosomes are stained with LAMP-1 
primary antibody, green colour; EGFR is stained in white; s-Cy5-Si NPs are represented 
in red) 
 
Since in vitro tests showed that the particles have very low cytotoxicity, in vivo 
optical imaging using Cy5-modified Si NPs were performed. s-Cy5-Si NPs were 
injected through the tail vein in female NMRI nu/nu mice. The animals were 
irradiated with 650 nm light and the signals at 700 nm were collected in time. 
The emission intensity, which is connected to the distribution of particles in the 
blood and in the bladder are showed in Figure 3.10. As can be seen, already at 
10 minutes post-injection many of the particles are in the bladder. 
In Figure 3.11, the optical images of mice at different times post-injection are 
shown. They are compared to a standard placed close to the mouse and consisting 
s-Cy5-Si NPs 
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in the same solution of s-Cy5-Si NPs injected in the mice. From the images, it is 
clear that, at time zero, only the tail is fluorescent because particles are being 
injected through the tail vein. Then particles start to diffuse in all the body, 
starting to reach the bladder where all NPs accumulate at 50 minutes post-
injection.  
 
Figure 3.10. Biodistribution of s-Cy5-Si NPs in the blood (red curve) and in the bladder 
(blue curve) of NMRI nu/nu mice 
 
 
 
Figure 3.11. Optical images of NMRI nu/nu mice at 0, 5, 20, 50 (going from left to 
right) minutes post-injection of s-Cy5-Si NPs; the bright spot on the top is a solution of 
s-Cy5-Si NPs with the same concentration of the solution injected 
 
Figure 3.12 shows the biodistribution in organs after mice sacrifice. As it can be 
seen, the majority of the particles are in the bladder and in the intestine. The 
accumulation in intestine suggests that s-Cy5-Si NPs are following both of the 
two possible excretion pathways for NPs, i.e. renal excretion, through kidneys 
and bladder, and hepatobiliary excretion through the liver and the intestine. 
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Although the system can be improved reducing accumulation in the intestine, the 
result obtained is very promising for a future multimodal probe since particles 
do not accumulate in other organs and the majority of them are excreted already 
at 50 minutes post-injection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12. Biodistribution by optical imaging in organs of sacrificed mice after 
injection of s-Cy-Si NPs.  
 
 
3.3.3 Coupling of Si NPs with 64Cu complexes for in vivo PET 
imaging 
 
In literature, to date, there is only one example of in vivo PET imaging with 
ultrasmall Si NPs[17] and in this experiment, NPs accumulate in the liver. 
Therefore, it results interesting to compare the in vivo behaviour of the two kinds 
of ultrasmall Si NPs prepared, by performing PET imaging. 
Stomach 
 
Intestine 
 
Bladder 
 
Urine 
 
Kidneys 
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Si NPs, prepared both by microemulsion and hydrothermal method were coupled 
to the commercially available S-2-(4-Isothiocyanatobenzyl)-1,4,7-
triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-NOTA), a common ligand for 
copper. The coupling happens between the isothiocyanate moiety of the ligand 
and the amino groups on the Si NPs surface to form a thiourea bond in the final 
NOTA-Si NPs (Figure 3.13). 
 
 
Figure 3.13. Reaction scheme of Si NPs coupling with p-SCN-Bn-NOTA ligand 
 
After the reaction is completed, NOTA-Si NPs are purified from unreacted 
ligand by dialysis against water. Subsequently, the particles were mixed with a 
[64Cu]CuCl2 solution to complex them with the radionuclide 64Cu in order to 
perform PET. The [64Cu-NOTA-Si NPs] obtained in this way, were injected 
through the tail vein in male Wistar rats to perform biodistribution studies and in 
female NMRI nu/nu squamous cell carcinoma (A431) tumour bearing mice to 
perform in vivo PET imaging. In Figure 3.14, the comparison between PET 
images obtained for [64Cu-NOTA-Si NPs] prepared by microemulsion, 
[64Cu-NOTA-Si NPs (micro)], and hydrothermal, [64Cu-NOTA-Si NPs (hydro)], 
method is shown. As can be seen from this Figure, [64Cu-NOTA-Si NPs (hydro)] 
accumulate in the bladder at 50 minutes post-injection while [64Cu-NOTA-Si 
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NPs (micro)] accumulate in the bladder too, but a certain percentage remains also 
in the intestine at 50 minutes post-injection.  
The two curves in the lower part of Figure 3.14 represent the activity, expressed 
as percentage of injected dose, present in the bladder versus time post-injection. 
The curves grow in time showing that the particles are accumulating in the 
bladder to be subsequently, excreted. The mice used bear a tumour, in the back 
or right hind leg, but no accumulation of particles in the tumour site was 
observed. This can be due to the lack of any cancer-specific targeting agent and 
because the NPs are too small to show enhanced permeability and retention effect 
(EPR effect). EPR is the effect by which particles tend to accumulate in higher 
concentrations in cancer tissues in respect to healthy tissues[28-30]. Indeed, the 
tumour microvascular endothelium exhibits a higher permeability to particles or 
bigger macromolecules in respect to healthy ones[30]. Our hypothesis is that  
 
 
Figure 3.14. PET images at different times post-injection of NMRI nu/nu mice injected 
with [64Cu-NOTA-Si NPs] made by microemulsion (top left) or hydrothermal (top 
right) method; percentage of injected dose versus time post-injection in the bladder of 
mice injected with [64Cu-NOTA-Si NPs (micro)], bottom left, or with [64Cu-NOTA-Si 
NPs (hydro)], bottom right  
64Cu-NOTA-Si NPs (micro) 
 
64Cu-NOTA-Si NPs (hydro) 
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ultrasmall Si NPs possess a too small dimension to show EPR effect, so they 
have to be properly engineered to target cancer cells. 
As mentioned before, only  one example of in vivo PET imaging of ultrasmall Si 
NPs, namely dextran-coated manganese-doped Si NPs, has been reported so 
far[17] and, in this experiment, it was found that NPs accumulate in the liver. NPs 
can be eliminated by renal clearance, i.e. through kidneys and bladder, or by 
hepatobiliary excretion, i.e. through liver and intestine, or by a combination of 
the two excretion mechanisms. Renal clearance is a highly desirable trait for 
diagnostic nanoparticles in order to reduce retention in non-targeted tissue, to 
observe efficient excretion of unbound probes from the body and to minimize 
nanoparticle toxicity[31]. As it has been proposed in literature[32], NPs that can 
have a future in theranostics should have a hydrodynamic radius ≤ 5.5 nm and 
non-toxic components that, preferably, could be biodegraded into clearable 
components. All the NPs, studied in this thesis, meet these requirements and our 
results are very promising since both kinds of Si NPs do not accumulate in the 
liver. In particular, Si NPs made by the hydrothermal method accumulate only 
in the bladder, being completely excreted. 
To deeply investigate the behaviour of the two types of Si NPs, biodistribution 
experiments were performed. For these studies, rats were sacrificed at specific 
times post-injection, organs were weighed and the activity present in the organs 
was measured. 
In Figures 3.15 and 3.16 the biodistribution experiments reported both as 
percentage of injected dose (% ID) and as standardized uptake value [SUV = 
(activity/g tissue)/(injected activity/body weight)] are shown. 
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Figure 3.15. Biodistribution of [64Cu-NOTA-Si NPs (hydro)], expressed as % ID 
(upper figures) and SUV (bottom figures), at 5 and 60 minutes post-injection in male 
Wistar rats.  
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Figure 3.16. Biodistribution of [64Cu-NOTA-Si NPs (micro)], expressed as % ID 
(upper figures) and SUV (bottom figures), at 5 and 60 minutes post-injection in male 
Wistar rats.  
 
From Figures 3.15 and 3.16, it is evident that after 60 minutes, both kinds of Si 
NPs are mainly excreted through urine, but [64Cu-NOTA-Si NPs (micro)] 
accumulate in some percentage in the intestine as already discussed before in this 
Chapter. In Figure 3.17, a histogram shows the ratios between renal and 
hepatobiliary excretion for both kinds of Si NPs used. 
 
92 
 
 
Figure 3.17. Histogram showing the ratio between renal and hepatobiliary mechanism 
of excretion for [64Cu-NOTA-Si NPs (hydro)] and [64Cu-NOTA-Si NPs (micro)] 
 
[64Cu-NOTA-Si NPs (hydro)] follow mainly a renal mechanism of excretion 
while [64Cu-NOTA-Si NPs (micro)] follow both mechanisms (renal and 
hepatobiliary). In both cases, NPs do not accumulate in other organs and 
therefore, they represent a very promising platform for future multimodal 
imaging. In addition, [64Cu-NOTA-Si NPs (hydro)] behave in a very ideal way 
as they accumulate directly in the bladder, which represent the preferred 
excretion pathway for NPs as mentioned before[31-32]. 
 
3.4 Conclusions 
In this Chapter, Si NPs made by the two different methods discussed in 
Chapter 2, were tested in vitro to assess their cytotoxicity and, subsequently, 
functionalized with a dye or a radiotracer to study their behavior in vitro and in 
vivo. In in vitro tests, NPs made by microemulsion method, although not too 
toxic at low concentrations, show higher cytotoxicity than hydrothermal-
prepared ones that, in contrast, show very high cell viability even at 
concentration as high as 1 mg/mL confirming the high biocompatibility of this 
system. Cy5-Si NPs were characterized and it was found that they show both the 
emission properties of Si NPs and of the dye. In addition, their surface is still 
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available for further couplings showing the presence of free amine-groups on the 
surface after the functionalization with the dye. Cy5-Si NPs showed a very low 
cytotoxicity and, from flow cytometry measurements, it resulted that NPs are, 
most probably, uptaken by cells through an endocytosis mechanism. Confocal 
microscopy seems to confirm this mechanism of uptake since NPs are 
co-localized with lysosomes. In vivo optical imaging experiments showed that 
Cy5-NPs are excreted very fast, being already in the bladder at 50 minutes post-
injection, but some accumulation in the intestine was also observed. Finally, both 
kinds of amine-terminated Si NPs were coupled to a 64Cu complex and their 
behavior in in vivo PET imaging was compared. Both kinds of NPs are mostly 
excreted through renal clearance, but NPs made by microemulsion method, 
follow also the hepatobiliary mechanism of excretion showing some 
accumulation in the intestine. Hydrothermal prepared-Si NPs behave in an ideal 
way as they are entirely excreted through the bladder already at 50 minutes post-
injection. The slightly different behaviour, both in vitro and in vivo, of the two 
kinds of NPs could be ascribed to the slightly different composition and 
properties of the NPs, as explained in Chapter 2. The results achieved are 
promising for the future application of these NPs in multimodal imaging. 
 
 
3.5 Experimental section 
 
3.5.1 Coupling of Si NPs with cyanine 5 
Materials 
Cyanine 5 NHS ester and its water soluble analogue, sulfo-Cyanine 5 NHS ester were 
purchased from Lumiprobe. 
 
Synthetic procedure 
Cy5- and sulfo-Cy5-modified Si NPs (Cy5-Si NPs and s-Cy5-Si NPs) were prepared 
simply mixing the particles with the desired NHS ester of the dye. In a typical 
experiment, 100 mg of amine-terminated Si NPs (either prepared by microemulsion or 
94 
 
by hydrothermal method) were dispersed in 4.0 mL of absolute ethanol. Then 0.4 to 0.6 
mg of Cy5- or s-Cy5-NHS ester is added. The final solution is shaken for 12 hours in 
the dark. After reaction is completed, the sample was purified by dialysis against water 
(MWCO: 1 KDa; Spectra/Por® 7 dialysis tubing) for several days until the external 
water does not contain free dye. 
 
3.5.2 In vitro experiments 
Cell culture 
Tissue culture reagents were purchased from GIBCO Invitrogen Corporation/Life 
technologies Life Sciences unless otherwise specified. The adherent human tumour cell 
lines A549 (ATCC-CCL-185) were maintained as monolayer cultures in MEM 
supplemented with 10% Fetal Bovine Serum (FBS) at 37 °C and 5% CO2. All cell lines 
were confirmed to be mycoplasma negative using the LookOut mycoplasma PCR 
detection kit (Sigma-Aldrich) and were tested monthly. 
 
MTS assays 
Cellular viability was determined by the MTS assay, which measures the reduction of 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium (MTS) to formazan by mitochondria in viable cells. 10 000 cells were 
seeded in each well of a 96-well plate (Greiner) and incubated for 24 hours before 
exposing to nanoparticles.  The medium was replaced by nanoparticle dispersions, 
freshly prepared by diluting the nanoparticle stock in serum-free MEM, or medium 
supplemented with different concentration of FBS. The nanomaterials to be tested were 
added to the wells at the following doses: 15.62 µg/ml, 31.35 µg/ml, 62.5 µg/ml, 125 
µg/ml, 250 µg/ ml and 500 µg/ml. After the incubation period (24 hours) the cell culture 
media was removed from each well. The CellTiter 96 AQueous One Solution Reagent 
(Promega) was added to each well of the 96 well plate. The plate was incubated with 
the MTS reagent for 60 minutes at 37 °C in a humidified, 5% CO2 atmosphere. 
Formazan absorbance was measured at 490 nm using a microtiter plate reader 
(Varioskan Flash, Thermo Scientific, MA, USA). Recorded data were processed as 
follows: the average background level was subtracted from each well. The resulting 
absorbance from each dosing well was normalized to the absorbance value of untreated 
cells. Additional control experiments, namely the MTS reagent mixed with 
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nanoparticles only, were performed to assess potential interference of the nanoparticles, 
and did not reveal any interference of the NPs used with the MTS assay. 
 
Flow cytometry 
A total of 100 000 cells were seeded in 24 well plates (Greiner), and incubated for 24 h 
before exposing to nanoparticles.  The medium was then replaced by the nanoparticle 
dispersions, freshly prepared by diluting the nanoparticle stock to a concentration of 
250 µg/mL in serum-free MEM, or medium supplemented with different concentration 
of FBS, for 7 hours. For flow cytometry, cells were washed once with MEM supplement 
with 10% FBS and twice with PBS and harvested with trypsin. Cell pellets were then 
fixed at room temperature with 4 % formalin (Sigma-Aldrich) for 20 min, and 
resuspended in PBS before cell-associated fluorescence (15 000 cells per sample) was 
measured using an Accuri C6 reader (BD Accuri Cytometers). The results are reported 
as the median of the distribution of cell fluorescence intensity, averaged over three 
independent replicates.  
 
Confocal microscopy 
For confocal microscopy, 100000 cells were seeded onto 35 mm plates with 15 mm 
diameter glass coverslips and grown for 24 h prior to exposure to nanoparticles. Cell 
were exposed to nanoparticles at a concentration of 250 µg/ mL for 7 hr. For organelle 
and protein staining, samples were then washed three times with 1mL PBS, fixed for 
20 min with 1mL of 4 % formalin at room temperature. The cell-membrane was 
permeabilised using 1 mL of 0.1 % saponin (Sigma Aldrich) solution for 5 min at room 
temperature and cell were then incubated for 30 min at room temperature with a 
blocking solution of 1 % bovine serum albumin fraction V (Sigma Aldrich) in 
PBS–Tween to prevent antibody non-specific binding. Samples were then incubated for 
1 h at room temperature with a primary antibody 1 : 200 rabbit polyclonal to LAMP-1 
(Abcam) and with a primary antibody 1 : 200 mouse monoclonal antibody to EGFR 
(Abcam, to aid visualization of the cell under the microscope), washed three times with 
1 mL PBS, and then incubated at room temperature for 1 h with 1 : 400 dilution of 
Alexa Fluor® 488 goat anti-rabbit IgG and with 1 : 400 dilution of Alexa Fluor® 647 
goat anti-mouse IgG as secondary antibodies (Molecular Probes, Life Technologies). 
Samples were washed three times with 1 mL PBS and incubated for 5 min with DAPI 
(Sigma Aldrich) before mounting with MOWIOL (Polysciences Inc.) on slides for 
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imaging. The cells were observed using a Carl Zeiss LSM 510 Meta laser scanning 
confocal microscope with lasers at 364 nm and long pass filter LP 385 nm (DAPI), 488 
nm and band pass filter 505– 530 nm (LAMP-1 antibody), 543 nm and band pass filter 
558–612 nm (EGFR antibody) and 633 nm and band pass filter 644–719 nm 
(nanoparticles). 
 
3.5.3 Coupling of Si NPs with NOTA ligand 
Materials 
S-2-(4-Isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (SCN-Bn-
NOTA; #B-605) was purchased from Macrocyclics. 
 
Synthetic procedure 
[NOTA-Si NPs (micro)] and [NOTA-Si NPs (hydro)] were prepared dispersing 1 mg 
of amine-terminated Si NPs (either prepared by microemulsion or by hydrothermal 
method) in 150 µL of deionized water and placed in a 1.5 mL low protein binding 
Eppendorf-tube. A specific amount of SCN-Bn-NOTA (0.1 or 0.8 µmol/mg - according 
to the used amount of nanoparticles) was dissolved in 100 µL of deionized water and, 
then, added to the NPs dispersion. The final dispersion was then shaken on a 
thermo-mixer (Eppendorf) at 750 rpm for 16 h at 25 °C. All samples, which were used 
for in vivo experiments, have been purified by dialysis against deionized water (MWCO 
500 – 1000 Da, Spectra Por Float-A-Lyzer G2, 1 mL). Afterwards a defined aliquot 
was freeze-dried to obtain the final concentration of particles.  
 
3.5.4 Radiolabeling of [NOTA-Si NPs (micro)] and [NOTA-Si 
NPs (hydro)] 
 
The production of 64Cu was performed at Cyclone® 18/9 (Helmholtz-Zentrum 
Dresden-Rossendorf) in a 64Ni(p,n)64Cu nuclear reaction with specific activities of 
150–250 GBq µmol-1 Cu diluted in HCl (10 mM).[33] An aliquot of [64Cu]CuCl2 solution 
(20–100 MBq) was buffered with MES (2-(N-morpholino)ethanesulfonic acid)/NaOH-
buffer (0.1 M; pH 6). Typically, a specific amount of nanoparticles, up to 10 µg, was 
mixed in a 1.5 mL low protein binding Eppendorf-tube with a specific aliquot of 
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[64Cu]Cu(II)-solution (varying up to 40 MBq) and addition of MES/NaOH buffer 
(0.1 M; pH 6) up to a final volume in the range of 150-200 µL. The particles have been 
labelled by means of mechanical shaking for 30 min at 25 °C. To check the full labeling, 
a 5.0 µL aliquot of the reaction was combined with 2.0 nmol EDTA (pH 7.0) and the 
labeling process of the nanoparticles (Rf = 0) was monitored by radio-TLC using 
ITLC-SA plates (Merck Millipore) in combination with a mobile phase of 0.9% NaCl 
in dH2O. As control, separate radio-TLC analysis of [
64Cu]Cu–EDTA (Rf = 0.9) was 
performed in the same mobile phase. Evaluation of radio-TLC was carried out using a 
radioactivity thin layer analyser (Rita Star, Raytest). 
 
3.5.5 Animal experiments 
All animal experiments were carried out according to the German regulations on animal 
welfare (approved by Landesdirektion Dresden, 24-9168.21-4/2004-1). Male Wistar 
rats (aged 7-9 weeks; Harlan Winkelmann GmbH, Borchen, Germany) and female 
NMRI nu/nu mice (aged 7-14 weeks; Technische Universität Dresden, Oncoray, 
Germany) were housed under standard conditions with free access to standard food and 
tap water. For PET experiments in tumour-bearing mice, about 2x106 A431 cells were 
injected subcutaneously in the back or right hind leg of NMRI nu/nu mice according to 
the protocol published elsewhere. 
 
3.5.6 Biodistribution 
Two groups of four rats (5 and 60 min) were intravenously injected into a lateral tail 
vein with 0.5–5.0 MBq of 64Cu-labeled nanoparticles, which were dissolved in 0.5 mL 
of electrolyte solution E-153 (Serumwerk Bernburg, Germany) at pH 7.2. The specific 
activity ranged from 5.0 to 30 GBq/μmol at the time of injection. Animals were 
sacrificed at 5 and 60 min post injection. Blood and the major organs were collected, 
weighed, and counted in a Wallac WIZARD automatic γ-counter (PerkinElmer, 
Germany). The activity of the tissue samples was decay-corrected and calibrated by 
comparing the counts in tissue with the counts in aliquots of the injected tracer that had 
been measured in the γ-counter at the same time. The activity amount in the selected 
tissues and organs was expressed as percent of injected dose (% ID). The activity 
concentration in the biodistribution measurements were calculated as SUV [SUV = 
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(activity/g tissue)/(injected activity/body weight)] and expressed as means ± standard 
deviation (mean ± SD) for each group of four animals. 
 
3.5.7 In vivo small animal positron emission tomography 
(PET) 
Rats or mice were anesthetized (Desfluran in oxygen/air (30 %), positioned and 
immobilized prone with their medial axis parallel to the axial axis of the scanners 
(NanoScan PET/CT, Mediso, microPET® P4, Siemens preclinical solutions). The 
radiotracer was administered intravenously as an infusion using a syringe pump over 
one minute (Harvard Apparatus, flow rate: injection volume as mL/min) through a 
needle catheter into a lateral tail vein. The standardized uptake values (SUV) were 
calculated from the ROI as the ratio of activity concentration (Bq/mL) at time t and 
injected dose (Bq) at the time of injection (t0) divided by body weight (g). For the 
demonstration of the increasing activity uptake, the early (midframe time 3 min post 
injection) images were subtracted from the late image (midframe time 50 min post 
injection). 
 
3.5.8 Characterization 
HR-TEM 
Samples for HR-TEM were prepared drop-casting an ethanolic solution of the 
sample on carbon coated copper grids (Quantifoil, GmbH). The analysis were 
performed using a FEI Titan 80-300 transmission electron microscope operated 
at 300 KV. 
 
XPS  
For XPS measurements, a dispersion of Si NPs in ethanol or water is deposited 
on aluminium support and allowed to dry overnight in a low-vacuum chamber 
before the introduction in the ultra-high vacuum chamber of the XPS system. 
Other experimental details as in Chapter 2. 
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Photophysical measurements 
Absorption spectra were acquired using a double-beam Shimadzu UV-3600 UV-
Vis-NIR spectrophotometer. 
Steady-state emission spectra were recorded on a HORIBA Jobin-Yvon IBH FL-
322 Fluorolog 3 spectrometer equipped with a 450 W xenon arc lamp, as the 
excitation source, and a TBX-4-X single-photon-counting device as the detector. 
Emission and excitation spectra were corrected for source intensity (lamp and 
grating) and emission spectral response (detector and grating) by standard 
correction curves.  
Time-resolved measurements were performed on FluoTime 300 “Easy Tau” 
spectrometer (PicoQuant) equipped with subnanoseconds LDH sources powered 
by a PicoQuant PDL 820 variable (0.2-80 MHz) pulsed power supply. 
Measurements were performed using a PicoHarp TCSPC (Time-Correlated 
Single Photon Countings) module. The decays were fitted by means of 
PicoQuant FluoFit Global Fluorescence Analysis Software (PicoQuant GmbH, 
Germany). 
PLQY were measured on a Hamamatsu Quantaurus-QY integrating sphere 
equipped with a 150 W CW Xenon source.  
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Chapter 4 
Functionalization of carbon dots for 
bioimaging 
 
Abstract 
This Chapter is dedicated mainly to the functionalization of carbon dots with a 
dye or a radiotracer and to the in vivo experiments in order to make a 
comparison with the behaviour of silicon nanoparticles. The ultrasmall carbon 
dots (3 nm size), displaying multi-coloured emission, were surface-modified 
with the same dye or 64Cu complex used for Si NPs and their behaviour in in 
vivo PET imaging experiments was studied and compared with that of the 
ultrasmall Si NPs. 
 
4.1 Introduction 
Thanks to their biocompatibility, bright multi-coloured emission and stability 
against photobleaching, carbon quantum dots (CQDs) are promising materials 
for bioimaging[1-2]. CQDs can be prepared through facile one-step synthesis. 
However, it is more difficult to control their size, their shape and their surface 
chemistry. The structure of CQDs is still object of research but, in contrast to Si 
NPs, their shape cannot be approximated to a spherical particle.  As discussed 
in Chapter 1, CQDs have been already widely used in bioimaging although 
they were discovered only ten years ago[3]. In this thesis, we want to compare 
CQDs to Si NPs as materials for bioimaging. Indeed, silicon and carbon 
possess many similar properties and it is very interesting to compare the in vivo 
behavior of ultrasmall NPs made by these two elements. In this part of the 
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thesis, we studied the photoluminescence properties of CQDs and we coupled 
them with the dye cyanine 5 in order to make a comparison with Cy5-modified 
Si NPs. Furthermore, CQDs have been tested in in vivo PET imaging and the 
results compared to those obtained in analogous tests done with Si NPs. 
 
4.2 Preparation and characterization of CQDs 
CQDs were prepared according to a reported procedure[4] by microwave 
treatment of an aqueous solution of L-arginine hydrochloride (2M) and 
ethylenediamine (2M). Starting materials were processed in a common kitchen 
microwave oven operated at a nominal power of 700 W for 3 minutes. The 
reaction took place at ambient pressure and temperature was not monitored. 
Figure 4.1 shows the scheme of the synthetic route followed for the production 
of carbon dots.  
 
Figure 4.1. Synthetic route followed for the preparation of CQDs. 
When the reaction was completed, CQDs were purified by dialysis. Figure 4.2b 
reports a typical HR-TEM image, showing the presence of NPs with an average 
size of 3.07 ± 0.6 nm (Figure 4.2a). As shown in the high magnification 
micrograph of a single particle (inset of Figure 4.2b), these CQDs are 
crystalline with an interplanar distance of 2.1 Å, consistent with the reported 
spacing in graphene[5] and (0001) graphite basal plane[4].  
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Figure 4.2. a) Size distribution histogram of CQDs (average size 3.07 ± 0.6 nm); b) 
HR-TEM image of carbon dots; the inset shows a high magnification image of a 
single particle. 
We studied the photoluminescence properties of these CQDs. In Figure 4.3a, 
we report the UV-vis absorption spectrum of the CQDs and in Figure 4.3b, the 
emission spectra obtained at different excitation wavelengths. All the spectra 
were acquired in ethanol. Both, in absorption and emission, CQDs show the 
typical features reported in literature data[1, 4, 6-8].  
 
Figure 4.3. a) Absorption spectrum and b) emission spectra (at different excitation 
wavelengths reported on the top right) of CQDs in ethanol 
The UV-vis spectrum in Figure 4.3a shows a broad absorption band in the 
range of 250 - 550 nm, with a typical quantum feature at approximately 300 
nm, typical of aromatic structures.[4] The position of the emission maximum 
20 nm 
2 nm a) 
b) 
a) b) 
106 
 
(Figure 4.3b) shifts toward higher wavelengths when using excitation radiation 
of increasing wavelength. Simultaneous to the red shift, we observed a decrease 
of the emission intensity. More in detail, the emission maximum red-shifts 
from 411 to 510 nm, a total of 100 nm, when changing the excitation 
wavelength from 350 nm to 450 nm. By exciting at 500 nm, CQDs still show a 
weak emission centered at 550 nm. PLQY for CQDs in ethanol is of 7-8 % at 
all the excitation wavelengths. Lifetimes can be fitted with a multi-exponential 
decay as reported for similar NPs[9] and, in particular, with a bi-exponential 
decay, the two components being  τ1 = 2.5 ns (81 %) and τ2 = 7.8 ns (19 %) 
(λexc: 375 nm; λem: 440 nm). 
As already mentioned, there has been a strong debate in the literature whether 
the luminescence in CQDs comes from size or surface chemistry effects. There 
are reports showing that also CQDs with excitation-independent emission can 
be prepared[10-11]. However, it is well established[9, 12] that the presence of 
different emissive sites on the surface of each particle largely influences the 
photoluminescence properties. As extensively discussed in Chapter 1, CQDs 
can be considered as quasi-spherical particles or as flat nanosized graphene 
structures. In both cases, the surface of the material presents multifunctional 
surface sites that are most probably responsible for the shift in the emission 
wavelength when varying the excitation wavelength. In particular, the synthetic 
method used is known to lead to a surface rich of amino, carboxylic and 
hydroxyl groups, which contribute in different ways to the luminescence of the 
CQDs. 
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4.3 Surface modification of CQDs with cyanine 5 dye  
In order to make a comparison with Si NPs, CQDs were coupled to cyanine 5 
dye (Cy5-CQDs). The reaction is very similar to the one reported in Chapter 3 
for Si NPs. A scheme for the synthetic route is shown in Figure 4.4. 
 
Figure 4.4. Synthetic route for the preparation of Cy5-CQDs 
  
After the reaction is completed, Cy5-CQDs were purified by dialysis against 
water. In Figure 4.5, the absorption spectra of the free Cy 5 dye, free CQDs and 
Cy5-CQDs are compared. The spectrum of Cy5-CQDs presents the general 
absorption trend of CQDs at lower wavelengths, including the typical shoulder 
at 300 nm. At higher wavelengths the spectrum is dominated by the absorption 
bands (600 and 645 nm) typical of the dye.  
In Figure 4.6, the emission spectra in ethanol of the free Cy5 dye, free CQDs 
and Cy5-CQDs are compared. The excitation wavelength is 350 nm, falling in 
a region where the most part of the absorption can be ascribed to the quantum 
dots rather than to the dye. Interestingly, the spectrum of the Cy5-CQDs shows 
both, the emission of the CQDs and of the Cy5.  
More in detail, the emission peak relative to the CQDs in the Cy5-CQDs 
sample is red-shifted compared to the naked CQDs. The emission maximum in 
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Figure 4.5. Absorption spectra in ethanol of free Cy5 (blue line), free CQDs (red 
line), Cy5-CQDs (black line)  
 
the naked CQDs sample is centered at 410 nm (when exciting at 350 nm) while 
in the Cy5-CQDs the maximum is centered at 428 nm. The peak relative to Cy5 
does not show any significant shift when comparing the Cy5-CQDs sample to 
the free dye. A similar behavior was observed also in the case of the coupling  
Figure 4.6. Emission spectra (λexc: 350 nm) in ethanol of naked CQDs (black line), 
Cy5-CQDs (red line) and free Cy5 (green line) 
 
of the same cyanine 5 dye with Si NPs (see Chapter 3).  
The PLQY were measured in ethanol. Regarding the emission window of the 
dye, we observe a small increase of the PLQY of the Cy5-CQDs (23 %) with 
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respect to the free dye (16 %) when exciting at 630 nm. The PLQY in the 
emission window of CQDs is instead decreasing from a value of 7 % in the 
naked CQDs to a value close to 1 % in the sample of Cy5-CQDs when exciting 
at 350 nm. This trend is different from what observed in Cy5-coupled Si NPs in 
which PLQY increases both, in the dye and in Si NPs emission windows. The 
reason for the different behavior in comparison with Si NPs is unclear. 
However, both systems display different properties and mechanisms 
responsible for photoluminescence and, although many analogies between 
inorganic and carbon-based NPs are reasonable, they could be over-
simplifying[11]. The excited state lifetimes in ethanol of the naked CQDs, free 
dye and Cy5-CQDs are reported in Table 1. 
In the emission window of the CQDs, the decay can be fitted with a bi-
exponential function for both, the naked CQDs and Cy5-CQDs. The lifetime of 
the dye measured in its emission window did not change after the coupling with 
the CQDs. The data regarding the free components at λem = 440 nm (for free 
Cy5) and at λem = 668 (for naked CQDs) are missing in the table because of the 
very small emission of each component in the emission window characteristic 
of the other one. 
Table 1. Lifetimes of the free Cy5 dye, free CQDs and Cy5-CQDs 
 Lifetime (λexc= 375 nm; λem= 
668 nm) 
Lifetime (λexc= 375 nm; λem= 
440 nm) 
Cy5 τ1 = 0.9 ns (100 %)  
CQDs  τ1 = 2.7 ns (80 %) 
τ2 = 8.4 ns (20 %) 
Cy5-CQDs τ1 = 1.0 ns (100 %) 
 
τ1 = 2.2 ns (77 %) 
τ2 = 8.6 ns (23 %) 
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Since the emission of free CQDs is red-shifting when using increasing 
excitation wavelengths, it is interesting to explore the emission of the 
Cy5-CQDs sample at different excitation wavelengths.  
The emission spectra in ethanol of Cy5-CQDs at different excitation 
wavelengths are reported in Figure 4.7. We observed that when increasing the 
excitation wavelength, the peak of CQDs is red-shifting (similarly to what 
happens for free CQDs), while the peak of the dye is not appreciably shifting. 
We noted that the characteristic emission peaks of CQDs are always red-shifted 
in Cy5-CQDs in comparison to the emission peaks of the naked CQDs at the 
same excitation wavelength. In order to put in evidence this observation, the 
position of the emission maxima of the naked CQDs are marked with a dashed 
line in Figure 4.7. The larger red-shift of Cy5-CQDs respect to the naked CQDs 
indicates that the dye influences the emission characteristics of the CQDs, in 
line with the already discussed influence of surface effects on the 
photoluminescence of carbon-based nanoallotropes[1]. 
Figure 4.7. Emission spectra, in ethanol, of Cy5-CQDs at different excitation 
wavelengths  
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4.4 In vivo positron emission tomography of CQDs 
Although CQDs were tested in vivo for the first time only in 2009[2], they have 
been widely used in bioapplications[1, 8, 13-16]. 
Recently Si NPs and some carbon-based nanomaterials, such as nanodiamonds 
have been compared for their properties and bioapplications[17]. They both 
show very good stability and very high biocompatibility in comparison to 
classical semiconductor quantum dots. Therefore, we found very interesting to 
compare in this thesis the obtained ultrasmall Si NPs and CQDs to see how 
their behavior in vivo differs. PET was performed using 64Cu-labelled CQDs in 
the same conditions used for Si NPs and described in Chapter 3. As in the case 
of Si NPs, CQDs were coupled to the commercially available S-2-(4-
isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-
NOTA), a common ligand used for radioisotopes in PET[18]. Also in this case, 
the coupling happens between the isothiocyanate moiety of the ligand and the 
amine groups present on the surface of CQDs to form a thiourea bond in the 
final NPs (NOTA-CQDs) as shown in Figure 4.8.   
 
Figure 4.8. Reaction scheme for the coupling of CQDs with p-SCN-Bn-NOTA ligand  
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After the reaction is completed, NOTA-CQDs were purified from unreacted 
ligand by dialysis against water and afterwards, they were mixed with a 
[64Cu]CuCl2 solution to coordinate them with the radionuclide 64Cu (64Cu-
NOTA-CQDs). Once purified, 64Cu-NOTA-CQDs were injected, through the 
tail vein, in male Wistar rats to do biodistribution studies and in female NMRI 
nu/nu squamous cell carcinoma (A431) tumour bearing mice to perform in vivo 
PET imaging. In Figure 4.9, PET images obtained for 64Cu-NOTA-CQDs at 
different times post-injection are showed. As can be seen, the activity of CQDs 
is detected mostly in the bladder at 50 minutes post-injection, but a fraction is 
in the gallbladder and in the intestine. The behaviour observed for CQDs is 
similar to the one observed for [64Cu-NOTA-Si NPs] (made by microemulsion 
method), but the quantity of material that remains in the body and accumulates 
in organs is higher than in the case of Si NPs. The curve in Figure 4.9b 
represents the activity, expressed as percentage of injected dose, present in the 
bladder versus time post-injection. The curve grows in time showing that the 
particles are accumulating in the bladder to be subsequently, excreted. On the 
other hand, CQDs are accumulating more in the organism in respect to Si NPs. 
The curve presents a value of 40 % ID (percent of the injected dose) in the 
bladder at 50 minutes post-injection for CQDs, but the analogue curves for Si 
NPs of both kinds present a value of more than 60 % ID. Therefore, the activity 
of the CQDs is excreted slower than Si NPs and both are mainly cleared 
through renal pathway and through hepatobiliary excretion.  The chemical 
identity of the activity excreted through hepatobiliary mechanism was not 
established. It could be intact CQDs but also free metal complexes deriving 
from catabolized CQDs. The mice used bear a tumour, in the back or right hind 
leg, but no accumulation of particles in the tumour site was observed as in the 
case of Si NPs.  This could be explained with the absence of specific targeting 
agents on the NPs surface and with the too small size to show enhanced 
permeability and retention effect (EPR effect)[19-20], as shown in Chapter 3. Our 
hypothesis is that the NPs we are using for this study, both Si NPs and CQDs, 
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possess a too small dimension to show EPR effect, so they have to be properly 
engineered to target cancer cells. Nevertheless, the aim in this work is to show 
that imaging of organs and tissues with such NPs is possible and that NPs are 
excreted very quickly from the body. In the future design of a multimodal 
imaging probe, NPs could also be functionalized with targeting agents. 
 
 
 
 
 
 
Figure 4.9. a) Positron emission tomography images, at different times post-injection, 
of NMRI nu/nu mice injected with 64Cu-NOTA-CQDs; b) percentage of injected dose 
versus time post-injection in the bladder of mice injected with 64Cu-NOTA-CQDs  
 
To deeply investigate the behaviour of CQDs in vivo, biodistribution 
experiments were performed. For these studies, rats were sacrificed after 
certain times post injection, organs were weighed and the activity present in the 
organs measured. In Figure 4.10, the biodistribution experiments, reported both 
as percentage of injected dose (% ID) and as standardized uptake value (SUV = 
(activity/weight of tissue)/(injected activity/body weight) are shown. 
a) b) 
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Figure 4.10. Biodistribution of 64Cu-NOTA-CQDs, expressed as % ID (upper figures) 
and SUV (bottom figures), at 5 and 60 minutes post-injection in male Wistar rats.  
 
From the histograms in figure 4.10, it is evident that at 60 minutes post-
injection CQDs are mainly excreted through the urine, but an appreciable 
quantity is still present in the liver and in the intestine. Therefore, it results very 
interesting to compare the two mechanisms of excretion, renal and 
hepatobiliary, and compare this ratio to the same ratio for Si NPs. In figure 
4.11, a histogram that shows the ratios between renal and hepatobiliary 
excretion for CQDs and both kind of Si NPs used, is reported.  
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Figure 4.11. Histogram showing the ratio between renal and hepatobiliary mechanism 
of excretion for [64Cu-NOTA-Si NPs (hydro)] (blue), [64Cu-NOTA-Si NPs (micro)] 
(green) and [64Cu-NOTA-CQDs] (orange) 
 
It is evident also from this graph, that [64Cu-NOTA-Si NPs (hydro)] are the 
most promising material among the three kinds of particles reported so far in 
this thesis. [64Cu-NOTA-Si NPs (hydro)] are eliminated almost entirely through 
renal excretion, i.e. through kidneys and bladder. CQDs are also mostly 
eliminated through the bladder, but partially stack in the liver and the intestine 
as it was already shown in the biodistribution graph. CQDs are accumulating in 
a slighter lower percentage in the intestine compared to [64Cu-NOTA-Si NPs 
(micro)]. On the other hand, when using CQDs some activity remains in the 
body in other organs, such as the spleen, as can be seen in the SUV graph at 60 
minutes post-injection (Figure 4.10), while when using [64Cu-NOTA-Si NPs 
(micro)], the activity is coming only from the kidneys (when looking at the 
SUV) and from the intestine (activity in intestine can be measured only in 
terms of % ID). In conclusion, all the ultrasmall NPs studied for PET imaging 
in this thesis, meet the requirements[21] for future theranostics applications (size 
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≤ 5.5 nm, non-toxic components that could biodegraded into clearable 
components).  Also if compared to CQDs, [64Cu-NOTA-Si NPs (hydro)] results 
the best system amongst the ones used following mainly a renal clearance 
mechanism that is very fast. Nevertheless, CQDs have a similar behaviour to Si 
NPs, as expected, but follow both renal and hepatobiliary mechanism of 
excretion giving some accumulation in liver.  
 
4.5 Conclusions 
 
In this part of the work, ultrasmall CQDs (size ≈ 3 nm) were prepared, their 
multi-coloured emission investigated, their coupling with dyes and radiotracers 
performed and in vivo studies conducted. Due to the similar, but not identical, 
properties of carbon- and silicon-based materials, some comparison between 
these two materials in respect to surface modification with the same labels and 
to in vivo behaviour has been attempted. Cy5-CQDs display both the emission 
of the NPs and that one of the dye. In addition, the emission maximum 
pertaining to CQDs is red-shifted in the sample modified with cyanine 5 with 
respect to the free CQDs as it was observed also for Si NPs (Chapter 3). 
Finally, CQDs were labelled with the NOTA-64Cu complex to be used in in 
vivo PET imaging for direct comparison with Si NPs. Both experiments of 
imaging and biodistribution were done. The results show that CQDs have a 
similar, but not identical, behaviour to the one of Si NPs, especially the ones 
prepared by microemulsion synthesis. Indeed the majority of activity comes 
from the bladder after 50 minutes from injection of NPs in mice, but 
biodistribution studies show that CQDs follow both renal and hepatobiliary 
mechanism of excretion as for Si NPs made by microemulsion method. On the 
other hand, CQDs are excreted from the body slower than Si NPs and some 
accumulation in organs, such spleen and liver is observed. In conclusions, all 
the NPs used in this study are suitable for in vivo imaging, showing all of them 
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a fast excretion through the bladder. However, amongst the three kinds of NPs 
investigated, Si NPs made by hydrothermal method behave in the most ideal 
way being entirely excreted through renal clearance already 50 minutes after 
injection in the body without showing accumulation in organs. All these 
findings give promising expectations and important information on the design 
of a future multimodal probe. 
 
 
4.6 Experimental section 
4.6.1 Synthesis of CQDs 
Materials 
All the chemicals were purchased from Sigma-Aldrich, Fluka or Acros. 
Dialysis tubes were purchased from Serva (MWCO: 1 KDa; Spectra/Por® 7 
dialysis tubing). 
 
Synthetic procedure 
CQDs were prepared, according to a reported method, [4] by microwave 
treatment of an aqueous solution of L-arginine hydrochloride (2M) and 
ethylenediamine (2M). 5.6 g of L-arginine hydrochloride and 1.78 mL of 1,2-
ethylendiamine were dissolved in 13.3 mL of deionized water. The starting 
solution was processed in a common domestic microwave oven, operated at a 
nominal power of 700 W for 3 minutes. The reaction took place at constant 
pressure (1 Atm) and the temperature was not monitored. When the reaction is 
completed, CQDs have been purified by dialysis against water (MWCO: 1 
KDa; Spectra/Por® 7 dialysis tubing). The typical reaction produces a final 
amount of  ≈ 1.2 g of CQDs. 
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4.6.2 Coupling of CQDs with cyanine 5 
Materials 
Cyanine 5 NHS ester was purchased from Lumiprobe. Dialysis tubes were 
purchased from Serva (MWCO: 1 KDa; Spectra/Por® 7 dialysis tubing). 
 
Synthetic procedure 
Cy5-CQDs were prepared simply mixing the particles with the NHS ester of 
Cy5. In a typical experiment, 5.85 mg of CQDs were dispersed in 5 mL of 
water. Then, 50 μL of this dispersion were added to a solution of Cy5-NHS 
ester in DMSO (156.7 μg of Cy5 in 100 μL of DMSO). The coupling has 
occurred at room temperature, shaking the solution for 12 hours in the dark. 
After reaction is completed, the sample was purified using dialysis against 
water (MWCO: 1 KDa; Spectra/Por® 7 dialysis tubing) for several days until 
the external water does not contain free dye. 
 
4.6.3 Coupling of CQDs with NOTA ligand 
Materials 
S-2-(4-Isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid 
(SCN-Bn-NOTA; #B-605) was purchased from Macrocyclics. 
 
Synthetic procedure 
NOTA-CQDs were prepared dispersing 1 mg of CQDs in 150 µL of deionized 
water and placed in a 1.5 mL low protein binding Eppendorf-tube. A specific 
amount of SCN-Bn-NOTA (0.1 or 0.8 µmol/mg - according to the used amount 
of nanoparticles) was dissolved in 100 µL of deionized water and, then, added 
to the NPs dispersion. The final dispersion was then shaken on a thermo-mixer 
(Eppendorf) at 750 rpm for 16 h at 25 °C. All samples, which were used for in 
vivo experiments, have been purified by dialysis against deionized water 
(MWCO 500 - 1000, Spectra Por Float-A-Lyzer G2, 1 mL). Afterwards a 
defined aliquot was freeze-dried to obtain the final concentration of particles.  
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4.6.4 Radiolabeling of NOTA-CQDs  
The production of 64Cu was performed at Cyclone® 18/9 (Helmholtz-Zentrum 
Dresden-Rossendorf) in a 64Ni(p,n)64Cu nuclear reaction with specific activities 
of 150–250 GBq µmol-1 Cu diluted in HCl (10 mM). [22] An aliquot of 
[64Cu]CuCl2 solution (20–100 MBq) was buffered with MES (2-(N-
morpholino)ethanesulfonic acid)/NaOH-buffer (0.1 M; pH 6). Typically, a 
specific amount of nanoparticles, up to 10 µg, was mixed in a 1.5 mL low 
protein binding Eppendorf-tube with a specific aliquot of [64Cu]Cu(II)-solution 
(varying up to 40 MBq) and addition of MES/NaOH buffer (0.1 M; pH 6) up to 
a final volume in the range of 150-200 µL. The particles have been labelled by 
means of mechanical shaking for 30 min at 25 °C. To check the full labeling, a 
5.0 µL aliquot of the reaction was combined with 2.0 nmol EDTA (pH 7.0) and 
the labeling process of the nanoparticles (Rf = 0) was monitored by radio-TLC 
using ITLC-SA plates (Merck Millipore) in combination with a mobile phase 
of 0.9% NaCl in dH2O. As control, separate radio-TLC analysis of [64Cu]Cu–
EDTA (Rf = 0.9) was performed in the same mobile phase. Evaluation of radio-
TLC was carried out using a radioactivity thin layer analyser (Rita Star, 
Raytest). 
 
4.6.5 Animal experiments 
All animal experiments were carried out according to the German regulations 
on animal welfare (approved by Landesdirektion Dresden, 24-9168.21-4/2004-
1). Male Wistar rats (aged 7-9 weeks; Harlan Winkelmann GmbH, Borchen, 
Germany) and female NMRI nu/nu mice (aged 7-14 weeks; Technische 
Universität Dresden, Oncoray, Germany) were housed under standard 
conditions with free access to standard food and tap water. For PET 
experiments in tumor-bearing mice, about 2x106 A431 cells were injected 
subcutaneously in the back or right hind leg of NMRI nu/nu mice according to 
the protocol published elsewhere. 
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4.6.6 Biodistribution 
Two groups of four rats (5 and 60 min) were intravenously injected into a 
lateral tail vein with 0.5–5.0 MBq of 64Cu-labeled nanoparticles, which were 
dissolved in 0.5 mL of electrolyte solution E-153 (Serumwerk Bernburg, 
Germany) at pH 7.2. The specific activity ranged from 5.0 to 30 GBq/μmol at 
the time of injection. Animals were sacrificed at 5 and 60 min post injection. 
Blood and the major organs were collected, weighed, and counted in a Wallac 
WIZARD automatic γ-counter (PerkinElmer, Germany). The activity of the 
tissue samples was decay-corrected and calibrated by comparing the counts in 
tissue with the counts in aliquots of the injected tracer that had been measured 
in the γ-counter at the same time. The activity amount in the selected tissues 
and organs was expressed as percent of injected dose (% ID). The activity 
concentration in the biodistribution measurements were calculated as SUV 
(SUV = (activity/g tissue)/(injected activity/body weight)) and expressed as 
means ± standard deviation (mean ± SD) for each group of four animals. 
 
4.6.7 In vivo small animal positron emission tomography 
(PET) 
Rats or mice were positioned and immobilized prone with their medial axis 
parallel to the axial axis of the scanners (NanoScan PET/CT, Mediso, 
microPET® P4, Siemens preclinical solutions). The radiotracer was 
administered intravenously as an infusion using a syringe pump over one 
minute (Harvard Apparatus, flow rate: injection volume as mL/min) through a 
needle catheter into a lateral tail vein. The standardized uptake values (SUV) 
were calculated over the ROI as the ratio of activity concentration (Bq/mL) at 
time t and injected dose (Bq) at the time of injection (t0) divided by body 
weight (g). For the demonstration of the increasing activity uptake, the early 
(midframe time 3 min p.i.) images were subtracted from the late image 
(midframe time 50 min p.i.). 
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4.6.8 Characterization 
 
HR-TEM 
Samples for HR-TEM were prepared drop-casting an ethanolic solution of the 
sample on carbon coated copper grids (Quantifoil, GmbH). The analysis were 
performed using a FEI Titan 80-300 transmission electron microscope operated 
at 300 KV. 
Photophysical characterization 
Absorption spectra were acquired using a double-beam Shimadzu UV-3600 
UV-Vis-NIR spectrophotometer. 
Steady-state emission spectra were recorded on a HORIBA Jobin-Yvon IBH 
FL-322 Fluorolog 3 spectrometer equipped with a 450 W xenon arc lamp, as 
the excitation source, and a TBX-4-X single-photon-counting device as the 
detector. Emission and excitation spectra were corrected for source intensity 
(lamp and grating) and emission spectral response (detector and grating) by 
standard correction curves.  
Time-resolved measurements were performed on FluoTime 300 “Easy Tau” 
spectrometer (PicoQuant) equipped with subnanoseconds LDH sources 
powered by a PicoQuant PDL 820 variable (0.2-80 MHz) pulsed power supply. 
Measurements were performed using a PicoHarp TCSPC (Time-Correlated 
Single Photon Countings) module. The decays were fitted by means of 
PicoQuant FluoFit Global Fluorescence Analysis Software (PicoQuant GmbH, 
Germany). Lifetimes were corrected with  
PLQY were measured on a Hamamatsu Quantaurus-QY integrating sphere 
equipped with a 150 W CW Xenon source.  
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Chapter 5  
 
Preparation, surface modification and 
characterization of silica-coated cobalt 
nanoparticles 
 
 
Abstract 
 
This Chapter deals with the preparation, characterization and surface 
modification of ultrasmall silica-coated cobalt nanoparticles. A synthetic method 
was optimized to obtain an ultrathin silica shell (≈ 2 nm) which has the dual 
function to reduce the toxicity of the cobalt core and allow further 
functionalization. Nanoparticles surface was modified with amine-moieties that 
are suitable for subsequent couplings. Some preliminary functionalizations with 
model dyes were done in order to show that nanoparticles surface can be 
successfully modified in the perspective of a future use in bioimaging.  
 
5.1 Introduction  
 
Magnetic nanoparticles are attracting increasing interest for bioapplications[1-5], 
especially for magnetic resonance imaging (MRI)[6-7], drug delivery[8] or also in 
therapy thanks to hyperthermia properties[9-11]. Many efforts have been directed 
to study metal oxide NPs such as ultrasmall iron oxide NPs, but the literature on 
ultrasmall cobalt nanoparticles (Co NPs) for bioapplications is still limited and 
there is still large room for exploring this field. Co NPs represent another 
promising alternative to be used as multimodal probes, provided that some issues 
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regarding their toxicity and biocompatibility[12] will be solved. First of all Co 
NPs, as other metallic magnetic NPs, possess higher values of saturation 
magnetization than the ones composed of metal oxides such as ferrite or iron 
oxides[13]. This is a very important point because it allows to retain the same 
magnetic properties of oxides using smaller quantities of particles or smaller 
magnetic cores. In addition, as reported for other magnetic NPs[13-15], Co NPs can 
switch their behaviour from ferromagnetic to superparamagnetic when they 
possess an ultrasmall dimension[14, 16-17].  
Synthetic methods to obtain cobalt nanoparticles have been well established and 
it is possible to obtain quite monodisperse Co NPs having sizes < 10 nm. 
Even though cobalt has a very important role in biological systems since it is a 
constituent of the vitamin B and it is present in several other vitamins[18], toxicity 
and instability have limited the use of cobalt nanoparticles in the past[12].  
For this reason, part of the research is focused on the surface modification of 
cobalt nanoparticles with a silica shell[19-22] with the aim to render them less 
toxic, more stable and to end up with an easier functionalizable surface. To date, 
there are not so many reports on ultrasmall silica-coated Co NPs (Co@SiO2 NPs) 
with a thin silica shell. Therefore, in this part of the work, some strategies to 
control the growth of the silica shell on ultrasmall Co NPs have been optimized. 
In addition, the Co@SiO2 NPs were covered with an amine-terminated layer in 
order to allow the further attachment of functionalities, such as dyes or 
biomolecules, suitable for supplying them with properties useful for multimodal 
imaging. 
 
5.2 Preparation of cobalt nanoparticles 
5.2.1. Synthetic route and characterization  
Cobalt nanoparticles (size 5 to 10 nm) are prepared according to a reported 
method[23-25], which is based on the thermal decomposition of Co2(CO)8  in the 
presence of aluminium alkyl compounds (AlR3). This technique produces 
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long-time air-stable cobalt nanoparticles thanks to the step of controlled 
("smooth") oxidation, which creates a thin cobalt oxide layer around particles 
preventing further oxidation. Particles size can be tuned by changing the length 
of the alkyl chain of the AlR3 compound or the molar ratio between Co2(CO)8 
and AlR3. The particles are, subsequently, stabilized by the addition of a 
surfactant, typically oleic acid and/or oleylamine. A general scheme for the 
synthetic route is shown in Figure 5.1. 
 
 
Figure 5.1. General scheme of the synthesis of cobalt nanoparticles 
 
The Co NPs used in this work are in the size range 5 - 8 nm. Nanoparticles of 
these dimensions have been studied and characterized in the literature[23-25]. 
Typical HR-TEM images, at low and high magnification, of Co NPs are reported 
in Figure 5.2. The size distribution histogram, reported in Figure 5.3, reveals an 
average dimension of 7.3 ± 1.5 nm.  
 
Figure 5.2. HR-TEM images of Co NPs; b) HR-TEM image at high magnification  
b) 
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Figure 5.3. Size distribution histogram of Co NPs 
 
5.3 Preparation of silica-coated Co NPs 
5.3.1 Synthetic route 
Silica-coated Co NPs (Co@SiO2 NPs) with ultrathin silica shell were prepared 
with a modification of a reported method [26-27]. Co NPs previously prepared and 
stabilized with oleylamine and oleic acid are shaked for 2 hours in the presence 
of a solution of (3-Aminopropyl)triethoxysilane (APTES). In this step, the 
surfactant, which acts as a stabilizer, is removed and substituted with APTES. 
Then, a modified Stöber process[28] step was actuated reacting overnight the 
intermediate NPs with tetraethyl orthosilicate (TEOS) in the presence of a base, 
such as ammonium hydroxide. The technique we optimized for the preparation 
of ultrathin silica shell allows to perform the reaction at room temperature, while 
in the previously reported method[26-27] 100 °C are required. 
The general scheme followed for the preparation of Co@SiO2 NPs is showed  in 
Figure 5.4. 
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Figure 5.4. Synthetic route for the preparation of Co@SiO2 NPs 
 
Obtaining an ultrathin silica shell is very challenging and in most of cases, NPs 
encapsulated in a silica matrix rather than isolated core/shell particles were 
obtained. When (3-Mercaptopropyl)trimethoxysilane (SH-PTMS) has been used 
in place of APTES and when quantities are a little higher than a threshold value, 
the synthetic route leads to the formation of either separated silicon oxide NPs 
(Figure 5.5a) or to a silica matrix (Figure 5.5b) that encapsulates Co NPs. This 
can be seen also from the EDX spectrum in Figure 5.5c where the silicon peak 
has a very high intensity showing the presence of a too high amount of silicon 
oxide. 
 
 
Figure 5.5. a) TEM image of silica NPs formed during the preparation of Co@SiO2 
NPs; b) TEM image of Co NPs encapsulated in a silica matrix; c) EDX spectrum 
showing a too high amount of silicon in the two samples 
 
a) 
b) 
c) 
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5.3.2 Characterization 
Silica-coated Co NPs (Co@SiO2 NPs) have been characterized by high 
resolution transmission electron microscopy (HR-TEM), energy filtering 
transmission electron microscopy (EFTEM), energy dispersive X-ray (EDX) 
analysis and X-ray photoelectron spectroscopy (XPS). 
In Figure 5.6a and 5.6b, a typical HR-TEM image and the size distribution 
histogram for Co@SiO2 NPs are shown. 
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Figure 5.6. a) HR-TEM image of Co@SiO2 NPs; b) size distribution graph (average 
size 8.5 ± 1.5 nm) of Co@SiO2 NPs 
 
As it can be seen, the average size of NPs is 8.5 nm ± 1.5 nm, therefore below 
10 nm even after silica coating. It must be noted, however, that this value can be 
affected by the difficulties in imaging the silica shell around the Co NPs, since it 
is ultrathin and not crystalline. Looking at the high magnification HR-TEM 
image, reported in Figure 5.7, the cobalt core is clearly visible and it shows a 
high crystallinity, similar to that observed in particles without the silica shell. 
Around the core, a first ultrathin shell is visible, formed by cobalt oxide 
originating from the synthetic route followed, which includes a smooth oxidation 
step at the end of the preparation aimed to stabilize the particles against further 
oxidation. An accurate observation reveals the presence, although with a scanty 
contrast, of a second thin shell that is not crystalline and can be assigned to the 
b) a) 
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silica shell. The thickness of the shell around the core, comprising both the cobalt 
oxide and the silica layers, can be estimated between 1 and 3 nm. 
 
Figure 5.7. High magnification HR-TEM image of Co@SiO2 NPs 
 
The electron diffraction pattern measured on the same sample is reported in 
Figure 5.8. The pattern shows clearly the coexistence of metallic cobalt and its 
oxide. No diffraction signal from the silica shell is visible, indicating that, if 
present, it is amorphous. 
 
Figure 5.8. Electron diffraction pattern, acquired in the HR-TEM microscope, of 
Co@SiO2 NPs 
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Hence, supplemental information is needed for assessing the presence of the 
silica shell. A first indication arises from EDX measurements, performed in the 
same HR-TEM microscope. As expected, Figure 5.9 shows the presence of the 
characteristics peaks of cobalt but also, at 1.75 keV, the Kemission of silicon.  
 
Figure 5.9. EDX spectrum of Co@SiO2 NPs 
 
Another evidence of the formation of the silica shell around Co NPs is given by 
the elemental maps obtained by energy filtering transmission electron 
microscopy (EFTEM). In particular, Figure 5.10a reports a conventional TEM 
image of the Co@SiO2 NPs while the EFTEM maps of cobalt and oxygen are 
reported in b) and c) respectively. All the maps pertain to the same area of 
interest, as they are obtained from the energy loss features of the electron beam 
of TEM. The map in d) is the overlay of the two elemental maps, with cobalt in 
green and oxygen in red. The overlay confirms that the cobalt core is surrounded 
by a cobalt oxide skin (the region were red and green are mixed), in turn 
surrounded by another shell, where oxygen is not superimposed with cobalt. This 
is better evidenced in the zoom on a single particle shown in Figure 5.10e, from 
which we clearly see that the outer red region belongs to a shell and not to a 
continuous matrix, since several dark spaces are present in between the particles. 
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Further evidence of the presence of the silica shell is provided by the XPS 
spectra. 
CoO 
Co core 
SiO2 shell 
Figure 5.10. a) HR-TEM image of Co@SiO2 NPs; EFTEM maps of (b) cobalt and (c) 
oxygen; d) false colour overlay of (b) cobalt and (c) oxygen; images a), b), and c) are 
from the same region of interest with the same field-of-view; e) overlay image zoomed 
on a single particle. 
a b 
d c
e
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The survey XPS spectrum of Co@SiO2 NPs, deposited onto an aluminium 
substrate by evaporation from a dispersion in ethanol, is reported in Figure 5.11 
with the relevant peak assignments. Note that Si 2p peak overlaps with the Co 3s 
band so that the Si 2s peak is better suited for quantification purposes.  
 
The high resolution spectrum of the most characteristic peak of cobalt, i.e. Co 2p, 
is reported in Figure 5.12. The spectrum shows the expected complex structure 
of cobalt 2p, arising from the presence of the different states of oxidation of 
cobalt, of the spin orbit splitting and of the typical intense satellite peaks typical 
of cobalt. Curve resolution and assignments have been made taking into account 
the literature data for Co 2p chemical shifts and spin orbit splitting[29]. The 
general shape of the band confirms the presence of elemental and oxidized 
cobalt.  
Figure 5.11. Survey XPS spectrum of Co@SiO2 NPs, deposited on aluminium 
substrate. Exciting radiation Al Kα. 
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Figure 5.12. Co 2p region of the photoelectron spectrum of Co@SiO2 NPs. 
 
Interesting information on the composition and structure of the Co@SiO2 NPs 
can be extracted from the intensity ratios of the peaks present in the spectrum. In 
particular, from the relative intensities of peaks due to Co 2p and Co 3p electrons, 
which have a large difference in kinetic energy (~ 705 eV and ~ 1425 eV 
respectively), it is possible to obtain an estimation of the thickness of an 
overlayer (in our case the silica shell) that attenuates the cobalt signals. The result 
of this estimation, explained in more details in the experimental section at the 
end of the Chapter, is consistent with a shell thickness of about 2 nm, in 
agreement with the estimations from TEM and EFTEM results. 
 
5.4 Surface modification of Co@SiO2 NPs with 
amine-moieties and dyes 
In order to perform future multimodal imaging it is necessary to functionalize 
the silica surface of Co@SiO2 NPs. Therefore, we modified the surface with 
amine-moieties, by reacting Co@SiO2 NPs with aminopropyltriethoxysilane 
(Co@SiO2-NH2 NPs). The general scheme for the reaction is shown in Figure 
5.13. 
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Figure 5.13. Amine functionalization of the Co@SiO2 NPs 
 
After purification by repeated centrifugation steps, Co@SiO2-NH2 NPs were 
characterized by XPS in order to check the success of the surface 
functionalization and to have an estimation of the amount of amine groups 
present at the surface.  
Figure 5.14 reports the N1s signal of the amine-functionalized sample, which is 
a single peak falling at a binding energy value of 399.1 eV, typical of amines. 
The appearance of the amine peak, not present before the functionalization step, 
is an indication that the functionalization took place. Also, the intensity ratio 
between N1s and Si1s peaks (≈ 0.2), of the same order of magnitude of that found 
for the amine terminated Si NPs (Chapter 2), indicates a coverage of the silica 
surface not dissimilar from that of the Si NPs, and is promising in the perspective 
of further functionalizations.  
Figure 5.14. XPS core-level N1s spectrum of amine functionalized CO@SiO2 NPs 
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In order to check the feasibility of the coupling of amine-terminated 
Co@SiO2 NPs with large molecules, in view of possible applications in 
multimodal imaging, we coupled the NPs with two different dyes, i.e. ATTO 655 
dye and Rhodamine B. The general scheme for the reaction of Co@SiO2-NH2 
NPs with the dyes is shown in Figure 5.15. In the case of ATTO 655, we used 
the commercially available N-hydroxysuccinimide ester of the dye to create the 
amide bond with the amine-moieties on the surface of NPs. In the case of 
Rhodamine B, the amide bond is formed between the surface amine groups of 
the NPs and the carboxylic group of the rhodamine B, in the presence of 
N-hydroxysuccinimide and N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC).  
 
Figure 5.15. Scheme for the functionalization of amine-terminated Co@SiO2 NPs with 
the dye (X= rhodamine B or ATTO 655). For the reaction conditions, see experimental 
part. 
 
The emission properties of dye-coupled Co@SiO2-NH2 NPs were measured after 
a careful purification involving several centrifugation cycles until the 
supernatant did not show any detectable photoluminescence. The emission 
spectra, reported in Figure 5.16 show, in both cases, the typical features of the 
respective dyes. 
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Figure 5.16. a) Emission spectra (λexc = 630 nm) in ethanol of free ATTO 655 (black 
line) and ATTO-Co NPs (red line); b) Emission spectra (λexc = 544 nm) in ethanol of 
free Rhodamine B (black line) and RhB-Co NPs (red line) 
 
Confocal microscopy measurements, performed on ATTO-Co NPs, deposited 
from the solution on a glass substrate, show that the dye signal is co-localized 
with the NPs aggregates, as shown in Figure 5.17. The co-localization of the dye 
with NPs suggests that the dye is attached on the surface of NPs showing that it 
is possible to modify the surface of Co@SiO2 in view of a future use in 
bioimaging. 
 
Figure 5.17. Confocal microscope images of ATTO-Co NPs (λexc = 630 nm); on the 
right: bright field image showing NPs aggregates; on the left: detected emission 
(λexc = 630 nm) of the ATTO 655 dye co-localized with NPs 
 
 
 
 
a) b) 
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5.5 Conclusions 
Ultrasmall silica-coated cobalt NPs were prepared and characterized. TEM, 
EFTEM, EDX, and XPS measurements confirm the presence of an ultrathin not 
crystalline silica shell (≈ 2 nm) around Co NPs. The surface of Co@SiO2 NPs 
was further functionalized with amine moieties in order to render it more easily 
functionalizable. The functionalization with amines was confirmed by XPS. 
Preliminary results on couplings with model dyes, indicate the feasibility of 
further modification of the surface of Co@SiO2-NH2 NPs with larger organic 
molecules, such as radiolabels for PET imaging or targeting agents for cancer 
cells, so prompting the SiO2-coated Co nanoparticles as potential probes in 
multimodal imaging.  
 
 
5.6 Experimental section 
5.6.1 Materials 
All chemicals were purchased from Sigma-Aldrich and employed without 
further purification unless specified differently. 
 
5.6.2 Synthesis of Co NPs 
In a 500 ml three-necked flask equipped with an effective (non-magnetic!) 
mechanical stirrer and a reflux condenser, 17.1 g of Co2(CO)8 , previously dried 
under argon, were dissolved in  300 ml of dry toluene. Then, either 17.6 mL of 
Al(C8H17)3 or 3 mL of Al(C2H5)3, depending on the final NPs size desired, are 
added under argon flow. The mixture is stirred vigorously (400 R/min) and 
heated at 110 °C for 16-18 hours. As carbon monoxide evolution proceeds, the 
brown colour of the solution turns black confirming the formation of Co NPs. 
The day after, temperature is increased to 150 °C for 1 hour. Then the mixture is 
cooled down to 20 °C and the step of smooth oxidation is conducted. A slow 
stream of oxygen (4.5 Vol % O2 in argon) will be slowly introduced in the 
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reaction mixture through a fine capillary immersed in the constantly stirred 
solution to form a thin layer of cobalt oxides. The reaction was kept under stirring 
for 6 hours. After decantation of the supernatant, the precipitated Co NPs 
particles were washed twice with fresh toluene. The particles are then stabilized 
adding 2 - 3 mL of surfactant (oleic acid, oleylamine) and heating at 60 - 70 °C 
for 0.5 - 2 hours. 
 
5.6.3 Synthesis of Co@SiO2 NPs 
In a typical reaction, 100 µL of a solution in toluene of 5 - 7 nm cobalt 
nanoparticles (concentration: 6.3 mg/mL; stabilizer: oleic acid/oleylamine) were 
diluted in 10 mL of ethanol and mixed with 5 µL of a solution 0.04 M of (3-
Aminopropyl)triethoxysilane (APTES) in ethanol. This solution was left under 
shaking for 2 hours. Then 5 µL of an ethanolic solution 0.04 M of tetraethyl 
orthosilicate (TEOS) and 5 µL of a solution 0.07 M of ammonium hydroxide in 
ethanol were added to the solution of cobalt nanoparticles and the mixture was 
left under shaking overnight. The day after, the solution was centrifuged at 5300 
rpm for 30 minutes and washed with ethanol at least 3 times to obtain a final 
dispersion of silica coated cobalt nanoparticles in ethanol with a concentration 
0.1 mg/mL. 
 
5.6.4 Preparation of amine-terminated Co@SiO2 NPs 
To obtain the amine-functionalization on the surface, Co@SiO2 NPs were mixed 
with 2.5 µL of an ethanolic solution 0.04 M of (3-Aminopropyl)triethoxysilane 
(APTES). The mixture was left under shaking overnight. The day after, the 
solution was centrifuged at 5300 rpm for 30 minutes and washed with ethanol at 
least 3 times to obtain a final dispersion of amine-terminated Co@SiO2 NPs. 
 
5.6.5 Coupling of amine-terminated Co@SiO2 NPs with dyes 
0.1 mg of the N-hydroxysuccinimidic ester of the ATTO 655 dye (1) were added 
to an ethanolic solution 0.1 mg/mL of amine-terminated Co@SiO2 NPs. The 
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solution was kept in the dark and under stirring overnight. The day after, samples 
were centrifuged at 5300 rpm for 30 minutes and washed with ethanol until no 
emission was detectable in the supernatant. 
In the case of rhodamine B (2), amine-terminated Co@SiO2 NPs were dispersed 
in dimethylformamide (DMF). Then 1.4 mg of N-hydroxysuccinimide and 2.2 
mg of N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) 
were added to the NPs solution. 6 mg of rhodamine B were dissolved in 4 mL of 
anhydrous DMF and added to the solution of NPs. Everything was flushed with 
nitrogen and the well-closed reaction mixture was left under stirring overnight. 
The day after, samples were centrifuged at 5300 rpm for 30 minutes and washed 
with ethanol until no emission was detectable in the supernatant. 
 
5.6.6 Characterization 
HR-TEM 
Samples for HR-TEM, EDX and EFTEM were prepared drop-casting an 
ethanolic solution of the sample on carbon coated copper grids (Quantifoil, 
GmbH). The analysis were performed using a FEI Titan 80-300 transmission 
electron microscope operated at 300 KV. 
 
Estimation of the thickness of the coating from XPS intensities 
 
The estimation was done by assuming a spherical geometry, with a cobalt core 
surrounded by a silica shell of constant thickness d. According to a literature 
model[30], d can be estimated to be ≈ 50% of the value that one would obtain in 
the case of a flat cobalt sample covered with an uniform silica overlayer. In the 
latter case, d can be evaluated from the intensity ratio between two photoelectron 
140 
 
lines of the cobalt substrate, having a large kinetic energy (KE) difference, 
namely Co2p (KE ~ 705 eV) and Co3p (KE ~ 1425 eV). Indicating as I1 and I2 
the two measured intensities, we can write[31]: 
)]cos/(exp[
))]cos/(exp[
2
1
0
2
0
1
2
1


d
d
I
I
I
I


                 (1) 
where 0
1I and 
0
2I  are the intensities that one would measure in absence of the 
overlayer (i.e, for pure cobalt), 1 and 2 are the inelastic mean free paths 
(IMFPs) of the respective photoelectrons in the silica matrix (obtained from 
literature[32]), and  is the angle between the normal to the surface and the 
direction of the measured electrons (in our case 90°). The intensities 0
iI  can be 
written as[31]  
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where N is the atomic density of cobalt (that cancels in the intensity ratio), 
i  is 
the photoionization cross section of the i-th orbital, available from tabulated 
data[33], and T(E) is the (known) transmission function of the spectrometer. By 
defining the "corrected intensity" of a peak as 
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The value of d obtained in this way must then be corrected for the spherical shape 
according to the already mentioned model[30]. 
 
Photophysical characterization 
Steady-state emission spectra were recorded on a HORIBA Jobin-Yvon IBH FL-
322 Fluorolog 3 spectrometer equipped with a 450 W xenon arc lamp, as the 
excitation source, and a TBX-4-X single-photon-counting device as the detector. 
Emission and excitation spectra were corrected for source intensity (lamp and 
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grating) and emission spectral response (detector and grating) by standard 
correction curves.  
 
Confocal microscopy 
An ethanolic dispersion of NPs was deposited, by drop-casting, on a glass 
substrate. The sample was then imaged on a Confocal Microscope LSM 710 
using excitation laser source of 630 nm. 
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Chapter 6 
Instrumental techniques 
 
Abstract 
In this Chapter, a short overview on the main techniques used during this thesis, 
is given. For each technique, the general features are described, while the details 
regarding particular experiments and measurements are reported in the 
experimental section of the pertinent Chapter. Commonly used spectroscopic 
techniques (such as UV-visible or infrared spectroscopy) are not discussed here. 
 
6.1 Transmission Electron Microscopy (TEM) 
Transmission electron microscopy (TEM)[1,2] is a technique capable to supply 
high resolution images, with resolution down to atomic scale. Therefore, it is a 
powerful technique for the morphological study of nanomaterials. Analogously 
to SEM (scanning electron microscopy), TEM technique is based on the 
interaction of matter with an energetic electron beam. According to the De 
Broglie law (p = h/λ) the wavelength associated to a 10 keV electron is about 
0.2 nm and it decreases by increasing the energy. For this reason, electron 
microscopies allow to overcome the resolution limitations of conventional 
optical microscopies, dictated by the diffraction limit. Actually, in electron 
microscopies the image resolution is dictated by other phenomena, such as 
electron scattering in SEM and lens limitations in TEM.  Since its development 
in the '30s of the past century by Knoll and Ruska and the spreading of its 
commercial availability in the second half of the '900, TEM became an 
invaluable tool in materials science and in biology.  
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In TEM technique the energetic electron beam (typical energy in the range 80 – 
400 keV) illuminates an ultra-thin sample and passes through it. Basically, an 
image is formed in a similar way of that of an optical microscope, but the lenses, 
due to the charged nature of the illuminating beam, are electromagnetic lenses. 
In Figure 6.1, a simplified scheme of the components of a TEM instrument is 
reported.  
 
 
Figure 6.1. Schematic illustration of the basic components of an electron microscope  
A typical instrument is vertically arranged. The electron source is located at the 
top of the column and the electron beam reaches the sample after being focused 
on the sample plane through the condenser lens. Right after the sample, the object 
lens generates the intermediate image which is then magnified by the 
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intermediate lens and projected on the plane of a position-sensitive detector by 
the projection lens. The system is maintained under high vacuum conditions in 
order to prevent the scattering of electrons.  Electrons encountering no objects 
do not suffer deviations, but when passing through a solid sample, part of them 
are diffracted either by elastic or inelastic processes. The images of the elastically 
diffracted and non-diffracted electrons are recombined on the plane of the 
detector, and the contrast is due to the scattering properties of the different parts 
of the sample. For example, inclusions containing heavy elements in a light-
element matrix will be imaged as darker areas in a more brilliant field (bright 
field image). It is also possible, by manipulating a suitable diaphragm, to allow 
only the diffracted electron to reach the detector, thus obtaining a "dark field" 
image in order to evidence particular features in the sample.  
TEM technique provides also important crystallographic information thanks to 
the possibility of recording electron diffraction images, which are interpreted in 
a similar way of the standard X-ray diffraction patterns, according to the Bragg's 
law. Moreover, the interaction processes occurring between the electron beam 
and the sample can be exploited for obtaining additional important information 
on the sample. As sketched in Figure 6.2, EFTEM images and EDX spectra can 
be obtained. Both techniques are based on processes involving inelastic 
interactions between the sample and the electron beam. The two techniques will 
be outlined briefly in the following sections. 
Figure 6.2. Scheme outlining the exploitation of inelastic scattering events for sample 
characterization  
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6.2 Energy-Filtered Transmission Electron 
Microscopy  
 
Energy-Filtered Transmission Electron Microscopy (EFTEM)[3] is based on the 
energy loss features of the inelastically scattered electrons in the TEM 
instrument. An electron energy loss spectrum (EELS) reports the intensity of 
inelastically scattered electrons as a function of the energy difference with the 
elastic ("zero loss") peak. In an EELS spectrum several features appear. In the 
higher energy loss regime (> 40 eV) steps or edges appear in the spectrum, at an 
energy loss value corresponding to the ionization of inner shell electrons of the 
elements present in the sample (ionization edge). The ionization edge reflects the 
atomic structure of the element and it is useful for elemental analysis. Figure 6.3 
shows a scheme of an energy loss spectrum. The ionization edges of the inner 
core electrons are low intensity features over a large background due to other 
energy loss mechanisms, such as plasmon losses. In order to quickly acquire 
elemental maps, EFTEM technique makes use of energy filters for obtaining 
intensity maps by using energy windows selected in the pre-edge (1,2 in Figure 
6.3) and post-edge regions (3 in Figure 6.3) that are subsequently 
computationally combined in order to take into account the background.  
 
Figure 6.3. Illustration of the main features of an energy loss spectrum with indication 
of the energy windows used (three windows method) for obtaining elemental maps in 
EFTEM 
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6.3 Energy dispersive X-ray spectroscopy 
The technique,[4] referred as energy dispersive X-ray spectroscopy (EDS, EDX 
or EDA), is commonly coupled with electron microscopies, either SEM or TEM. 
It is used for the quantitative determination of the composition of materials in 
the desired area.  
EDS is based on the X-rays fluorescence caused by the relaxation of core holes 
generated by electron-induced ionization of the inner shells of the elements. 
When the core hole is created, an electron from the outer shells will fill the core 
vacancy, with a simultaneous emission of an X-ray photon. The energy of the 
emitted X-ray radiation depends on energy difference between the two involved 
orbitals in the atom, so each element can be identified from the characteristic 
peaks in the EDS spectrum. EDS can be exploited in a spatially resolved way, 
by synchronizing the EDS data with a SEM or TEM image.  
Due to the competition between X-ray fluorescence and Auger emission 
pathways for the relaxation of the core-hole, EDS is more sensitive for heavy 
elements. In practice, only elements heavier than Beryllium can be detected.  
 
 
 
6.4 Emission and excitation spectroscopy[5] 
As it could be seen in this thesis, it is very interesting to investigate the 
photoluminescence properties of nanomaterials. In order to do this, a common 
spectrofluorimeter can be used to acquire both emission and excitation spectra. 
In Figure 6.4, the schematic setup of a spectrofluorimeter is shown. In brief, it is 
composed by an excitation source (in this thesis a 450 W xenon arc lamp), a dual 
grating monochromator through which the light passes to be directed to a 
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reference detector and to the sample. Emission of the sample is collected at 90° 
with respect to the incident excitation light. After, the light passes through a 
second monochromator to reach the detector that usually is equipped with a 
photomultiplier tube to amplify the signal received. The spectra are corrected for 
source intensity (lamp and excitation grating) and for detector spectral response 
and emission grating by standard correction curves (emission monochromator 
and Photomultiplier, PM). 
 
Figure 6.4. Schematic setup of a fluorimeter  
 
 
6.4.1 Integrating sphere 
Absolute photoluminescence quantum yields (PLQY) were measured using an 
integrating sphere (IS). This instrument is based on a hollow spherical cavity 
internally coated with a reflective material. The sample is positioned inside the 
IS. When the excitation light reaches it, the sample emits and the light is scattered 
and reflected, by the inner coating of the sphere, in all directions. In this way the 
effects of the original direction of the light are minimized. 
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A schematic setup for this instrument is shown in Figure 6.5.  
 
Figure 6.5. Schematic setup of an integrating sphere (MC = monochromator; OF = 
optical fiber, BT-CCD = back thinned CCD) 
 
In the general setup, the light coming from a xenon lamp is monochromatized at 
the selected wavelength and it arrives to the sphere through an optical fiber (OF). 
The sample is positioned inside the IS and the light, emitted by it, is collected by 
a detector, after passing through another optical fibre and a monochromator 
(MC2). The measurement for the reference (solvent in a quartz tube) is acquired 
in the same conditions used for the sample. Then the sample in the same solvent 
used for the reference is also measured. The software corrects the quantum yields 
for the reference to give the values of absolute PLQY according to the equation 
in Figure 6.6. 
 
Figure 6.6. Equation used by the software to calculate the PLQY. 
 
PLQY represents the ratio between the number of photons absorbed by the 
sample (Nabsorption), and the number of photons emitted by the sample (Nemission). 
In Figure 6.6 Iem stands for intensity of the emission and Iex for intensity of the 
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excitation light, S and R stands for sample and reference respectively, h is the 
Planck’s constant and c is the speed of light. 
 
 
6.4.2 Lifetime measurements 
To measure the excited state lifetime, a spectrofluorimeter equipped with a 
pulsed excitation source (typically a laser or a flash lamp) and a time-correlated 
single-photon counting (TCSPC) module is used. In Figure 6.7, the general setup 
it is shown. 
 
Figure 6.7. General setup for the measurements of lifetimes  
 
The sample is excited with a pulsed excitation source. Each pulse of the 
excitation source generates an electrical signal that represents the START input 
of the TAC (time-to amplitude converter). The sample excited from the pulse of 
the excitation source will emit. Every time a photon is emitted, the detector 
translates it in an electrical signal that represents the STOP signal for the TAC. 
The final voltage measured by the TAC is proportional to the time passed 
between the START and the STOP signals and it is recorded as a histogram in 
which the x-axis represents the time passed between the START and the STOP 
signals and the y-axis represents the number of photons emitted during this time. 
The final form of the graph is a decay that can be fitted giving the values of 
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excited state lifetime and the relative contributions of each components (for 
multi-exponential decays).  
 
6.5 X-ray photoelectron spectroscopy 
X-ray Photoelectron Spectroscopy (XPS) is a well-established technique for the 
study of solid surfaces[6,7]. Following the suggestion of its founder, K. Siegbahn, 
the technique is often referred to as Electron Spectroscopy for Chemical Analysis 
(ESCA), so outlining the analytical potentialities that, actually, make XPS one 
of the most important tools for investigating the chemical composition of solid 
surfaces. A deep description of the theoretical and experimental details of this 
spectroscopy is out of the scope of this work. To this aim, several reviews and 
handbooks are available. Here the discussion will be limited to some of the main 
features of the technique, in connection to the kind of information obtained for 
this thesis work. 
In XPS the material is irradiated with soft X-rays that cause emission of electrons 
("photoelectrons") from the material. Photoelectrons originating from depths 
close to the sample surface can escape without inelastic scattering. For a 
conducting sample, their kinetic energy KE is given by:  
KE = h – BE -  
where h is the energy of the exciting X-ray photon, BE is the electron binding 
energy  relative to the Fermi level of the sample and φ is the work function.  
In a XPS spectrometer, photoelectrons emitted are energy analyzed and the 
output is a spectrum of electron counts vs kinetic energy. On the basis of the 
above equation, the x-axis can be converted in BE so that the energy of the peaks 
can be regarded as the energy (with opposite sign) of the orbital from which the 
photoelectrons originate (Koopman's approximation). So, from a XPS spectrum 
we obtain information on the orbitals of the atoms present in the material and 
hence an immediate qualitative elemental information. Actually from a simple 
survey spectrum it is possible to identify any element of the periodic table 
(excluding hydrogen and helium, due to the very low photoionization cross 
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section) virtually without any spectral interference. Indeed, even in the case of 
overlap of the peaks of certain electrons of two different elements, it is possible 
to discriminate among the possibilities by looking for the expected positions of 
the other peaks. Additional chemical information can be extracted by other 
features present in the spectra such as Auger peaks and energy loss features.  
XPS supplies information on the chemical state of the elements detected, since 
BE of the core level electrons is influenced by the chemical environment, and 
this is reflected in a "chemical shift" of BEs that can be roughly related to 
oxidation state or to the charge density on the selected atom. Extensive 
compilations and databases of chemical shifts are, helping in the identification 
of the species present in the sample. Often the chemical shift is not enough for 
resolving among different chemical states, and curve resolution procedures are 
necessary. Modern instrumentation is provided with software for curve 
resolution, but several independent programs are available for such purpose.  
XPS is a surface technique since the useful information is brought by the 
electrons that did not suffer inelastic scattering events: for this reason the 
electrons originating from deeper layers have an increasingly lower probability 
to escape from the surface without inelastic scattering.  
In the case of an overlayer A of uniform thickness d over a homogeneous 
material B, the thickness intensities IA and IB of photoelectron peaks 
characteristic of the two layers can be evaluated as follows:  
)]
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where AI  is the intensity of pure A of infinite thickness; 
0
BI  is the thickness of B 
in the absence of the overlayer; AA  and  BA are the IMFPs of electrons of A and 
B in the material of the overlay A.  
A quantitative evaluation of surface composition can be obtained  from the peak 
intensities. Indeed the intensity Ij,A of a photoelectron peak originating from the 
j-th orbital of the atom A is proportional to the photoemission cross section i,A  
to the atomic density nA of the atom A and to the inelastic mean free A that, in 
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turn, depends on the kinetic energy KEj of the considered photoelectron. 
Moreover, the instrument teansmission function T(KE) must be considered.  
In practice we can write:  
Ij,A = k i,A nA (KEj)  
were k is a proportionality factor (depending, within the same experiment, on 
constant instrumental factors) that cancels out when considering intensity ratios 
and  is a parameter that includes the dependence on KE of both the IMFP and 
the transmission function, and is characteristic for the particular instrument used. 
Since all the quantities present in the above, with the exclusion of nA, are known 
quantities (either from measurements or from theoretical calculations), the above 
equation can be used for calculating the atomic ratios present within the sampled 
depth. 
 
6.6 Positron emission tomography 
Positron emission tomography (PET) imaging[8] can be performed only if the 
detected animal contains a radiotracer. In this thesis, 64Cu was used. This 
radioisotope is often used in nuclear medicine because it has a half-time of 12 
hours and it decays, by positron emission to 64Ni. In Figure 6.8 a general scheme 
for the positron emission process is shown. 
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Figure 6.8. General setup of a PET scanner.  
Positron emitters are neutron-deficient species. Therefore, they reach stability 
transforming a proton (p) into a neutron (n). During this process, a positive 
electron, also known as positron (β+), is emitted. The specific energy of the 
positron emitted depends on the radioisotope used. The positron emitted loses 
energy until it annihilates with an electron. This event produces two γ-photons 
with the same energies and which are emitted in opposite directions. These 
photons are detected in coincidence. The simultaneous detection of the two 
photons is the crucial characteristic of PET technique. From the position in which 
the emission of the two photons took place, it is possible to understand in which 
part of the body they were emitted giving the opportunity to study physiological 
processes by following the pathway of suitable tracers injected in the body. 
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Summary 
The aim of this thesis, titled "Design, synthesis and functionalization of 
ultrasmall nanoparticles for bioimaging" is the synthesis, characterization, 
functionalization and in vitro and in vivo investigation of different kinds of 
ultrasmall (< 5 nm) nanoparticles. The work focuses on silicon nanoparticles 
(Si NPs), carbon dots (CQDs) and silica-coated cobalt NPs (Co@SiO2 NPs), 
which exhibit luminescence or magnetic properties and can be functionalized 
through covalent bonds. This renders these systems very attractive for in vivo 
multimodal imaging, which requires the stable anchoring of multiple 
functionalities (e.g. labels and targeting agents) on a single nano-sized platform. 
The thesis is organized in six chapters. 
Chapter 1, after a brief introduction to nanoparticles and their applications in 
medicine, discusses the problems connected with accumulation of NPs in organs 
and the requirements that nanomaterials should meet for in vivo imaging. In this 
context, the current applications of the emerging field of ultrasmall NPs are 
illustrated, with particular attention to the perspectives in multimodal imaging. 
The second part of the Chapter gives an overview of the state-of-art on 
properties, methods of preparation, functionalization, in vitro and in vivo 
applications of ultrasmall Si NPs, CQDs and Co NPs. 
Chapter 2 focuses on the still challenging preparation of ultrasmall Si NPs and 
on their characterization from the morphological, compositional and 
photophysical point of view. Two synthetic strategies, microemulsion and 
hydrothermal synthesis, were optimized for obtaining amine-terminated NPs that 
were characterized by HR-TEM, EDX, ATR-FTIR, XPS, and photophysical 
measurements. Both methods allowed to obtain crystalline ultrasmall Si NPs 
(Figure S1) with narrow size distribution and an average size of 2.5 ± 0.6 nm and 
4.3 ± 1.3 nm, respectively, by microemulsion and hydrothermal approach. All 
the obtained Si NPs feature blue emission under UV irradiation (Figure S1). In 
both cases, the maximum of the photoluminescence (PL) is excitation-
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dependent, with a red shift at increasing wavelength. These tunable PL properties 
are more pronounced in the 2.5 nm Si NPs prepared by microemulsion method.  
On a several months timescale, the microemulsion-prepared NPs show more 
stable PL than the hydrothermal ones. In addition, the microemulsion synthesis 
leads to NPs with lower surface oxide content. On the other hand, the 
hydrothermal method allows to prepare, with an easier synthesis and much less 
purification efforts, larger quantities  of slightly bigger NPs (4.3 nm) that contain 
a higher amount of silicon oxide but display higher PL quantum yields  (13 %), 
although their emission is less stable in time. 
 
 
 
 
 
Figure S1. Main characteristics of amine-terminated Si NPs obtained by 
microemulsion technique: a) Size distribution graph (average size 2.5 ± 0.6 nm); b), c) 
HR-TEM images, in c) the crystal fringes of silicon are clearly visible; d) Emission 
spectra at various excitation wavelengths in ethanol (the excitation wavelengths, in nm, 
are reported on the top right); inset: pictures of the solution under ambient illumination 
(left) and under UV irradiation (right) 
 
Chapter 3 deals with the further surface modification of Si NPs with functional 
molecules, such as dyes (cyanine, Cy5) or radiotracers (64Cu-NOTA complex) 
suitable for in vivo optical or positron emission tomography (PET) imaging. In 
vitro tests in A549 cell lines (Figure S2a) assessed a low toxicity of both types 
of amine terminated NPs, with better performances of the hydrothermal NPs at 
higher concentrations (up to 1 mg/mL). The Cy5-functionalized NPs display low 
cytotoxicity and penetrate cells via an energy-dependent mechanism such as 
endocytosis. In in vivo experiments, either optical imaging with the red emitting  
Cy5-Si NPs (Figure S2c)  or positron emission tomography (exploiting the 64Cu-
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NOTA-Si NPs), show that the functionalized  Si NPs are readily excreted 
through the bladder (50 minutes post-injection in mice). However, in vivo PET 
imaging (Figure S2b) and biodistribution experiments show significant 
differences between the hydrotermal- and microemulsion-prepared Si NPs 
coupled with the 64Cu complex. In particular, while microemulsion-prepared 
NPs feature some accumulation in the intestine, hydrothermal NPs behave in an 
ideal way being completely excreted through renal pathway. The latter result 
demonstrates the feasibility of the application of ultrasmall Si NPs in in vivo PET 
imaging. The result is very promising because the only existing report on in vivo 
PET imaging with ultrasmall Si NPs, differently prepared, shows that they 
accumulate in the liver.  
 
  
 
 
 
Figure S2 a) MTS assay after 24 hours incubation in A549 cell lines of sulfo-cyanine 
5-modified silicon nanoparticles (s-Cy5-Si NPs) in cell culture medium at increasing 
amounts (SF = serum free) of fetal bovine serum (FBS); Pos (Qnano) are the positive 
control toxic NPs; b) PET images at different times post-injection of NMRI nu/nu mice 
injected with Si NPs made by microemulsion (top left) or hydrothermal (top right) 
method; c) Optical images of NMRI nu/nu mice at 0, 5, 20, 50 minutes post-injection 
of s-Cy5-Si NPs; the bright spot on the top is a solution of s-Cy5-Si NPs with the same 
concentration of the solution injected. 
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Chapter 4 is dedicated to the preparation, characterization, surface 
functionalization and in vivo experiments of carbon dots (CQDs) with the aim to 
compare the in vivo behavior of such material to Si NPs.  3 nm sized CQDs, 
displaying multi-coloured emission that red-shifts at increasing excitation 
wavelengths, were coupled with Cy-5 or with 64Cu-NOTA complex.  In vivo PET 
imaging of 64Cu-labelled CQDs (Figure S3) performed in the same conditions 
used for Si NPs, show that CQDs, analogously to Si NPs, are excreted through 
the bladder at 50 minutes post-injection. However, part of them, in contrast to 
Si NPs, stack in the liver and in the intestine. Biodistribution experiments show 
that CQDs are excreted through both renal and hepatobiliary elimination 
mechanisms, similar to microemulsion NPs.   
Figure S3. a) Positron emission tomography images, at different times post-injection, 
of NMRI nu/nu mice injected with 64Cu-NOTA-CQDs; b) Histogram showing the 
comparison between the ratio renal/hepatobiliary mechanisms of excretion for 64Cu-
NOTA-Si NPs, prepared by hydrothermal (hydro) or microemulsion (micro), and for 
64Cu-NOTA-CQDs  
 
Finally, Chapter 5 deals with the preparation and characterization of Co@SiO2 
NPs with total average diameter < 10 nm. Cobalt NPs (Co NPs) are attractive for 
in vivo applications because of the high saturation magnetization, which could 
allow the introduction in the body of a smaller amount of NPs compared to 
magnetic oxide NPs. The silica coating should have the dual function of isolating 
the toxic cobalt core from the biological environment and allowing an easy 
covalent functionalization of the NPs. A synthetic method was optimized for 
64Cu-NOTA-CQDs 
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Figure S4. EFTEM maps of cobalt and oxygen (green: cobalt; red: oxygen); a) false colour 
overlay of cobalt and oxygen maps; b) overlay image zoomed on a single particle. 
obtaining an ultrathin silica shell (≈ 2 nm) avoiding the formation of a continuous 
matrix (Figure S4). Particles were, then, functionalized with amine moieties, that 
can be subsequently used for further functionalization. Co@SiO2 NPs were 
characterized by means of TEM, EFTEM, EDX and XPS measurements.  XPS 
data and preliminary couplings with model dyes confirm the presence of amine-
moieties, suggesting the possibility to functionalize the surface in the perspective 
of a possible future use in bioimaging. 
Finally, Chapter 6 gives a short overview on the basic principles of the main 
instrumental techniques used during the thesis work. 
 
In conclusion, this thesis shows that ultrasmall NPs, such as Si NPs, CQDs and 
Co@SiO2 NPs can be prepared, characterized and functionalized through stable 
covalent bonds with dyes or radiotracers to study the in vitro and in vivo 
behavior.  NPs present the properties expected and, when tested in vitro, they 
showed very low cytotoxicity. Promising in vivo results have been obtained since 
both Si NPs and CQDs were excreted from the body in short times (50 minutes). 
In addition, Si NPs, made by hydrothermal method, gave the best result since 
they showed a very good behavior in in vivo PET imaging, being completely 
excreted after 50 minutes from injection in the body and showing no 
accumulation in organs. Finally, Co@SiO2 NPs were successfully prepared and 
Co core 
CoO 
a 
b
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surface functionalized, and couplings with dyes indicate the availability of the 
amine moieties for possible further couplings.  
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Résumé 
Cette thèse est centrée sur la synthèse, la caractérisation, la fonctionnalisation et les études in vitro 
et in vivo de différents types de nanoparticules (NPs) de très petite taille (NPs de silicium ; « carbon 
dots » ; NPs de cobalt couvertes de silice) qui présentent une luminescence ou des propriétés 
magnétiques et qui peuvent être fonctionnalisées par des liaisons covalentes. Tous les systèmes 
étudiés sont très intéressants pour l'imagerie multimodale in vivo, ce qui nécessite l'ancrage stable 
de fonctionnalités multiples sur une seule plate-forme nanométrique. Dans cette perspective, les 
NPs ont été fonctionnalisées avec des groupements amine et, puis, couplées avec des colorants ou 
des marqueurs radioactifs afin d'effectuer, in vivo, de l’imagerie optique ou de tomographie 
d'émission des positrons. Lorsqu’elles sont étudiées in vitro, les NPs ont présenté une cytotoxicité 
très faible. Les expériences in vivo ont donné des résultats très prometteurs puisque les NPs ont été 
excrétées par le corps en très peu de temps, principalement par un mécanisme de clairance rénale, 
avec une faible accumulation dans les organes. 
Mots-clés : nanoparticules ultrapetites ; bioimagerie ; biocompatibilité ; photoluminescence  
 
Résumé en anglais 
This thesis focuses on the synthesis, characterization, functionalization and in vitro and in vivo 
investigation of different kinds of ultrasmall nanoparticles (silicon nanoparticles: Si NPs; carbon dots: 
CQDs; silica-coated cobalt NPs: Co@SiO2 NPs) which exhibit luminescence or magnetic properties 
and can be functionalized through covalent bonds. All the systems studied are very attractive for in 
vivo multimodal imaging, which requires the stable anchoring of multiple functionalities on a single 
nano-sized platform. In this perspective, nanoparticles were functionalized with amine-moieties and, 
subsequently, coupled with dyes or radiolabels in order to perform in vivo optical or positron 
emission tomography imaging. When tested in vitro, ultrasmall nanoparticles showed very low 
cytotoxicity. In vivo experiments gave very promising results since nanoparticles were excreted from 
the body in short times, mainly through a renal clearance mechanism, with low accumulation in 
organs.  
 
Keywords: ultrasmall nanoparticles; bioimaging; biocompatibility; photoluminescence  
